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Development of poly(3-hydroxybutyrate) (P(3HB))/bioactive glass 
composite system for biomedical applications 
A range of P(3HB)/bioactive glass composites were developed with Improved 
mechanical, structural, bactericidal and biological properties, as suitable 
candidates for applications in hard tissue regeneration. The key components of 
the composite were P(3HB) and bioactive glass (45S5 composition). The addition 
of multiwall carbon nanotubes (MWCNTs) and Vitamin E was shown to offer the 
possibility of developing multifunctional composites possessing antioxidative 
properties and exhibiting electrical properties for possible applications as 
bioactive scaffolds with sensing functions. 
P(3HB) was produced from a novel gram-positive micro-organism 
(Bacillus cereus SPV) using biotechnology routes based on a 14 L fermentation 
strategy. 45S5 Bioglass® (BG) particles of micrometer (<5 pm) and nanometer 
(<50 nm) sizes were added in different concentrations (5-30 wt%) to the P(3HB) 
matrix to prepare composites (films and foams) using the solvent 
casting/particulate leaching technique. Addition of nanosized bioactive glass 
particles increased the Young's modulus (up to 57%), enhanced the 
hydrophilicity (up to 58%), improved the total protein adsorption (up to 186%) and 
induced nanostructured topography on the surface of the composites. The in vitro 
degradation study in simulated body fluid (SBF) showed the P(3HB)/BG 
composites to be highly bioactive and to exhibit improved water absorption 
behaviour. Cytocompatibility studies using MG-63 human osteoblasts revealed 
the P(3HB)/BG composites to be a suitable substrate for cell attachment, 
proliferation and differentiation. Implanting P(3HB)/BG composites 
subcutaneously in rats (up to 2 weeks) provoked a foreign body and a non-toxic 
response. The presence of BG in the polymeric matrix also showed a strong 
antibacterial effect on the growth of S. aureus. 
Inclusion of Vitamin E i. e. a biological antioxidant, significantly improved 
the wettability (up to 22%), increased the total protein adsorption (up to 300%) 
and rendered the P(3HB)/BG composites suitable for cell growth. The presence 
of MWCNTs (2-7 wt%) induced electrical conductivity in the P(3HB)/BG 
composites without hindering the bioactivity. The presence of MWCNTs in 
P(3HBYBG composites in high concentration (>2 wt%) caused MG-63 osteoblast 
cell death, whereas in low concentrations MWCNTs increased the cell 
proliferation. Overall, the novel composites developed in this project represent a 
very attractive group of materials for bone tissue engineering applications. 
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grown on P(3HB)/n-BG samples. A significantly higher activity is 
measured on Day 14, with significantly higher ALP activity of cells 
on P(3HB)/n-BG samples than for the control surface. 
Figure 4.15 Osteocalcin (Gla-OC) content of culture' medium of MG-63 
osteoblasts grown on the P(3HB)/n-BG composites as a function 
of time. Measurements correspond to osteocalcin levels on Day 1, 
Day 7 and Day 14. 
Figure 4.16 Histological examination of P(3HB) films implanted 
subcutaneously in rats after 2 weeks. Figure (a) shows a bi- 
rifringent image using polarized light of the film (x200), with both 
sides attaching to the surrounding tissues. A high density of cells 
is evident from this image (b) Histological image showing the 
presence of a fibrous capsule surrounding the film and the 
adjacent muscles (x200). Figure (c) shows the presence of well- 
developed blood vessels were evident (marked by arrow) (x400). 
The results indicate a mild response, predominantly a foreign body 
response by the P(3HB) implant. In all the images, no penetration 
or growth of the cells through the substrate was observed 
considering that films were non-porous. 
Figure 4.17 SEM micrographs at different magnifications (a-c) showing the in 
vitro bioactivity of P(3HB)/10 wt% m-BG foams (e. g. formation of 
hydroxyapatite-marked by arrows) and, (d) EDX spectrum 
performed on the composite scaffolds. 
Figure 4.18 (a) Cell proliferation study using Alamar blue assay for P(3HB) and 
P(3HB)/m-BG composite scaffolds on day 1,4 and 7. SEM 
micrographs of MG-63 cells grown for 7 days, (b) P(3HB) foams 
(arrow marks the MG-63 cell layer) , (c) higher magnification image of (b) showing cell attachment and division, (d) P(3HB)/m- 
BG foams highlighting the spread of the cells and bridging the 
pores (image enhanced by artificial colours) and, (e) P(3HB) 
foams demonstrating the ability of the cells to bridge the pores and 
also to take up the contours of the substrate (marked by arrows). 
Figure 4.19 Digital image of (a) foams after 7 days subcutaneous implantation 
in rats SD. 7 Days haematoxylin/eosin stained sections showing 
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the biological response of (b) P(3HB) foams (x200), (c-d) P(3HB) 
foams (x100), and (e-f) P(3HB)/BG foams (x100). 
Figure 4.20 Colony forming unit (CFU) study of S. aureues when grown In PBS 
medium, for various foams samples and for n-BG samples 
suspended In PBS. Each point represents the loglo of the mean 
number of viable counts. 
Figure 4.21 SEM micrographs of S. aureus attachment after 48 h on (a, b, c, e) 
P(3HB) foams and (d, f) P(3HB)/n-BG composite foams. A 
decrease in S. aureus cells on the surface of the P(3HB)/10 wt% 
n-BG foams is evident in (d) and (f) In comparison to (c) and (e), 
respectively. 
Figure 4.22 Change in the pH of the medium over the 48 h period, due to the 
immersion of P(3HB) and P(3HB)/10 wt% n-BG foams. The 
medium used was phosphate buffer saline with a pH of 7.4 that 
remained unchanged over the period of study. 
Figure 5.1 Scanning electron micrographs of (a) P(3HBV0 wt% Vitamin E 
film surface and (b) P(3HB)/20 wt% Bioglass /10 wt% Vitamin E 
film surface. 
Figure 5.2 Water contact angle value as a measure of hydrophobicity for the 
Vitamin E loaded P(3HB) and P(3HB)/Bioglasso composite 
systems. 
Figure 5.3 Differences in total protein adsorption on the surface of P(3HB) 
and P(3HB)/Bioglasso films. The graph highlights the significant 
difference induced by addition of Vitamin E on protein adsorption. 
Figure 5.4 Cell proliferation study on (a) samples with and without Vitamin E, 
(b) all tested samples relative to the control (control set to 100%). 
Figure 5.5 SEM micrographs of MG-63 cells grown on (a) P(3HB)/10 wt% 
Vitamin E (b) P(3HB)/10 wt% Vitamin E/20 wt% Bioglass® 
specimens at day 7 highlighting spreading, attaching and division 
of MG-63 cells. Images of cell growth on P(3HB) and 
P(3HB)/Bioglass® have been shown in Chapter 4. 
Figure 5.6 Scanning electron micrographs of (a) P(3HB) film, (b) MWCNTs 
used in this study, (c) P(3HB)/4 wt% MWCNT, (d) P(3HB)/7 wt% 
MWCNT, (e) P(3HB)/20 wt% Bioýlass®/7 wt% MWCNT, (f) 
interaction of MWCNT and Bioglass particle for P(3HB)/20 wt% 
Bioglass®/7 wt% MWCNT, (g) cross section of P(3HB)/20 wt% 
Bioglass®/7 wt% MWCNT. 
Figure 5.7 2D and 3D surface roughness map by white light interferometry 
(Zygo®) for (a) Sample 3 and (b) Sample 6 
Figure 5.8 Stress-strain curves for samples 2,3 and 4 highlighting the change 
in the slope of the curves along with the tensile strength of the 
different samples detailed in Table 5.5. 
Figure 5.9 (a) Four-point current-voltage measurements on P(3HB) and 
P(3HB) based composites. (b) Graph showing the decrease in 
electrical resistance as a function of MWCNT content. 
Figure 5.10 Cell proliferation study for 1,4 and 7 days, using Alamar Blue 
assay on (a) P(3HB)/m-BG composites containing different 
concentrations of MWCNTs, (b) all tested samples relative to the 
control (control set to 100%). 
Figure 5.11 SEM micrographs highlighting the spreading, attaching, dividing 
and communicating of MG-63 osteoblasts on the substrates after 
Day 7 when grown on (a) Sample 1, (b) Sample 2, (c) Sample 3, 
(d) Sample 4, (e) Sample 5 and (f) Sample 6. For samples key, 
see Table 5.5 
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Figure 5.12 SEM micrographs of (a) sample 6 before immersion In SBF, arrow 
mark highlighting the Bioglasso particles and (b) showing the 
formation of a homogeneous hydroxyapatite layer on the surface 
of the composite after two months of immersion in SBF, (c) 
Sample 4 after 45 days in SBF with MWCNTs marked by arrow 
and (d) EDX spectrum of sample 6 after two months, confirming 
the presence of calcium and phosphorus rich layer on the surface. 
Figure 5.13 XRD patterns of (a) Sample 1 (b) Sample 6 (c) Sample 6 
immersed in SBF for two months, showing the emergence of 
hydroxyapatite peaks marked by the arrow and the hydroxyapatite 
markers (vertical lines) 
Figure 5.14 IN plot for (a) Sample 4 and (b) Sample 6 after immersion In SBF 
for 0,15 and 30 days, Indicating the change In the electrical 
conductivity of the composites. 
Figure 5.15 Change in the current-voltage plot over the 45-day period in SBF 
for (a) Sample 2 and (b) Sample 6. The changes in the slope of 
the IN plot for Sample 6 clearly denotes the change in the 
resistivity of the samples, in comparison to Sample 2, which 
remains unchanged over the 45-day period. The IN graph is an 
average of 18 measurements over triplicates per samples. 
Corresponding images of (c) Sample 2 and (d) Sample 6 showing 
the unchanged surface of Sample 2 and the development of 
hydroxyapatite layer on the surface of Sample 6. (d) Schematic 
diagram showing the enveloping of MWCNTs by growing 
hydroxyapatite layer. 
Figure 5.16 Total protein adsorption for P(3HB) and P(3HB)/Bioglass® foams, 
with and without addition of 10 wt% Vitamin E. 
Figure 5.17 SEM micrographs of P(3HB)/MWCNT foams highlighting (a) the 
microstructure, (b) agglomeration of MWCNTs, (c) polymeric 
phase and MWCNTs agglomeration, and (d) the reinforcement 
achieved by MWCNTs in the polymer. 
Figure 5.18 Graphical representation of the parameters affecting the desired 
concentration of MWCNTs in a polymer matrix system, and 
possible optimisation of MWCNT loading. 
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Introduction 
Tissue regeneration by employing scaffolds made of biomaterials is increasingly 
becoming a significant branch of tissue engineering. Over time, various types of 
polymeric systems have been used to prepare scaffolds. These polymeric scaffolds 
when combined with an inorganic bioactive ceramic phase (i. e. forming a composite) 
have shown valuable potential to be used for hard and soft tissue regeneration. The 
use of composites, instead of using polymer or ceramics on their own, allows the 
freedom of tailoring the properties of the composite and thus making the "composite 
scaffold" approach more versatile. Reconstitution of functional tissue is a complex 
process involving several cellular mechanisms viz. signaling, sensing and migration. 
Although in most cases the use of a scaffold is sufficient to support and help 
regeneration of damaged tissue, in certain cases scaffolds are combined with growth 
factors or functionalising agents that are aimed towards a desired cell response (e. g. 
use of bone morphogenic proteins, antibiotic drugs, etc. ). 
Tissues are multi-component and multi-functional, while in most cases current 
biomaterials are designed to replace only one predominant function. Therefore the 
requirements for optimal tissue engineering scaffolds can be multifaceted including 
being a drug delivery vehicle or a biosensor besides serving as a mechanical 
support and a temporary extra cellular matrix. Nowadays, the strategy to design 
"smart scaffolds" lies in their capacity to instruct biological entities to entirely 
regenerate tissues by including chemical and/or biochemical markers that encourage 
cell differentiation or colonisation. Therefore a developed biomaterial must satisfy the 
material biomimetism, biological biomimetism as well as functional biomimetism. In 
this context, composites developed for tissue engineering should exhibit the ability to 
deliver multi purpose features (drug delivery vehicle, sensory function, mechanical 
support, bioactivity, provide structural cues, etc. ). 
With this background in mind, this project was designed to conduct a series of 
experimental tasks using combinations of materials selected with the purpose to 
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build a technology platform to support the development of such "multifunctional 
scaffolds". The main aim of this project was therefore to prepare novel multi-phasic 
composite systems with enhanced properties for potential use In bone tissue 
engineering. The two main components of the composites developed were a 
microbial derived biodegradable polymer, i. e. poly(3-hydroxybutyrate), and a 
bioactive inorganic phase, i. e. 45S5 Bioglass®. The mechanical and structural 
properties, the in vitro behaviour, and biocompatibility (in vitro cell culture and in vivo 
studies) of the composites were systematically Investigated. Multifunctional 
composites were achieved by adding carbon nanotubes, Vitamin E or nanosized 
bioactive glass particles, which led to the improvement of various properties, 
including mechanical properties, cellular behaviour and electrical conductivity. 
Chapter 1 starts with a summary on the recent trends in the field of bone tissue 
regeneration focussing on the strategies based on composite scaffolds. It examines 
the current need for improved scaffolds and the requisites that guide the 
development of successful tissue-engineering composites for scaffold applications. A 
broad range of synthetic polymers as well as bioceramics used in developing 
biodegradable and bioactive composites have been discussed, with special 
emphasis on polyhydroxyalkanoates (PHAs) and bioactive glasses, which were the 
materials used for this project. 
In Chapter 2 the production and isolation of poly(3-hydroxybutyrate) (P(3HB)) from 
a novel gram-positive microorganism, Bacillus cereus SPV, are summarised. The 
experimental details mentioned in this chapter include fermentation strategy, 
different extraction techniques, and their effect on the material properties of the 
extracted P(3HB). 
The aim of the study described in Chapter 3 was to develop a method to prepare the 
P(3HB)/Bioglass® composites (2-D morphology films and 3-D scaffolds). A complete 
characterisation of the composites was carried out to understand the effect of 
addition of Bioglass® particles (0-30 wt%) on various properties of the composites. A 
comparative study of using micron sized and nano sized bioactive glass particles on 
the mechanical, structural and thermal properties of the composites was also 
examined. 
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Chapter 4 gives a further Insight Into the behaviour of the composites when 
immersed in simulated body fluid environment. The experimental methods were 
designed with the objective of evaluating the acellular bioactivity and degradability of 
the composites. This chapter also reports on the in vitro cell culture studies 
conducted on composites using MG-63 human osteoblast cell lines, by evaluating 
cell proliferation, alkaline phosphatase activity and levels of osteocalcin using 
various biological assays. This chapter also discusses the in vivo biocompatibility of 
the developed composites (films and scaffolds) over a 14 days period, using a rat 
model and the antimicrobial property of P(3HB)/Bioglass® foams on the growth of 
Staphylococcus aureues. 
Chapter 5, includes a detailed description on the effects of addition of Vitamin E and 
multiwalled carbon nanotubes (MWCNTs) to the base P(3HB)/Bioglass® composites. 
Vitamin E being a strong biological antioxidant was added to improve the 
biocompatibility of the composites aiming at enhancing the growth of osteoblasts. On 
the other hand MWCNTs were added to the P(3H B)/Biog lass' composites to impart 
a nanostructured topography as well as to incorporate electrical conductivity (which 
can then render scaffolds suitable for biological sensors). Experiments were 
conducted to investigate the changes in the surface and electrical properties of the 
composites due to the addition of vitamin E and MWCNTs, respectively. 
The final chapter (Chapter 6) of the thesis presents the main conclusions from the 
research conducted in this project and discusses the plausible future work that 
needs to be carried out in order to improve the employability of the composites for 
desired bone tissue regeneration applications. 
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1. Research background 
1.1 Tissue engineering 
Tissue-biomaterials interactions have been studied over time with different objectives 
(Bio-inertness-*Bioactivity-Regenerative functional tissues) (Rabkin E et al. 2002), 
reflecting the logical evolution of related disciplines, such as cell and molecular 
biology, materials science, engineering, which has led to increased understanding of 
the interactions of materials with the physiological environment (Hench LL et al. 
2002). Tissue engineering (TE) encompasses the use of degradable scaffold 
materials exhibiting adequate mechanical and biological properties to enable tissue 
regeneration by exploiting the body's inherent repair mechanism i. e. "a regenerative 
allograft" (Goldberg VM et al. 1987). Materials used for tissue regeneration also 
serve as an adhesive substrate (scaffold) for seeded cells during in vitro culture and 
subsequent implantation. TE being the major component of regenerative medicine 
includes the principles of cell transplantation, materials science, and engineering 
towards the development of biological substitutes that can restore and maintain 
normal tissue function (Gomes ME et al. 2004). The success of TE has seen it being 
used for developing skin equivalents for treating burns, to a pivotal technique for 
regenerating various tissue types such as, blood vessels, bones, cartilage and 
vascular grafts (Persidis A 1999). Due to the complex nature of the medical problems 
involved, TE is being pursued from several perspectives which are summarized 
below (Hubbell JA 2003). 
" Used as a quantitative scientific tool: to gain insight into cell biology and 
physiology e. g. biomechanics of cell adhesion and migration, differentiation of stem 
cells etc (Lauffenburger DA et aL 2001; Viswanathan S et al. 2003). 
" Recreating the function of organs: such as, reconstitution of the pancreatic islet of 
Langerhans for the treatment of type I diabetes, the development of cells for 
transplantation in the brain to treat neurodegenerative diseases such as Parkinson's 
disease (Kordower JH et al. 2000; Pericin M et a/. 2002). 
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" Reconstruction of tissues for structural application, in which tissue morphology is 
paramount viz. reconstruction of bone, cartilage, blood vessels, skin etc. (Nikiason 
LE of al. 1999; Oberpenning F et al. 1999; Ameer GA of al. 2002) 
Among the above-mentioned objectives, bone tissue repair or regeneration has been 
a common yet a complicated clinical problem in orthopaedic surgery and in the field 
of craniofacial tissue repair). Use of autogenic and allogenic bones for treating bone 
defects has been in place for a long period of time (Betz RR 2002). However, these 
methods of treating bone defects are complicated with issues such as immunological 
response and biocompatibility (Bonfiglio M et a/. 1972; Goldberg VM et al. 1987). 
Hence there is a pragmatic shift to regenerate or substitute damaged tissues through 
use of alternative tissue regeneration strategies, and this is a major focus in the field 
of bone tissue engineering (as reviewed in this thesis). 
1.1.1 Tissue regeneration 
The clinical need for tissue regeneration and articular repair has caused the field of 
tissue engineering of bone and cartilage to develop at a steep rate and it has 
progressed to become one of the most promising alternatives in the field of bone 
regeneration (Vacanti JP et al. 1999). Tissue engineering represents an alternative 
approach towards regeneration and repair of damaged tissues, avoiding the need for 
a permanent implant (Langer R et a/. 1993). 
Due to the medical and market potential, there is significant academic and corporate 
interest in the area of TE, and its financial investment continues apace. The organ 
and tissue transplantation market in the U. S. was estimated at $11.7 billion in 2005 
and is expected to rise at an average annual growth rate of 5.2% to $15.1 billion by 
2010. The U. S. tissue transplantation market totalled about $6.8 billion in 2005 and is 
projected to grow at an average annual growth rate of 5.5% 
(www. marketresearch. com; The Market for Organ and Tissue Transplantation and 
Alternatives" Business Communications Company Inc, October 1,2005 Pub ID: 
WA1188185). This demonstrates the sustained interest in this area, driven in part by 
positive results regarding specific products and processes in clinical settings. 
Technical advances in the various components of the industry have also shown to 
contribute towards the market growth (Persidis A 1999). 
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Tissue engineering, being a broad field has been considered for various applications 
in clinical and surgical field. However, the recent advances in the fields of stem cell 
research, genomics and materials technology has given TE a renewed impetus 
towards the specific goal of tissue regeneration (Gomes ME of a!. 2004). Tissue 
regeneration involves several steps starting from isolating the cells to a final in vivo 
implant, as summarised in Figure 1.1. Tissue regeneration typically employs 
exogenous three-dimensional extracellular matrix (ECM) in the form of scaffolds to 
engineer new natural tissues from isolated cells (Rosso F of a!. 2005). The cells can 
be seeded to the scaffold in vitro and then Implanted at the site, or alternatively the 
scaffold can be directly implanted at the site of defect and allowing the cells to grow 
through the scaffold. The former approach can therefore employ the advances of 
stem cell research and attracts much more attention. Along with providing temporary 
support (mimicking the ECM) for attachment, growth, proliferation and differentiation 
of cells, the scaffold should also maintain its mechanical strength and biological 
properties while providing a foundation upon which new tissue can be regenerated. 
Cells are expected to infiltrate the scaffold pore structure and to proliferate and 
differentiate therein, provided the scaffold is biologically compatible with the cells. 
Once new tissue has been regenerated, the scaffold should preferably have 
degraded completely as remaining scaffold material (debris) could cause a physical 
hindrance against effective tissue regeneration. Hence polymers used for tissue 
engineering scaffolds are generally preferred to be degradable. While the polymer 
matrix is degrading, it is vital that the degradation of the scaffold is tuned to retain 
sufficient mechanical integrity to support itself. 
The above-mentioned strategy works well in cases where the tissue around the 
defect has inherent potential for regeneration. However, in contrasting situations 
where tissue lacks regenerative ability, scaffolds have to be combined with relevant 
cells, usually also with growth factors, which have the potential to accelerate tissue 
regeneration. In such scenario combinations of scaffolds and drug delivery systems 
can be developed to create a suitable environment, which will have the additional 
function of minimising microbial infections and maximising tissue regeneration (Pitt 
CJ 1990; Gittens SA et al. 2001). 
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Figure 1.1 Various stages involved in the field of tissue regeneration (Gomes ME et al. 2004) 
1.1.2 Bone tissue engineering scaffolds 
Bone tissue regeneration is one of the areas within tissue regeneration that has 
gained considerable attention by the research community (Vacanti JP et al. 1999; 
Hench LL et al. 2002; Rose FRAJ et al. 2002). Critical size bone defects due to 
trauma or disease are very difficult to repair via the natural growth of host tissue. 
Therefore, there exists a need to fill these defects with a bridging (usually porous) 
material (termed scaffold), which should also, in combination with relevant cells and 
signalling molecules, promote the regeneration of new bone tissue. The biomaterials 
of choice for the development of bone tissue engineering scaffolds are those 
exhibiting bioactive properties (Hench LL et al. 2002). The definition of bioactivity of 
materials has different aspects, but in the context of the present project 'bioactivity' 
was referred to the ability of a material to form a biologically active hydroxyapatite 
layer on its surface upon immersion in physiological fluids. Bioactive materials react 
with physiological fluids and form tenacious bonds to bone through the biological 
interaction of collagen fibres with the material surface and thus they can transfer 
loads to and from living bone. Prominent bioactive materials are inorganic 
compounds such as bioceramics, including selected compositions of silicate glasses 
and glass-ceramics, as well as hydroxyapatite (HA) and related amorphous or 
crystalline calcium phosphates (Hench LL 1998b; Huang J et a/. 2008). 
Scaffolds are highly porous structures, which (Ma PX 2004; Chen QZ et al. 2006) 
serve as matrices to foster cell growth and provide mechanical support to the healing 
tissues (Peters MC et al. 1997; Sakiyama-Elbert SE et al. 2001). Tissue engineering 
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scaffolds therefore have a central role in the approaches of tissue engineering. 
Scaffolds can be broadly classified as conductive (create and maintain a space and 
provide a physical support that allows tissue regeneration), and Inductive (also used 
for drug/growth factor delivery to induce specific biological response) (Murphy WL et 
a/. 1999). Tissue engineering scaffolds can also function as vehicles for the 
transplantation of cells that can regenerate lost or diseased tissue. As mentioned 
above TE scaffolds must mimic the numerous functions of the natural extracellular 
matrix, including providing support for the adhesion and migration, and organizing 
cells into structures. Several fundamental scaffold design requirements have been 
identified and some of the basic requirements of a TE scaffold are summarized 
below. 
An ideal tissue scaffold (Murphy WL et al. 1999; Hutmacher DW 2000; Boccaccini 
AR et al. 2002): 
1) Must be made of a material which is non-immunogenic and biocompatible 
2) Degrades to non-toxic products, thus, has negligible toxicity and must not induce 
inflammation locally and systematically. 
3) Is chemically and mechanically stable while acting as a template for tissue growth 
in three dimensions. 
4) Must have mechanical properties sufficient to enable regeneration in load bearing 
positions. 
5) Must be processible into a variety of shapes for different sites of implantation 
enabling: 
a. Structural freedom (woven/non-woven mesh structure, sheets and arbitrary 
3D shapes) 
b. High interconnected porosity with controllable porosity and pore size for 
vascularisation, tissue growth and nutrient delivery 
6) Should have a suitable surface chemistry to promote cell attachment, proliferation 
and differentiation. 
7) Should promote angiogenesis 
8) Promotes favourable interactions/mobilization of host cells, having the ability to 
influence genes for efficient cell differentiation and proliferation. 
9) Allows the cells and ECM to interact with the support structure and bonds with 
the host tissue without formation of scar tissue 
10) Must have the ability to obtain the desired cellular response allowing the 
incorporation of biomolecules and growth factors. 
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Other properties required in tissue engineering scaffolds are stiffness matched to the 
host tissue and permeability so that the cells within the scaffold are not shielded from 
the mechanical stresses imposed on the tissue-scaffold construct, nor are excluded 
from the natural flow of cellular nutrients (Ramakrishna S et a/. 2001). Among various 
materials available polymers have the ability to fulfil most of the above-mentioned 
criteria and act as suitable scaffolding materials. Polymers used for preparation of 
scaffolds can be categorized as hydrophilic (collagen, poly(ethylene glycol)), or 
hydrophobic (polyhydroxyalkanoates, poly(lactide-co-glycolide)) and as natural or 
synthetic. Natural polymers are in general more intrinsically favourable due to their 
biocompatibility and favourable physiological functions, such as cell attachment, 
differentiation and chemotaxis. Whereas synthetic polymers provide a wider range of 
properties and greater versatility for designing reproducible tissue scaffolds with 
controlled microstructure, mechanical properties and degradation time (Yang S et al. 
2001; Griffith LG et a/. 2002). Some of the techniques used for preparing scaffolds 
are discussed in Section 1.3.1 along with their limitations and various relevant 
properties achievable. Since the requirements for optimal scaffolds are manifold 
(Hutmacher DW 2000), it is often considered that combination of degradable 
polymers and inorganic bioactive particles represents the best approach in terms of 
achievable mechanical and biological performance (Roether JA et al. 2002; Lu HH et 
al. 2003; Rezwan K et al. 2006). Not only the combination of the "right" biomaterials 
but also the structure and morphology of the scaffold, characterised by a highly 
interconnected, three dimensional (3D) pore network and tailored surface 
characteristics, determine the suitability of the scaffold for a given application. For 
bone tissue engineering, porosity of -90% and pore size >100 µm are desirable, 
along with high pore interconnectivity to facilitate attachment and proliferation of 
cells, in-growth of new tissue into the scaffold, and to enable mass transport of 
oxygen, nutrition and waste products (Hutmacher DW 2000; Ma PX 2004). 
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1.2 Overview of degradable polymers & bioactive 
ceramics 
1.2.1 Natural polymers 
Natural polymers can be classified as proteins (silk, collagen, gelatin, fibrinogen, 
elastin etc. ), polysaccharides (cellulose, amylose, dextran, chitin and 
glycosaminoglycans) or polynucleotides (DNA, RNA) (Yannas IV 2004). Natural 
polymers, due to their similar macromolecular structure to tissues, offer the 
convenience of recognition from the biological system, which in-effect avoids issues 
related to toxicity, inflammatory reaction and lack of recognition by cells, which are 
frequently provoked by many synthetic polymers (Yannas IV 2004). On the other 
hand, natural polymers are known to trigger occasional immunogenic responses and 
have inadequate mechanical properties for load-bearing applications (Yannas IV 
2004). Also because of natural polymers being structurally more complex than 
synthetic polymers, it is often complicated to identify the most suitable manufacturing 
techniques (solvent casting, compression moulding) to be used on them (Brown RA 
et al. 2005; Nazhat SN et al. 2007). The natural variability in the structure of the 
macromolecular substances further complicates the problem, as each of these 
polymers appears as a chemically distinct entity from one species (species 
specificity) to another and from one tissue to the following (tissue specificity) (Yannas 
IV 2004). Nevertheless, natural polymers due to their proven biocompatibility are 
being used for various biomedical applications such as cardiovascular applications, 
peripheral nerve regeneration, surgical sutures and drug delivery systems (Dang JM 
et al. 2006). In particular for bone tissue engineering applications, collagen gel is 
being increasingly considered (Brown RA et al. 2005; Kim HW et al. 2006; Sachlos E 
et al. 2006; Nazhat SN et al. 2007). 
1.2.2 Synthetic polymers 
Synthetic polymers represent the largest group of degradable polymers used in 
biomedical applications (Langer R et al. 2004). They exhibit in general predictable 
and reproducible mechanical and physical properties such as tensile strength, elastic 
modulus and degradation rate (Pachence JM et al. 2000; Gunatillake P et al. 2006). 
Possible risks such as toxicity, immunogenicity and favouring of infections can be 
reduced for synthetic polymers with constituent monomeric units having a well-known 
and simple structure. Moreover synthetic polymers provide the freedom to tailor the 
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material properties, including degradability, for specific applications. For example, 
degradable polymers have been used to repair nerves (Evans GRD of al. 1999), 
skin, vascular system (Sodian R of a/. 2000b) and bone (Kose GT et al. 2003). A 
large proportion of the currently investigated synthetic degradable polymers for tissue 
engineering scaffolds are polyesters (Boccaccini AR of al. 2005a; Rezwan K et a/. 
2006). Since tissue-engineering scaffolds do not have to be removed surgically once 
they are no longer needed; degradable polymers are of value in short term 
applications and can circumvent some of the problems related to the long-term safety 
of permanently implanted devices. However, because scaffold degradation products 
are released in the body, considerable attention is needed towards designing the 
composition of the scaffold (composite strategy, see below) and the testing for 
potential toxicity or inflammatory reactions as consequence of polymer degradation is 
of paramount importance. Some of the common synthetic polymers used in 
biomedical applications are listed in Table 1.1, where details of their potential 
application are given. A detailed description of polyhydroxyalkanoates (PHAs), which 
is the generic name of the polymeric family that includes poly(3-hydroxybutyrate), 
which is the polymer used in this project, is included in Section 1.4. 
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Chapter 1: Research background 
1.2.3 Bioactive ceramics 
Ceramics used in biomedical application i. e. bioceramics, are mostly of interest 
for the repair/enhancement of the skeletal system, comprising bone, joints and 
teeth, and they are to a lesser extent considered for soft tissue augmentation (El- 
Ghannam A 2005). According to the types of their interactions with host tissue, 
bioceramics can be categorised as being either bioinert (alumina, zirconia) (Marti 
A 2000) or bioactive (calcium phosphates, bioactive glasses and glass-ceramics). 
In addition, bioactive ceramics may be resorbable or non-resorbable, and all 
these may be manufactured either in porous or dense form, used as granules or 
coatings. Bioactive ceramics, such as hydroxyapatite (HA), tricalcium phosphate 
(TCP) and certain compositions of silicate and phosphate glasses (bioactive 
glasses) and glass-ceramics (such as apatite-wollastonite) react with 
physiological fluids and allow for bonding to hard (and in some cases soft) tissue 
(Hench LL 1998a; Hench LL 1998b). The most extensively used synthetic 
calcium phosphate ceramic for bone replacement is hydroxyapatite (HA) 
(Caio(PO4)6(OH)2) because of its chemical similarities to the inorganic component 
of bone and teeth (Hench LL et a/. 2004; Huang J et al. 2007). A description of 
some of the common bioceramics is presented in Table 1.2. Since for this project 
45S5 Bioglasso has been chosen as the bioactive inorganic phase, this material 
has been given focus in this section. 
Bioactive glasses are specially designed glasses consisting of CaO-Si02 glass 
with the addition of P205, Na20, B203 and/or CaF2 (Hench LL et al. 2004). A 
biologically active hydroxy-carbonate apatite (HCA) layer is formed on the 
surface of bioactive glasses when they are in. contact with physiologically relevant 
fluids (e. g. simulated body fluid) and when used in vivo. This HCA phase is 
chemically and structurally equivalent to the mineral phase present in bone, and 
provides a direct bonding to bone and bridging strongly host tissue with implants. 
Some specialised compositions of bioactive glasses (i. e. 45S5 Bioglass®) can 
bond to soft tissue as well as to bone, in either bulk or particulate form. 
As mentioned above, 45S5 Bioglass® is the first and most well studied 
composition developed by Hench et a!. (Hench LL et al. 1993) containing 45 wt% 
Si02,24.5 wt% Na20,24.4 wt% CaO and 6 wt% P2O5, which is also used in this 
present study. A characteristic of many bioactive materials is the formation of a 
biologically active hydroxyapatite surface layer in the presence of body fluids in 
vitro or in vivo (Hench LL et al. 1993). The materials with the highest levels of 
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bioactivity develop a silica gel layer that promotes HA formation. The level of 
bioactivity of a specific material can be related to the time taken for more than 
50% of the interface to bond to bone (to. 5bb), as shown in Equation (1.1) (Hench 
LL et al. 2004): 
Bioactivity index, IB = 1OO/tO. 5bb ------- (1.1) 
Materials having an IB value greater than 8 are classified as Class A biomaterials 
(e. g. 45S5 Bioglass®), and they bond to both soft and hard tissue. On the other 
hand, materials having an IB value between 0 and 8 are categorized as Class B 
biomaterials (e. g. hydroxyapatite) and bond only to hard tissue. Class A bioactive 
materials are also osteogenetic and osteoconductive while Class B bioactive 
materials exhibit only osteoconductivity (Hench LL et a!. 1993; Hench LL 1998a). 
A key factor determining the bioactivity of bioactive glasses is their ability to 
undergo surface dissolution to promote formation of hydroxyapatite. The 
structure of Bioglass® is regarded as a three dimensional Si02 network, modified 
by incorporation of other oxides (Hench LL et a!. 1993). Three key compositional 
features distinguish bioactive glasses from traditional soda-lime-silica glasses: (a) 
they contain less than 60 wt% of Si02, (b) they have high Na20 and CaO content 
and (c) they exhibit high CaO: P205 ratio (Hench LL et a!. 2004). These 
compositional features make the surface highly reactive when exposed to an 
aqueous medium and therefore leading to in vitro and in vivo bioactivity. 
The interfacial bond between bone and a biomaterial prevents motion between 
the two materials to occur and mimicking the type of interface that is formed 
when natural tissues repair themselves. This type of interface requires the 
material to have a controlled rate of chemical reactivity. An important 
characteristic of a bioactive interface is that it changes with time, as do natural 
tissues, which are in a state of dynamic equilibrium. The rate of tissue bonding 
depends on the rate of HCA formation. The formation of HCA on a biomaterial is 
caused by a sequence of reactions between the implanted material and the 
surrounding tissue. Broadly, three main processes occur during bonding of 
bioactive glass to bone, i. e. ion exchange, dissolution and precipitation, involving 
altogether 11 stages, and is discussed in Chapter 4 for the materials developed 
in this project. It has been also found that reactions on 45S5 Bioglass® surfaces 
release critical concentrations of soluble Si, Ca, P and Na ions, -which induce 
favourable intracellular and extracellular responses (Xynos ID et al. 2001). For 
14 
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example, a synchronised sequence of genes is activated in osteoblasts that 
undergo cell division and synthesise an extracellular matrix, which mineralises to 
become bone (Xynos ID et al. 2001). In addition, bioactive glass compositions 
doped with AgO2 have been shown to elicit anti-bactericidal properties while 
maintaining their bioactive function (Bellantone M et a/. 2002). More recently, 
45S5 Bioglass® has also been shown to increase secretion of vascular 
endothelial growth factor (VEGF) in vitro and to enhance vascularisation in vivo, 
suggesting scaffolds containing controlled concentrations of Bioglass® might 
stimulate neo-vascularisation which is beneficial to large tissue engineered 
constructs (Day RM et aL 2004). 
The excellent properties of bioactive glasses and their long history of applications 
in biomedical implants (Jones JR et al. 2001) has prompted extensive research 
regarding their use in bone tissue engineering and regeneration strategies, 
mainly in the form of powder aggregates, porous substrates (foam, scaffolds) 
(Chen QZ et a/. 2006) and also as a particulate addition (as filler or coating) to 
degradable polymers (Roether JA et al. 2002; Lu HH et al. 2003; Maquet V et a/. 
2004). 
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Chapter 1: Research background 
1.3 Composite material approach 
For a material to be used in bone tissue engineering it is necessary to exhibit 
matching mechanical properties to those of bone. Bioactive ceramics suffer from 
low fracture toughness (I. e. brittleness) and due to their relatively high stiffness 
they pose the problem of stress shielding effect. Similarly, the lack of 
mechanical strength of polymers is an impediment towards their use in load 
bearing applications. Moreover, polymers can be easily fabricated to form 
complex shapes and structures yet, in general, they lack a bioactive function 
(e. g. strong bonding to bone), being too flexible and weak to meet the 
mechanical demands in surgery and in the physiological environment. 
Therefore, combinations of stable (poly(methyl methacrylate), polyethylene) 
(Bonfield W et al. 1981; Ramakrishna S of al. 2001; Juhasz JA of al. 2004) or 
degradable polymers (Rezwan K et al. 2006) with bioactive ceramics have been 
proposed for use in hard tissue applications. However, besides the 
consideration of the material weakness in polymers and ceramics, there is also 
another significant drive towards the use of the composite strategy, which is the 
possibility of mimicking or approaching the microstructure of bone itself. Bone 
can be treated as a hard and lightweight composite material, formed mostly 
(70%) of calcium phosphate (providing suitable rigidity and compressive 
strength), collagen (providing toughness, elasticity and resistance to crack 
propagation) and embedded with living cells, as shown in Figure 1.2. The 
inorganic phase is mainly crystalline hydroxyapatite and the organic part of the 
matrix is predominantly Type 1 collagen. There are therefore several reasons for 
the combination of degradable polymers and bioactive ceramics for tissue 
engineering applications, which are summarised as follows. 
" The combination of polymers and bioceramics leads to improvement in 
mechanical properties due to the inherent higher stiffness and strength of the 
inorganic material (Blaker JJ et al. 2005; Pramanik N at al. 2006). 
" Addition of bioceramics to degradable polymers can alter the polymer 
degradation behaviour, by buffering the pH of the nearby solution as well as 
contributing to the water absorption capability of the composites (Li H et al. 
2005a; Li H et al. 2005b). 
" The incorporation of a bioactive inorganic phase such as hydroxyapatite, 
Bioglass® or tricalcium phosphate allows the composite to interact with the 
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surrounding bone tissue by forming a tenacious bond via the growth of a 
carbonate hydroxyapatite layer (i. e. bioactivity, as mentioned above). 
" The presence of bioactive inorganic phases also helps to alter the surface 
characteristics of the composites. Addition of ceramics induces a surface 
roughness (micro or nano topography) on the composite, which changes the 
wettability, affecting the adsorption of proteins and consequently having an 
effect on cell growth (Wei G et al. 2004). 
In many cases composites have been shown to provide the necessary support 
for cell attachment and proliferation as well as augmenting the tissue capacity to 
regenerate. Moreover the development of composite materials for tissue 
engineering is attractive because it is possible in principle to engineer their 
properties (examples shown in Table 1.3) to suit the mechanical and 
physiological demands of the host tissue by controlling the volume fraction, 
morphology and arrangement of the reinforcing phase. The broad field of 
composite materials can be applied in this regard using microstructure-property 
correlations. 
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The Composites classification can be based on the matrix materials (metals, 
ceramics or polymers) or on the reinforcement morphology 
(microscale/nanoscale particulates, long/short fibres). It has been shown that 
increased volume fraction and higher surface area to volume ratio of inclusions 
favour bioactivity (Brunner TJ et a/. 2006; Loher S et al. 2006). Therefore for 
certain applications incorporation of fibres is preferred instead of particles (Kim 
HW et al. 2006). In addition, the reinforcement shape, size and distribution in the 
polymeric matrix strongly influence the mechanical properties. In particular, the 
size of the filler particles is an important parameter that affects the mechanical 
properties of composites due to marked microstructural differences that 
contribute towards the enhanced reinforcement-matrix interfacial bonding. For 
example, the larger specific surface area of nanoparticles when used as fillers 
should lead to enhanced strengthening effect. Moreover, nanoscale particles 
should lead to increased bioactivity, when compared to traditional micron-sized 
inclusions due to their larger specific surface area. Additionally, the use of 
nanoparticles in a polymeric matrix mimics the structure of natural bone, which 
contains nano-sized hydroxyapatite crystallites combined with collagen (Su X et 
a/. 2003). Stronger composite scaffolds might be achievable by increasing the 
organic/inorganic interfacial bonding by using surface functionalized particles 
(Sousa RA et al. 2003; Franco PJH et al. 2004). 
The inclusion of nanoparticles into the polymeric matrix with the objective of 
improving the mechanical properties as well as of incorporating nano- 
topographic features that mimic the nanostructure of natural bone is currently 
under intensive research (Hansen JC et al. 2007; Liu H et al. 2007; Liu Y et a/. 
2007; Torres FG et al. 2007). In addition, the tailoring of roughness and 
topography of the pore surfaces is being explored due to the profound effect that 
surface roughness has on early cell attachment behaviour as well as possibly on 
subsequent cell adhesion, cytoskeletal organization and gene expression (Berry 
CC et al. 2006; Dalby MJ et al. 2006). It is now accepted that the response of 
host tissue at the protein and cellular level to nanostructured surfaces is different 
than that observed to conventional (µm-size) surfaces (Liu H et al. 2007). 
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1.3.1 Scaffold processing strategies 
An ideal scaffold, apart from the characteristics mentioned in Section 1.1.2, must 
have optimal micro-architecture (e. g., pore size, shape and specific surface 
area) for diffusion of nutrients, clearance of wastes, adequate mechanical 
stability and for rapid cell growth. Porosity plays an important role in determining 
the characteristics of a scaffold, as it affects the mechanical properties 
(generally porosity has an inverse relation with the mechanical strength and 
stiffness). Average pore size, pore size distribution, pore volume, pore 
interconnectivity and pore shape are important parameters to consider while 
designing a scaffold. A minimum pore size (Table 1.4) is required for tissue in- 
growth and high 3-D interconnectivity is necessary for better cell spreading and 
vascularisation (Hutmacher DW 2000; Yang S et al. 2001). It is thus very 
important to quantify and optimise the porosity and to understand the 
relationship between scaffold properties (mechanical properties, permeability) 
and pore structure (Jones JR et al. 2007). 
Table 1.4 Optimal pore sizes for bone regeneration (adapted from (Yang S et at. 2001)). 
Studies conducted using ceramics (Klawitter et al 1971) and polymers (Whang eta!. 1999) 
Pore size (pm) Porosity 
(%) 
Mineralized tissue in-growth/comments 
2-6 - 33.5 No tissue in-growth 
15-40 46.2 No bone in-growth, fibrous tissue in-growth 
30-100 (80% pores <100) 46.9 50 pm of bone in-growth, osteoid and fibrous tissue in- 
growth 
. 50-100 (63% pores <100) 46.9 20 pm of bone in-growth by 11 weeks and 500 µm of in 
growth by 22 weeks, osteoid and fibrous tissue in growth 
60-100 (37% pores <100) 48 600 pm of bone in-growth by 11 weeks and 1,500 µm of 
in growth by 22 weeks, osteoid and fibrous tissue in- 
s100 35.3 growth 
5200 51 Not statistically different from untreated controls 
5350 73.9 Not statistically different from untreated controls 
Statistically significant more bone than all other group 
It is recognised that pore structure and therefore properties of scaffolds are 
dictated by the choice of the manufacturing process. From the materials science 
perspective, the present challenge in tissue engineering is to design and 
fabricate reproducible bioactive and bioresorbable 3-D scaffolds of tailored 
porosity and pore structure, which are able to maintain their structure and 
integrity for predictable times, even under load-bearing conditions. The range of 
scaffold manufacturing techniques developed in recent years is immense, 
covering distinct methods such as the use of porogens, chemical segregation 
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and rapid prototyping (Hutmacher DW 2000; Yang S et al. 2001; Liu X at a!. 
2004; Weigel T et a!. 2006). Although each of these techniques has the ability to 
produce scaffolds with suitable pore architecture (as shown in Figure 1.3), they 
also have certain limitations as listed in Table 1.5. 
It is interesting to note that although numerous techniques are available for 
scaffold preparation; only few of these techniques have been employed for 
polyhydroxyalkanoates (PHA), the polymers of interest in this project. Among 
them, solvent casting and particulate leaching techniques have been extensively 
used for films and scaffold preparation (LI J et a/. 2005; Zheng Y et al. 2007). 
Wang et al. (Wang Z et al. 2006) demonstrated that PHA microstructures can be 
produced using soft lithographic methods (micromoulding and hot embossing), 
for hosting and culturing cells in a local microenvironment of controlled 
morphology. Ultra fine PHA fiber (0 2.3-3.7 pm) mats have been prepared using 
electrospinning technique (Suwantong 0 et a/. 2007) and have been shown to 
exhibit a lower modulus than solvent cast films showing also superior 
biocompatibility for fibroblasts attachment. Similarly, PHA/hydroxyapatite 
composite nanofibrous films were prepared using electrospinning (Ito Y et al. 
2005). A graded porous PHA scaffold has also been prepared using an 
emulsion technique (Cai Z et a/. 2003) wherein, porosity greater than 90% and 
macropores and micropores ranging from 5-30 pm to 100-500 nm, respectively, 
were achieved. In earlier investigations, compression moulding and injection 
moulding have been used to prepare non-porous PHA as well as 
PHA/hydroxyapatite composite samples (Knowles JC et al. 1992b). 
Combination of particulate leaching and compression moulding has shown that 
the porosity of the scaffolds can be tailored and therefore a range of mechanical 
properties is achievable (Chen LJ et al. 2002; Li H et al. 2004) 
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Fiore 1.3 SEM micrographs of scaffolds prepared using (a) particulate leaching of PLLA 
foams with paraffin spheres (Ma PX et al. 2001), (b) thermally induced phase separation of 
PDLLA foam (Blaker JJ et al. 2005), (c) liquid-liquid phase separation of PLLA fibers (Ma PX et al. 
1999), (d) emulsion freeze drying of agarose/PLLA (Moscato S 2006), (e) Electrophoretic 
deposition of PDLLA/Bioglass® foams (Roether JA et al. 2002) and (f) PLGA scaffolds prepared 
using rapid prototyping (Yong Y et al. 2005). 
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Chapter 1: Research background 
1.4 Polyhdroxyalkanoates (PHA) 
Polymers from the poly(a-hydroxy acid) family such as PLLA and PGA have been 
extensively investigated to develop tissue engineering scaffolds as 
comprehensively discussed in the literature (Rezwan K et al. 2006). However, 
recently (since 1980s)' members of the poly (ß-hydroxyalkanoate) family (Table 
1.6) have emerged as promising alternative biopolymer for biomedical 
applications. 
Table 1.6 Classification of aliphatic polyesters on the basis of their chemical structure 
Chemical structure Examples 
-}-o-CH C l: 
Poly(a-hydroxy acid) 
PGA 
PLLA 
RO 
ýOC i 
CH2 C 
I 
Poly(ß-hydroxyaikanoate) 
O 
I 
O_ CH -I 
Y Polv(o -hvdroxvbutvrate) 
P(3HB) 
P(3HB-co-3HV) 
PPL 
PCL 
PES 
0 Poly(butylenes succinate) 11 II Poly(butylene succinate-co-butylene 4mn 
o- CH 0-C-(CH C adipate) 
x 
Poly(alkylene dicarboxylate) 
PHAs are naturally occurring degradable polymers produced by many type of 
microorganisms (Section 1.4.2). More than 100 different types of PHAs with 
different chemical structures have been reported (Steinbüchel A 2001). Members 
of the PHA family can exist as homopolymers of hydroxyalkanoic acids, as well 
as copolymers of two or more hydroxyalkanoic acids. The monomer 
compositions of PHAs are variable and they can be manipulated by means of the 
substrate used and the growth conditions (Section 1.4.3). Depending on the 
number of carbon atoms (C-atoms) of the monomers, PHAs are classified as 
'A general search using Polyhydroxyalkanoates as the keyword in "Web of Science" in 
the period 1980-1989 resulted in 23 hits, whereas for 1990-1999 gave 278 and in 2000- 
07 provided 603 results. 
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short-chain-length PHA (scl-PHA, 3 to 5 C-atoms), medium-chain-length PHA 
(mcl-PHA. 6-14 C-atoms) and long-chain-length PHA (Icl-PHA, >C14), as shown 
in Figure 1.4 (Steinbüchel A et al. 1995; Lee SY 1996a; Lee SY 1996b; Doi Y et 
a/. 2002). 
Functional Group Polymer PHA 
(R) classification 
Hydrogen (H) 3-hydroxypropionate 
Methyl (CH3) 3-hydroxybutyrate scl-PHA 
Ro Ethyl (C2H5) 3-hydroxyvalerate 
o-c 
i 
-cH2-ll 4n Propyl (C3H7) 3-hydroxyhexanoate 
Butyl (Calls) 3-hydroxyheptanoate 
Pentyl (C5H) 3-hydroxyoctanoate 
Hexyl (C6H13) 3-hydroxynanoate mcl-PHA n=100 - 300000 Heptyl (C, H, 5) 3-hydroxydecanoate 
Octyl (C8H) 3-hydroxyundecanoate 
Nonyl (C9H, s) 3-hydroxydodecanoate 
Figure 1.4 Chemical structure of generic PHA and its classification as scl-PHA and mcl-PHA 
Further discoveries and availability of new polymers within the PHA family are 
resulting in new PHAs with a wide range of chemical structures and an 
assortment of properties. In the case of copolymers, the systematic change of 
physical properties due to different co-monomer compositions adds another 
dimension to the variability among the PHA family (Doi Y et al. 2002; Chen GQ et 
a/. 2005). The different chemical structure not only affects the properties 
(mechanical, thermal, structural) of the polymers but also changes the mode/rate 
of their degradation in aqueous or biological medium (Section 1.4.4 and 1.4.5). 
1.4.1 Historical outline 
The first and the most common representative of the PHA family, poly(3- 
hydroxybutyrate) (P(3HB)), was isolated from Bacillus megaterium in 1926 and 
characterised for the first time by Lemoigne at The Pasteur Institute (Paris, 
France) (Lemoigne M 1926). Since its discovery, various microorganisms have 
been used to produce P(3HB). One of the shortcomings of Lemoigne's method 
was the low yield (<44% dry cell weight), which was enhanced years later by 
using a spectrophotometric method (Williamson DH et a/. 1958). Since the 
discovery of P(3HB), effort has been made towards increasing the percentage of 
P(3HB) content in the bacterial cells. As an example, under fermentation 
controlled techniques, P(3HB) yields up to 80% of dry cell mass have been 
reported (Ward AC et al. 1977). Subsequent investigations have been carried out 
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to extract the polymer from microorganisms in the most efficient way (Jacquel N 
at al. 2008). The first attempts towards commercial production of P(3HB) was 
made by Baptist and Werber at W. R. Grace & Co. (USA) in the 1960s, which also 
earned them patents to produce prosthetic devices and sutures. Until 1974, 
P(3HB) was thought to be the only microbial polymer making up the PHA family. 
This idea was challenged by Wallen and Rodwedder, on their discovery of more 
complex polyesters (3-hydroxybutyric acid, 3-hydroxyvaleric acid and traces of 3- 
hydroxyhexanoic acid) (Wallen LL at al. 1974). This finding had a major impact 
on research and leading also to major commercial interests associated with the 
production and development of this microbial polyester. ICI (Imperial Chemical 
Industries, UK) started worldwide commercialization of a family of Poly(3- 
hydroxybutyrate-co-3-hydroxyvalerate) (P(3HB-co-3HV)) copolymers with the 
trade name Biopol® in the early-1980s. Presently P(3HB) and P(3HB-co-3HV) 
with different mol% of HV are available in the market. Tepha Inc., (USA) is 
focusing on commercialising products made of poly(4-hydroxybutyrate) (P(4HB)). 
Similarly, a joint program by Procter & Gamble Co. and Kaneka Corp. (Japan) is 
aiming towards commercialisation and large scale production of scl-mcl PHAs 
(known as Noda)TM), such as poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) 
(Noda I et al. 2005). Key milestones related to PHA development (not covering 
the molecular and genetical aspect) since their discovery in 1926 along with the 
major countries involved in PHA research & development are shown in Figure 
1.5. 
1920-1960 1960-1980 
" Identification & estimation of " Use of plasticizers to improve the 
P(3HB) in low quantities (<30% :: "". mechanical properties of P(3HB) . dcw) ""ý ý ''ý; ".; " 
Increasing the polymer yield up to 90% 
" Determination of the function and ::.. ""''" dry cell weight 
properties of P(3HB) and P(3HB) : ý""""""""""""""""""; ; """"""""""""""""""' 
granules in microbial cells 
....  ..... 0 ...................... . 1980-2000 
2000-present : : :" Production of PHAs containing 3-, 4-, 5- 
" " PHA production in recombinant hydroxyalkanoate units 
bacteria and plants ." "' Industrial production & 
" " Large scale production and "" commercialisation of PHAs 
commercialisation of Nodax® ; '"" . : ': " Identification of 3HHx, 3H0 in PHA : " 
" Launch of medical products '" family; production of terpolymers 
based on P(4H6) by Tepha Inc. ;" Focus on biomedical applications of 
PHAs and PHA/BIP composites for TE 
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T--/ 
."4 
ýr 
w 
ýý 
r 
Figure 1.5 Major advances towards development of PHA since its discovery by Lemoigne 
and countries actively participating in PHA research (red denotes research mainly towards PHA 
synthesis; blue denotes research focussing on the application of PHAs) 
1.4.2 Occurrence and extraction of PHAs 
PHAs are produced biosynthetically from various microorganisms (Table 1.7), 
wherein they are essentially reserve polymers and act as storage compounds of 
carbon and energy, which is accumulated by the microorganisms during 
imbalanced growth conditions (nutrient limiting medium containing excess 
glucose) (Anderson AJ et al. 1990). Surprisingly, efforts are also being made to 
produce PHAs from transgenic plants and genetically engineered plants at a 
reduced cost (Pouton CW et al. 1996; Snell KD et al. 2002). There are more than 
300 different organisms reported to synthesize PHAs, but only few have been 
employed for PHA production because of their ability to be cultivated efficiently to 
high cell densities with a high PHA content in a relatively short period of time 
(Lee SY et al. 1998). The percentage of P(3HB) in bacterial cells is normally low 
(1-30%), but under controlled fermentation conditions of excess carbon and 
limiting nitrogen, high yield (80%) of P(3HB) can be obtained. Various nutrient- 
limiting media have been used to produce PHAs, as shown in Table 1.7. These 
accumulated reserve polymers when needed are readily broken down 
intracellularly (Section 1.4.5) by the microorganism and used for energy or 
biosynthesis. Thus, all naturally produced PHAs are inherently degradable as 
they can be depolymerised and used by the bacteria that produces them. For 
example, P(3HB) is synthesised by R. eutrophus under various nutrient limiting 
conditions (nitrogen, oxygen and phosphorous) (Anderson AJ et al. 1990) and 
the reutilisation of P(3HB) proceeds within A. eutrophus by hydrolase enzymes 
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which depolymerise the polymer to initially its oligomeric and eventually its 
monomeric constituents (Handrick R et al. 2000; Jendrossek D et al. 2002). 
PHAs are stored as inclusion bodies within the cell cytoplasm, as shown in 
Figure 1.6. These inclusions contain polyester, water and fatty acids which help 
prevent crystallization of the PHA inside the cell, proteins which appear to 
function as scaffolding materials, enzymes for synthesizing the PHA, and 
depolymerases for breaking it down into monomers (Rehm BHA 2003). A cell 
may contain several such inclusions (Anderson AJ et al. 1990). P(3HB) 
constitutes 97-98% of dry cell weight of the granule, the remainder being 
composed of protein (2%) and lipid (0.5%) (Lundgren DG et al. 1964). The 
amount of PHA stored in a cell varies and can range from 10 to 90 % dry cell 
weight (dcw). 
op " ýN 0% 
'K 
8. %%b, 4 
f' 
a 
A 
e ý0 
0s- CO P 
" a. % 
Figure 1.6 (a) Phase contrast light microscopy of recombinant R. eutropha cells, PHA 
inclusions appear as light retractile inclusion bodies in the cell cytoplasm. (b) TEM image of PHA 
granules in bacterial cells, marked by arrow (Sudesh K et al. 2004). 
Either a water-based separation or solvent-based extraction can be used for 
isolating PHA from the bacterial cells. Techniques such as enzymatic (Schumann 
D et al. 2006), physical (Holmes PA et al. 1990), supercritical extraction (Hejazi P 
et al. 2003) and hypochlorite treatment (Ramsay JA et al. 1990) have been 
reported. Mild polar components like acetone and alcohols break down the non- 
polymer cell material (nucleic acids, lipids and phospholipids, peptidoglycan and 
proteinaceous materials) leaving PHA granules intact, although some mcl-PHAs 
are soluble in acetone. In contrast, chloroform and other chlorinated 
hydrocarbons dissolve all PHAs. Differential digestion of non-polymer cell 
material can also be achieved with alkaline solutions of sodium hypochlorite. 
However, this method is shown to damage the polymer by a loss in the molecular 
mass of the polymer and is restricted to small-scale extraction. Nevertheless, 
optimization of the separation conditions (pH, temperature, duration) can reduce 
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the degradation and improve the degree of purity of the final product (Ramsay JA 
et al. 1990). Therefore combinations of lipid extraction and polymer dissolution 
are used in conjunction with each other. The dissolved polymer is then 
precipitated in alcohol (methanol, ethanol). The purity of the polymer can be 
increased by pre-treating the dried cell mass with non-PHA dissolving solvents 
and also by re-precipitation of the polymer solution. Among all the extraction 
techniques employed, one common aspect is their inability to retain the 
amorphicity of the PHAs and a reduction in the molecular weight of the extracted 
polymer (Section 1.4.5). 
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1.4.3 Chemical structure of PHAs 
In the case of PHAs, the monomers can be 3,4 or 5-hydroxyalkanoates'. 
Although P(3HB) is the most widely reported polymer, there are more than 100 
polymers in the PHA family. However, only few of them have been completely 
identified, and this is predominantly because of the small-scale production of 
other PHAs. To date, PHA monomers with straight, branched, saturated, 
unsaturated and also aromatic monomers have been discovered (Steinbüchel A 
et a!. 1995; Braunegg G et a!. 1998). Even functionalised groups in the side 
chain that allow further chemical modification e. g. halogens, carboxyl, hydroxyl, 
methyl esters etc. have been reported (Kessler B et a!. 2001; Kim YB et a!. 
2001). The length of the side chain and the presence of the functional group on 
the side chain will in retrospect affect the properties of the polymer (thermal, 
mechanical, structural, molecular). 
Most of the production of polymers within the PHA family is triggered by feeding 
precursor substrates that exhibit structures related to the constituents (for 
example, by feeding 4hydroxybutyric acid we get P(3HB-co-4HB), for more 
examples refer to Table 1.7) (Zinn M et a/. 2001). This is because the chemical 
structure of biosynthetic PHA depends on the substrate specificity of PHA 
synthase (an enzyme that catalyses the production of PHA). The PHA 
synthases of bacteria can be classified for production of scl-PHAs or/and mcI- 
PHAs (Yoshie N et a/. 2002), for example, the PHA synthase of R. Eutropha 
incorporates scl-hydroxyalkanoic acids (3HB, 3HV, 4HV, 5HV etc. ), whereas the 
substrate specificity of Pseudomonas oleovorans synthases is rather broad, 
polymerising mcl-hydroxyalkanoic acids (Braunegg G et al. 1998). 
* Polyhydroxyalkanoates are fatty acids i. e. linear molecule of carbon and hydrogen, with 
carboxyl group at the end. These monomers have a hydroxyl group at the 3rd carbon (ß 
position). The hydroxyl group of one monomer is attached to the carboxyl group of 
another by an ester bond. 
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CH3 
II 
0 
O--CH-CH: -C 
0 
I) 
o-c -c -CH2-c 
(b) " 
CH3 
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CH2 
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-II0 
1 ýO-CH-CH=C + 
(c) " 
O1_+_citi_] C 0-cFt-a42-a+2-c 
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CH3 
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' 4O_cLcH2J] [O_OHa_Lf 
(e) 
Figure 1.7 Chemical structures of some of the common co-polymers of PHA family; (a) 
P(3HB), (b) P(4HB), (c) P(3HHx), (d) P(3HB-co-4HB) and (e) P(3HB-co-3HV). (n=100-30000) 
Bacterial PHAs are usually a P(3HB) homopolymer or a copolymer consisting of 
two or more hydroxyalkanoate units (examples mentioned in Section 1.4.4). 
However, there are also reports of having 3 or more constituents within a PHA 
chain (Noda I et a/. 2005). It has been shown that the monomeric composition of 
the PHA within the cells can be regulated by the supply of specific fatty acids. 
For example, the mol% of 4HB units in P(3HB-co-4HB) can be changed by 
altering the concentration of 4hydroxybutyric acid in the production medium 
(Saito Y at al. 1996). A very common aspect similar to copolymers involving scl 
and mcl-PHA such as P(3HB-co-3HHx) and P(3HB-co-3H0) is that they are 
random copolymers. The changes in the chemical structure (some common 
chemical structures shown in Figure 1.7) arise either from the length of the 
pendant groups, which extend from the polymer backbones or from the distance 
between the ester linkages in the polymer backbones, which causes a disparity 
in the properties of various PHAs. Due to the variable composition of PHAs, 
materials made of them can have very different physicochemical properties, 
wide range of mechanical properties and degradation rates. 
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1.4.4 Properties of Various PHAs 
Despite the large group of PHA available only some of them have been fully 
characterised for use in the biomedical field. Among these polymers, P(3HB) 
has led and paved the way for other PHAs such as P(3HB-co-3HV), P(4HB) and 
P(3HB-co-3HV-3HHx) to be used for biomedical applications (Williams SF et al. 
1999; Chen GQ et al. 2005; Valappil SP et a/. 2006). The below mentioned 
section highlights the properties of some common PHAs that are reported for 
use in biomedical applications, and cements the fact that the physical and 
mechanical properties of co-polymers can be changed extensively by altering 
the concentration of the monomers. 
1.4.4.1 PoIy(3-hydroxybutyrate) P(3HB): P(3HB) can be extracted from 
bacteria with a high degree of purity without any inclusion of catalyst residues, 
and as a stereo-regular and isotactic polyester. In addition to its biocompatibility 
and biodegradability, P(3HB) has also been reported to show piezoelectric 
properties (Fukada E et al. 1986; Fukada E et al. 1988; Knowles JC et al. 1991), 
which can stimulate bone growth and healing. P(3HB), with its short methyl side 
chain is highly crystalline and a relatively stiff, rigid material exhibiting tensile 
strength comparable to polypropylene (Williams SF et al. 1999; Martin DP et al. 
2003). P(3HB), being a natural thermoplastic polyester, it has mechanical 
properties comparable to synthetically produced degradable polyesters such as 
the polylactides (Engelberg I et a/. 1991). P(3HB) has an orthorhombic unit cell 
and P(3HB) crystals usually show a lamellar morphology and form spherulites 
when crystallized from the melt into bulk materials. It is known that P(3HB) 
undergoes degradation through random chain scission reaction. Biodegradation 
of P(3HB) occurs through hydrolysis of ester linkages (Freier T et al. 2002a; 
Freier T et a/. 2002b). Composites of P(3HB) with various bioactive ceramics 
have been prepared for hard tissue applications (as reviewed in Section 1.5). In 
tandem with composites various attempts have been made to form blends using 
members of the PHA family, poly(e-caprolactone) (Kumagai Y et al. 1992a), PLA 
(Ferreira BMP et al. 2001) poly(vinyl acetate) and poly(ethylene oxide) (You JW 
et al. 2003) Reports have also shown that the mechanical properties of P(3HB) 
films can be improved by the addition of plasticizers (El-Hadi A et al. 2002). The 
properties of P(3HB) can vary in-between samples due to different organisms 
used for production, different extraction techniques employed and also due to 
different sample preparation methods used. As a result the properties of P(3HB) 
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quoted in the literature vary to some extent. The differences in the measured 
properties (e. g. crystallinity, thermal and mechanical properties) of the polymer 
can be ultimately attributed to the variations in the molecular weights of the 
extracted polymers (Anderson AJ et al. 1990; Sudesh K et al. 2000). For 
example, the monomers of P(3HB) are polymerised into high molecular weight 
polymers in the range of 200,000 to 3,000,000 Da (Byrom D 1994) but number- 
average molecular weight as high as 20 MDa (Kusaka S et al. 1997) and as low 
as 13,000 Da (Reusch RN et a/. 1988) have been reported. Typical properties of 
P(3HB) are summarised in Table 1.8. 
Table 1.8 Various properties of P(3HB) as reported in literature. Several reports have 
shown the extreme values of the measurements; hence a range has been quoted rather than a 
unique value. 
Properties Measurements 
Melting Temperature 160 -1770C 
Glass transition temperature -4 to +15°C 
Tensile strength 15 - 40 MPa 
Tensile modulus 1.1 - 3.5 GPa 
Crystallinity 55 - 80% 
Elongation at break 1-6% 
Density 1.16 - 1.243 g1cm3 
Polydispersity Index 1.9-2.1 
Degradation period >52 weeks 
Mode of degradation Hydrolytic (chain scission), bacterial depolymerase 
Water contact angle 66-800 
1.4.4.2 Poiv(3-hydroxybutyrate-co-3-hydroxyvalerate) P(3HB-co-3HV): 
P(3HB-co-3HV) is a copolymer of P(3HB) and it can exist with various mol% 
hydroxyvalerate (HV) units. However, P(3HB-co-3HV) copolymers have been 
shown to exhibit isodimorphism, with the HB and HV units co-crystallising. This 
helps the copolymer to keep its high crystallinity along with retaining the 
hydrolysis and chemical resistance exhibited by P(3HB). P(3HB-co-3HV) with as 
high as 97 mol% of HV units have been reported and it has been shown that a 
change from P(3HB) lattice to PHV lattice takes place at 40 mol% HB. At <40 
mol% HV, HV units can crystallise in the PHB lattice and at >40 mol% HV, HB 
units can crystallise in PHV lattice (Asrar J et aL 2002a). As shown in Table 1.9 
addition of HV makes the polymer more flexible and reduces the mechanical 
strength. This makes P(3HB-co-3HV) more easily processible than P(3HB) itself. 
The crystallinity of P(3HB-co-3HV) can range between 39 and 69% depending 
on the mol% of HV. The degradation rate of P(3HB-co-3HV) can be controlled 
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by monitoring the copolymer composition. Still, P(3HB-co-3HV) degrades at a 
slow rate, and similar to P(3HB) it looses its properties at a slower pace than 
poly(Iactide-co-glycolide) systems. Galego et al. (Galego N et al. 2000) showed 
that increasing the HV content results in a decrease in the melting temperature 
as well as in the mechanical strength and modulus of the polymer. In their study 
they found 8 mol% HV to be the optimum addition in terms of mechanical 
properties. Addition of HV to P(3HB) also results in lowering the water contact 
angle (Tesema Y et al. 2004) and consequentially increasing hydrophilicity. In 
addition, various in vitro and in vivo results have confirmed the biocompatibility 
of the P(3HB-co-3HV). 
Table 1.9 Changes induced in the properties of P(3HB-co-3HV) by changing the HV 
content in the copolymer (Asrar J et al. 2002a). 
(mol% 3HV) Crystallinity 
% 
Tg 
OC 
Tm 
CC 
Mw UTS 
(MPa) 
E 
(GPa) 
Elongation 
(%) 
0 69: t 0.2 1 171 370000 36 2.5 2.5 
7 58.7 ± 0.7 -1 160 450000 24 1.4 2.8 
11 57.8 ± 0.5 2 145 529000 20 1.1 17 
22 54.7 ± 0.7 -5 137 227000 16 0.6 36 
1.4.4.3 Poly(3-hydroxybutyrate-co-4-hydroxybutyrate) P(3HB-co-4HB): 
Copolymers of 3-hydroxybutyrate and 4-hydroxybutyrate have been produced 
by A. eutrophus, A. latus, Pseudomonas spp. and various other species as 
mentioned in Table 1.7. The 4HB monomer can be adjusted to vary in the range 
of 0-100 mol% and the copolymers have been shown to have a statistical 
random distribution of 3HB and 4HB units (Saito Y et a/. 1994; Saito Y et al. 
1996). The inclusion of 4HB units in the copolymer decreases the crystallinity 
compared to P(3HB), however the crystallinity of P(3HB-co-4HB) can vary 
between 15 and 55% depending on the 4HB content. This is due to the 
presence of the bulky 4HB units, which are excluded from the crystalline phase 
leading to a reduction of the crystallisation rate. Addition of 4HB up to 16 mol% 
decreases the tensile strength. from 43 to 26 MPa, while the elongation to break 
increases from 5 to 444%. Moreover, 4HB content from 64-100 mol% gradually 
imparts higher tensile strength, as can be seen from Table 1.10. The true tensile 
strength of P(4HB) alone can be as large as 1 GPa. Due to the high flexibility of 
P(4HB) in comparison to synthetic absorbable polymers such as PGA and 
PLLA, this polymer is being investigated for cardiovascular applications (Martin 
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DP et a/. 2003). The contrast in properties between P(3HB) and P(4HB) mainly 
rises because of the difference in their chemical structure, as shown in Figure 
1.7. 
Table 1.10 Influence of 4-hydroxybutyrate on the properties of P(3HB-co-4HB). (Saito Y et 
al. 1994; Saito Y et al. 1996) 
mol% 
4HB 
Tm 
(°C) 
Tg 
(°C) 
Crystallinity 
(%) 
TS 
(MPa) 
Stress at Yield 
(MPa) 
CbnIk 
(%) 
0 179 4 60±5 40 -na- 5 3 166 -na- 55±5 28 34 45 10 -na- -na- 45±5 24 28 242 
16 130 -7 ' 45±5 26 19 444 
64 50 -35 15±5 17 -na- 591 82 52 -39 18±5 58 -na- 1320 100 53 -48 34±5 104 -na- 1000 
TS= tensile strength 
1.4.4.4 Poly(3-hydroxybutvrate-co-3-hvdroxyhexanoate) P(3HB-co- 
3HHx): P(3HB-co-3HHx), being an example of scl-mcl-PHA is a relatively new 
polymer within the PHA family compared to P(3HB) and P(3HB-co-3HV). 
Various gram-negative bacteria have been reported to produce this polymer 
(Asrar J et al. 2002b). Random copolymer P(3HB-co-3HHx) has been produced 
by Doi et al. (Doi Y et a/. 1995) and has shown to have less crystallinity than 
P(3HB) and an elongation comparable to P(3HB-co-4HB). Although P(3HB-co- 
3HHx) belongs to the same PHA family as P(3HB) and P(3HB-co-3HV), the 
introduction of a hydroxyhexanoate co-monomer into the polymer backbone of 
P(3HB) significantly increases the flexibility and changes the degradation 
kinetics of the polymer accompanied by a reduction in polymer stiffness. Doi et 
a/. (Doi Y et al. 1995) have shown in their earlier experiment that the crystallinity 
of P(3HB-co-3HHx) decreases steeply (i. e. increase in flexibility) with increasing 
fraction of 3HHx as shown in Table 1.11. This shows that the 3HHx units are 
excluded from the P(3HB) crystalline phase. Increasing the mol% of 3HHx to 20 
mol% increased the water contact angle from 630 to 850, thus making the 
polymer more hydrophobic (Wang YW et al. 2005b). Large scale production of 
P(3HB-co-3HHx) has been carried out by Chen et al. (Chen GQ et al. 2001). 
Apart from P(3HB-co-3HHx) copolymers, blends of P(3HB) and P(3HB-co- 
3HHx) have been used for various cell culture studies (Zheng Z et al. 2005). 
However, the reduction in crystallinity for the case of blends is much less than 
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for the copolymer. Moreover the total protein adsorption on the surface of blends 
is much higher than that of P(3HB) or P(3HB-co-3HHx) on their own. 
Table 1.11 Thermal and mechanical properties of P(3HB-co-3HHx) films obtained by 
solvent casting. (Doi Y et al. 1995) 
mol% Tg Tm Crystallinity TS Cbnak 
3HHx (°C) (°C) (%) (MPa) (%u) 
0 4 177 60±5 43 5 
10 -1 127 34±5 21 400 
15 0 115 26±5 23 760 
17 -2 120 26±5 20 850 
25 -na- -na- 18±5 -na- -na- 
TS= tensile strength 
1.4.4.5 Terpolymers: Along with copolymers, two different terpolymers from 
the PHA family have been reported and characterised, namely P(3HB-co-3HV- 
co-4HB) i. e. poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-4-hydroxybutyrate) 
and P(3HB-co-3HV-co-3HHx) i. e. poly(3-hydroxybutyrate-co-3-hydroxyvalerate- 
co-3-hydroxyhexanoate). Terpolymers can be produced from the same species 
of bacteria, which are capable of producing mcl PHAs by manipulating the 
carbon source and using co-feeding strategies (Table 1.7). Different 
concentrations of monomeric constituents in P(3HB-co-3HV-co-4HB) have been 
achieved using fed-batch fermentation by Madden et al. (Madden LA et al. 2000) 
The highest concentration of 3HV and 4HB achieved by Madden et al. is 
restricted to 15 mol%. This behaviour was because increasing the 3HV and 4HB 
concentrations meant using large amounts of precursors (propionic acid and y- 
butyrolactone), which can get accumulated in the culture and inhibit further 
polymer synthesis. This hurdle was overcome (up to 40 mol% of 3HV and 93 
mol% of 4HB) by Chanprateep et al. (Chanprateep S et al. 2006) by using two 
step cultivation strategy employing Alcaligenes sp. and using 1,4-butanediol and 
valeric acid as the precursors. NMR results indicated P(3HB-co-3HV-co-4HB) to 
be a random terpolymer. The presence of 3HV and 4HB monomers had a 
profound influence on the thermo-mechanical properties of the polymer, as 
shown in Table 1.12. The crystallisation rate of the terpolymers also decreased. 
This was due to the presence of bulky 4HB units that cannot co-crystallise within 
the P(3HB) lattice due to their longer backbone than P(3HB), which was not the 
case for the 3HV units that can be incorporated within the P(3HB) lattice. The 
heat of fusion for the terpolymer decreased on increasing the concentration of 
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3HV and 4HB. Low heat of fusion denotes a reduced crystallinity, which in turn 
makes the terpolymer more ductile (as shown in Table 1.12). Similarly Park et 
al. (Park SJ et al. 2001) have been able to produce P(3HB-co-3HV-co-3HHx) 
using recombinant E. coli strains and in a 2.5 L fermentation vessel. P(3HB-co- 
3HV-co-3HHx) has also been accumulated in Rhodospirillium rubrum (Brand) H 
et al. 1989) and A. caviae (Doi Y et al. 1995). 
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1.4.5 Degradation of PHAs 
The ability of PHAs to be degraded in various environments is a key factor for 
their biodegradability. PHAs have - been reported to be degraded In natural 
environments such as soil (Savenkova L et al. 2000), sea water (Doi Y et al. 
1992a), lake water (Mergaert J et al. 1995) and in vivo (rats, rabbits sheep) 
(Freier T et al. 2002a; Qu XH et al. 2006). Microorganisms attack PHAs by 
secreting depolymerase enzymes that break the polymer into its basic 
constituents. Under aerobic conditions the final biodegradation products are 
water and carbon dioxide; under anaerobic conditions methane is also 
produced. For the case of enzymatic degradation PHAs can undergo 
extracellular as well as intracellular degradation (Jendrossek D et al. 2002), as 
discussed below. 
1.4.5.1 Microbial degradation: PHAs being solid polymers with high 
molecular weight are incapable of being transported through cell walls, hence 
the microorganisms secrete intracellular (in PHA accumulating bacteria) or 
extracellular (PHA degrading microorganism) PHA degrading enzyme 
(depolymerase) to hydrolyse the solid PHA into water soluble oligomers and 
monomer. The resulting products are then utilised by the microorganism as 
nutrients within their cells. A model proposed and generally accepted for 
intracellular PHA degradation is that under normal condition of PHA 
accumulation, a protein layer present on the granule surface prevents access of 
the soluble depolymerase. Under conditions when PHA is used as a carbon and 
energy source, a protein (activator) is produced, which counteracts the inhibitor 
protein and hydrolysis is induced (Dawes EA 1973). Doi et a/. (Doi Y et al. 
1992b) studied the depolymerase activity in R. eutropha and found that the rate 
of polymer hydrolysis was 10 times slower than its synthesis. The roles of the 
activator and inhibitor proteins have been further studied by various groups to 
understand the mechanism of the enzyme activity (Saito T et al. 1995). 
In comparison, the extracellular enzymatic degradation is clearly established 
and is proved to be a heterogeneous reaction. Firstly, the enzyme is adsorbed 
onto the surface and secondly the hydrolysis of the polymer chain takes place. It 
has been shown for P(3HB) that an increase in the crystallinity decreased the 
enzymatic hydrolysis and also the rate of enzymatic degradation for P(3HB) 
chains in an amorphous state was 20-fold higher than the rate for P(3HB) chains 
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in crystalline state (Kumagai Y et al. 1992b). The key aspect of microbial 
degradation is the binding of P(3HB) depolymerase on to the substrate. It has 
been shown that the binding domain of the P(3HB) depolymerase adsorbs 
selectively to the crystalline phase on the film surface, after which the enzyme 
predominantly hydrolyses the amorphous phase (Sudesh K et al. 2000). Hence 
a semi-crystalline polymer is more suitable to be efficiently degraded by 
enzymes. For example, it has been shown that P(3HB-co- 20mol% 3HV) 
degrades much faster than P(3HB-co-l0mol% 3HV) and P(3HB) in household 
compost heaps and 109 microbial strains were capable of degrading the 
polymers in the compost (Mergaert J et a/. 1992). A more sophisticated model 
for enzymatic degradation of PHAs is proposed by Numata et al. (Numata K et 
a/. 2004). 
The differentiation in intracellular and extracellular degradation is important from 
the point of view of the form of PHAs. Intracellular PHA is present in high 
molecular weight form (105-106Daltons), it is in amorphous state and the granule 
surface layer consists of proteins and phospholipids. In contrast, the 
extracellular PHAs are partially crystalline. The presence of a plasticizer (most 
probably water) has been proposed to explain the amorphous state of P(3HB) 
granules in vivo (Lauzier CA et al. 1994). Therefore the activity, biochemical 
pathways and molecular properties of the intracellular and extracellular PHA 
degrading enzyme may be different (Jendrossek D 2002). Also, the enzymes 
responsible for utilising the PHA are known to vary between microorganisms. A 
complete description of various organisms capable of degrading PHAs and the 
factors that can affect the rate of degradation have been elaborately discussed 
by Jendrossek et al. (Jendrossek D et aL 2002). 
1.4.5.2 Hydrolytic and in vivo degradation: The general scheme of 
P(3HB) degradation follows some surface modifications, increase in crystallinity, 
no relative changes in mechanical properties and a slow change in molecular 
weight over the first few months. By the end of one year there is an accelerated 
rate of degradation, with the material losing its physical integrity. In vitro 
degradation studies on P(3HB) films in buffer solution showed no mass loss 
after 180 days, but a decrease in molecular weight started after 80 days (Doi Y 
et al. 1989a; Freier T et a/. 2002a). This time period was to allow for the water to 
permeate in the polymer matrix. The degradation of the polymer happens 
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through random chain scission in both the amorphous and crystalline regions of 
the polymer matrix. This is accompanied by a reduction in the molecular weight 
and an increase in the crystallinity is observed. Then at molecular weight values 
of about 13,000 to 10,000 mass loss begins (Kurcok P et al. 1995; Freier T et a/. 
2002b). A general conclusion for P(3HB) from the available literature is the 
confirmation of its slow in vitro degradation, for example the mass-loss-half life 
of P(3HB) in buffer solution was found to be in the range of 56 to 152 weeks 
(Freier T et al. 2002a). Hydrolytic degradation study (in water and PBS) of 
poly(hydroxyoctanoate), which is a mcl-PHA, showed no significant changes on 
the surface. The water absorption reached a maximum of 16% after 24 months 
of incubation (Marois Y et a/. 2000). The weight loss was also minimal, i. e. 1% 
after 24 months. However, there was approximately 30% reduction in the 
molecular weight after 24 months of incubation (Marois Y et aL 2000). In vitro 
degradation of P(3HB) films in the presence of pancreatin (contains a mixture of 
enzymes) showed no additional mass loss of the films compared to simple 
hydrolysis, but the decrease in MM, of the films was accelerated about threefold 
in the presence of pancreatin. Pancreatin was however unable to catalyse the 
rate of degradation for PLLA under a similar environment (Freier T et al. 2002a). 
In vivo degradation of PHAs remains a contentious issue, mainly due to the 
differences in samples tested (processing technologies) and the variety of 
implantation and animals models used (Freier T et al. 2002b), as summarised in 
Table 1.13. Most of the in vivo degradation results are based on P(3HB), hence 
there is potential of exploring in vivo degradation for other PHAs. The in vivo 
degradation rate of P(3HB) has been found to be lower than that of PULA and 
PLLA (PDLLA>PLLA>P(3HB)) and it is generally concluded that P(3HB) 
degrades in vivo, but at a much slower rate than polylactides (Qu XH of al. 
2006). Typically, P(3HB) is completely absorbed in vivo in 24 to 30 months 
(Malm T et a/. 1992). After four weeks, crystallinity (the crystallinity increased 
until 4 weeks), Young's modulus and microhardness were shown to decrease 
steadily (Behrend D et a/. 2000). P(3HB) stents plasticized with triethyl citrate, 
showed a faster degradation rate than unplasticized P(3HB), as the material was 
completely resorbed at 16-26 weeks after implantation into the iliac arteries of 
rabbits (Behrend D et al. 1998). Also mcl-PHA, e. g. poly(3-hyroxyoctanoate-co- 
3-hydroxyhexanoate), has been reported to degrade slowly (Williams SF et al. 
1999). While P(3HB) and P(3HB-co-3HV) generally degrade slowly in vivo, 
which is consistent with in vitro observations, P(4HB) is an exception (Williams 
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SF et al. 1999; Martin DP et al. 2004). However, the degradation rate of PHAs is 
faster in vivo than in vitro. The differences in the degradation pattern between in 
vitro and in vivo further indicate that in vitro degradation studies are not always 
good indicators of in vivo degradation behaviour. 
1.4.6 Biological response of PHAs 
One of the key factors driving PHAs towards biomedical applications are their 
monomeric constituent. For example, P(3HB) leads on degradation to 3- 
hydroxybutyric acid that is a normal metabolite found in human blood (0.6-18 
mg/L) (Reusch RN 1992), similarly the monomeric constituent of P(4HB), i. e. 4- 
hydroxybutyric acid, is also found in mammalian body (brain, kidney, heart, 
muscle) (Nelson T et a/. 1981; Williams SF et al. 2002). A recent research 
conducted by Xiao et a/. (Xiao XQ et al. 2007) demonstrated that the 
degradation product of P(3HB), Le. D-3-hydroxybutyric acid, reduced the 
number of cells undergoing apoptosis and also showed the potential use of 
P(3HB) as an effective neural protective agent. Owing to the natural occurrence 
of certain degradation products of PHAs in the human body and their non- 
toxicity, various biomedical applications of PHAs have been investigated, viz. 
wound management (sutures, skin substitutes, nerve cuffs, surgical meshes, 
staples, swabs) (Williams SF et al. 1999), vascular system (heart valves, 
cardiovascular fabrics, pericardial patches, vascular grafts) (Sodian R et al. 
2000b; Martin DP et al. 2003), orthopaedics (scaffolds for cartilage engineering, 
spinal cages, bone graft substitutes, meniscus regeneration, internal fixation 
devices) (Chen GQ et al. 2005) and in drug delivery systems (Pouton CW et al. 
1996). PHAs have been used in the form of non-woven fibrous materials, 
meshes, films, sutures, and other products to be used in surgery, 
transplantology, drug delivery, tissue engineering and pharmacology (Williams 
SF et al. 1999). Various in vitro and in vivo studies on PHAs have demonstrated 
a favourable biocompatible response in contact with various cell lines 
(fibroblasts, endothelium cells, isolated hepatocyte and osteoblasts), as shown 
in Table 1.14 and 1.15, respectively. 
P(3HB) has been shown to have excellent biocompatibility and lack of toxicity 
towards fibroblast cell lines (Yang X et al. 2002), chondrocytes and osteoblasts 
(Kose GT et al. 2003; Torun Kose G et al. 2003). Similar conclusions can be 
drawn from the cell culture studies involving P(3HB-co-3HV). Rivard et al. 
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(Rivard CH et al. 1995) demonstrated that P(3HB-co-3HV) sustained a fibroblast 
proliferation rate similar to that observed in collagen sponges. In addition, 
P(3HB-co-3HV) materials maintained their integrity during the whole culture 
period (0-35 days) while the collagen foams contracted substantially. Also, it 
was found that the total protein production on P(3HB-co-3HV) foams was twice 
that on collagen foams. Some of the earliest (1960) in vivo response (rabbits) of 
P(3HB) revealed a granulomatous foreign body reaction without affecting the 
underlying area (Baptist JN et al. 1965). Since these early investigations, 
various experimental analyses have demonstrated various degrees of 
biocompatibility and biodegradability in various tissue applications for different 
polymers of the PHA family. However, there are reports of P(3HB) inducing 
some level of inflammatory responses as shown by Löbler et al. (Loblex M et al. 
2002) and Unverdorben et al. (Unverdorben M et al. 2002). For example, 
Unverdorben et al. (Unverdorben M et al. 2002) found that P(3HB) stents can 
induce inflammatory and proliferative reactions. 
Luklinska et a!. (Luklinska ZB et a!. 1997) studied the interface between 
P(3HB)/hydroxyapatite composites and bone, and showed dense bone 
formation on the composites after 6 months. In separate investigations, the 
strength of the in vivo interfaces developed between cortical bone and polymer 
implants has been reported to be higher for P(3HB) than for polyethylene 
(Tanner KE et al. 1990). Kumarasuriyar et a!. (Kumarasuriyar A et a/. 2005) 
further cemented the possibility of using P(3HB-co-3HV) as an appropriate 
substrate to augment bone regeneration by showing that the attachment of pre- 
osteoblast like cell lines on solvent casted P(3HB-co-3HV) films to be 
comparable to that on various matrix proteins. Chaput et a!. (Chaput C et a!. 
1995) studied cytotoxicity of P(3HB-co-3HV) on fibroblasts and found that when 
the portion of hydroxyvalerate in the polymer increased from 7 to 22 mol%, a 
slight cytotoxic effect was recorded. P(3HB-co-3HHx) also showed 
biocompatible response towards various cell lines, viz. chondrocytes (Deng Y et 
a/. 2003), nerve cells, osteoblast and fibroblast cells (Zhao K et a/. 2003). Yang 
et al. (Yang X et al. 2002) demonstrated that P(3HB-co-3HHx) showed better 
ability to support the growth of fibroblast and osteoblast cells compared to 
P(3HB) and PLA and surface treatment with lipase showed an increase 
biocompatibility (Zhao K et a/. 2003; Wang YW et al. 2005b). 
45 
N 
0 
0 
C 
0 
2 
4) 
O 
N 
N 
CD 
O 
y-+ 
tß 
0 
21-1 ß 
E 
E 
C/) 
12 
iv H 
MEE 
cr) ý.. ý 
C» N f9 p Co 
p0) -- CD ca 
- c_OON a O) 
CU cq Co C> ý C> C) zg C» C: ) 00 C, 4 
yZý °>ýY-'Zp os Co ää "" C) c:: ) 
U Ou'W cC ýD2ý ÖQm 
2 
=) 
CN > 
c .. «s o3 a) cZ a) I- 
Z 
0) (n 
, E2 U) 
2 
-i6 M 
CoYYLL. 
mw (0= t)-°a 
ODDCL 
90cö8 c% 
NN "fl O 
cu C» (n 
a (1) e) c 
.Eac 
E 
N"2 
(3 
CN=2 
v, 
E ý° CEcäö 
:sc- CD 
C "C Q 
"C NN. 
mM Edo E cfi aý °E 
c 
CO 4. C) vi ca. 
Vi - 
to a' NNCC"03EN9c º- G a) -NC cu 
° 
N 
.ýö u) 
vScCC 
°' a0c: 
Ncc c» o 
ýi cv o° v> oä ý' 
3 
° 
E c2.4-- 19 
"o 
aý aý cn EE 0) uo Ln u> o 
Co Jc: 
C= 
3\ cm cn aý öN a> E aý 
0 y'C 
Iý =t0 3 
ÖN Cp C+"ýC 
0Üß 
U) :g 0O Nc cca 
ý`a. ý= c 
N"ýE c°o 
ö 
cN .ý 
N ... y r. -. UN 'C3 N° N `n ý. 
N C) C .2C= 12 
o° Q v° s cu vý UE 
°r 
C) 
cýu v -0 CO *- °? Eo "`=- ö ccni 
cN v°) '. = 20 a3 c 
`ö` dI-- är 
;6n aý .ýEv c° `- op aöaEo cu ac: 
' Co E. .0 Ui co E32E "" E ý, E °ý -.., e c3c öc°Zz°c°ý. 
iýz°c°nö 
C*" 0 0c. ÜäZ--E c> 
<i ýýý'ýE 
H 
CO 
Q 
Tiý 
OOY 
O 
OÖQ 
VO9O 
Q 
y 
º` 
N 
J. s 
.Z=U C 
cu "KD le cu 
cu cQ Co 
U) 
CU -, CU 
, 
P» 
z3 :3 ci :3000o00Ö cu -OÖ (C " 
(O 2 Co 
25 q) CCcccyC ri "= 
o cu co NCCC ýmcamcacacacacao Eýi ca c, ö. rý 5ý 5ýý c c`o ý a 
z3 
OO O>>> ; 
9. 
Nvy `- 
O 
ELÜ 
ja (d) wV MN. 
+ 
NE N= N= 
O N+ CO. ) 
Q2MMM 
CL ään. ä 
It 
n 
lot 
cv 
v 
a) 
Cu 
F- 
ý 
m c`p co iü 29 c 
Ö4 
ý G> N 
ý Oý O 
N 
N W 
m 
Q) tý ý^ LQý 
ý N ýU rýý ^ C 
E 
OÖ O2 .N zO 2 
O Oj 
yc00 
ýO''''ý c9 
- N V 
c. l ' . ý. G. i ýr . C'4 . CN .. i . .iN. 
N 
d 
V 
C 
G) 
I- 
d 
O' 
eU8 20 Imc ýv x 
. CL 
c 
N` 
MMNyO 
NEQ vý °L 
412 . 92 cn r_ 
öü en .n! N3'g 
zL ýeTi 
NN a) CyQC 
.ý . 
°C iý ýp N 
9 
e. 
c= U) a' Z?. i°Eä. 
°Nö2 
E .c .oZc 
äý $e ai c 
mL °ý . °°ö. Hc °' 
-J cl E Eg 0 cm cNa >oö i°v °"c {°cb °c8 °iä 
°°ýNý 
ý Q"3 ao ca 
ýý ýý 
aý 
N ii 
ia) 
NOO r- et N XO°N . rs y LO 
kg 
+rý 
N 
Üj N= 
QN 
"ý 
ýM VOO 
O o. N 
a) 
3MLOC 
.ýC cm 
3w '3 ca CS oo cM° ýt ' ý° vý 
' 
ca mecE 
O C- SS Mx. 
NMK 
N= OMMm -o N +-ý 
y ýj OC0 0) 
(L) 6Od_ 
cß °CCCCn fd O° O ýt CO CNYZMvN C) ß. ca m= y-C C) NVOONN 
0 F) 1: 2- 0ON Gý 'dy0C 0) 
VC 
+r7 ßMC 
'ZU >, 2 c° ü¢övö; _ °'c'ö 
° °c 
t cya 
ö_ 
W 
Ci. 
NÜ° 
Ü° Q. 0 n 
N :3 : Ei V- ym2c 
12- m (L) L2) 
E0° c° 
c°'a c33 g ja 
NN 
.a ö°C (0 H 
4- 
v 
._mE ca cv ca rn a .o -o Nc EE°Ey 
. 'ten 
E 0.0 
CD (L) 
0 (D 
0 
Oý'ý NE. =" = Cmay a) a>_CE(L)ca°- wEe =Cý .0 .0 Ein öZ cCO :i. 00 (L) :3 >- 0z Q)>csm M :3 =ä >mm C clý iQ. o W- 
N 
C 
G7 
E 
E 
0 tý 
N 
C 
4, 
U 
iX Cu 
YMx 
6 ) 
xm x 
MM M9-. 
C=ý) 
'r 
MM M 
CL 
" l) 
M 
66 Co Co CID Z: ,, 6 - 9Y 
mm m Xmm --CO r12 
M o y m«t3 CD m . gy m Co CID Ici 
M 
Z: aM 
M 
(D M_ C M_ 
M_ 
W M_ 
M_ 
M_ 
M_ 
_Q) L. L aa a. M=O. a. m a. m n. amn. a. CL CC d 
L- CD 
ea 2 
00 
V) 
O 
V 
Q 
0. 
CO 
eD 
N 
E 
O 
.0 
I 
142 N 
rn 
N 
r- O 
N O 
a 
a, 
fi 
rn 
t 
LM 
v) 
N 
S a 
O E 
E 
O U 
E 
O 
H 
I- 
10 
N 
4) 
O 
CR 
a-- O 
O 
E 
E 
CO 
In 
d 
.ä is F- 
N 
N 
C 
d 
r.. 
N 
H 
cm 
c 
c 
ii 
C 
0 
w 
CL 
rn ^ N 
N 
Lfl 
Ö 
Co j 
0 
ED Co C: ) 
CY) N . a) p - 
04 cn 
Id 
W 
.. 
co CD 
U/)'-cL - 
C" 
1 . 
ca (1) c < Q) (L3 '7 o 
Ncv. cýa72 c 
F' E 
cv 
pý cx (n (n . oOC 'Y 
- 
CO RS .C 
ö 0 
E v Co 
E ca 
N ý ' 
c 
' 
°" 
ö 
Q 
E , C i 
3c0 
a) aci 
- 
E 
'C 
cco 
ý im u) C rn d Q Co 
päC 
O 
"ý 
aC' 
2NC 
cv 
Oß 
v3 
gO 
cv ö 
CO CO 
O 2 p t 
C cU 
C r-. 
m 
c 
p 
p öC O N 
Eö E. 5 tee -v c ca 
Co .c Ec 
, cý a) 
aý c 
" 
°3 N 
O 
N 
p 
OC 
O 
M 
C 
' Q) m ö C O 
O .C 
(1) C2N .NO p O C: 1. N M a) NE c 2 
1.0 O 
>. Nc 
OOO 
ö 
O d 
ß (4 CO 
2p 3D 
bO 
c, o CJ cu 
2C 
rý 12 
y 
` 
! 
GO 
O 
ON. CD 
c 
ty 5 
m NNC 
N- 
0N 
42 e 
O ri 
C» C. 
C (O > 
"° co CO 0, = 
OV 
cm 
ONC 
ý 
- c12 
ý. C 
8 
mE 
- 
CN 
°' 
O 
LöN . öE a 
NC N 
C 
NC "3 
ÜM p n 
- (6 
= 
p 
ö E(D cNa E2v c aý 
c 
" 
2 
C 
m c: +ý7 +N. + (n :3 
C ý > 
c2 
fl- 
p 
cC 
ON«. 
E0 CO 
_ 
(n 
c 
co 
pc 
0 
LC) 
y Ü 
N (D Q- o °' 
G) 
C ý. ä 
ý v i C C C 
,c N 
C 
' hH 
( ( ( 
Hy 
CO (0 (0 
o 
N "C 
N 
t 
+m O 0 U O 
V EO vC _ 
""" """ " " " 
a) L 
C 
M 
E 
O 
Cl) V 
2- O 
(D CD ii 
I'M n U) "C 
Cl) 2 z 0 v, ä 
C13 
M 
CL 
ö 
ö 04 
N 
C ýD 
Q) 
N 
c) 
cm LL. 
LL) äs 
o 
Eö 
fU N 
Cl. a) 
Ee 
8 ý. 
cä 
o 
c 
u 
CC 
N NN 
C. - 12 
cv N `+D 
LD -CJ 
ö CCU 
oN 
C 
0 M. 2 
omC 
m *5 
NQC 
o l_a Eo 
dÖN 
ýCym 
ý 
u) 
0u 
0 
0- 0 
E0 
CxÖ 
.S-N 
ýO M -C R7 0 
--ý'' 
rn 
N G) U 
J4 
ÖN 
ýý?? 
a> o 
E 
5 
C> E 
cu ý 
rn 
N 
C) 
s "c c CL Ü 
U, 
EN 
3 :. 
o 
c aD 
c: U) N. V 
LWC 
c3 "UO 
In 
LL < 
-- 
. -. LO ö N 
Q 
Cy 
C 
U 
v 
N 
"O 
'I-- O 
Vf 
0) 
N 
d 
O 
N 
O 
O 
E 
aý 
aý 
0 
c 
a) 
N 
O 
CO (d 
E 
g' 
D 
.ý 
co ,ý 
C 
G) Q) 
GN 
8 
N -c 
p 
Co 
Ný 
E 
.. S [U N 
""°_ ä NC 
.D E 
0 
G 
:O 
c0 N ý- 
L- O 
CU 
C 
O 
E3 
aN- 
.CÜZ GN 
(n :3 j2 O 
ýO 
(NC >ö3 
(Cc 
cu cu NNN 
_NO 
43 E E 
CO CO = 
a 3 
Co N 
t 
(0 
N at 
gN 
> > is ca > 5` 75 
0 
c 
o (D CY) (Z 
z ,o 
M 
cnPU) 
C/) 
aý 
as 
s> 
m 
3: S s T C) W C ä = v C ) L 
c a cr) C) 
Chapter 1: Research background 
1.4.7 Comparison with other polymers 
PHAs are increasingly challenging the domination of the polylactide family of 
copolymers for biomedical applications. Although PHAs have been around since 
1920s, their real potential for a range of biomedical applications has been 
recognised only in the last 25 years. The present thrust towards the property of 
biodegradability is going to lead to more research on the development of PHAs 
for biomedical applications. Counting on the potential and possible merits of 
PHAs gives a slight edge of these polymers over any other synthetic polymer 
family, however in reality the commercial availability of PHAs is the major 
obstacle for their progress. A comparative study between PHAs and other 
generic synthetic polymers is presented in Table 1.16. 
Table 1.16 Comparison of PHAs with other synthetic polymers commonly used for 
biomedical applications. 
Properties Pol h drox alkanoates Vs. other synthetic polymers 
Thermal & Thermally unstable (narrow range between the degradation and melting 
mechanical temperature), melting temperature is similar to most of the other synthetic 
polymers. Mechanical properties comparable and in some cases superior to 
other synthetic polymers (Table 1.12). It retains its strength for a longer 
duration while degrading. Ultra high molecular weight PHAs can be produced 
to enhance the mechanical properties. 
Degradation The degradation rates of scl-PHAs are much slower than the widely used 
rate synthetic polymers such as PDLA, PLGA etc. However, mcl-PHAs have faster 
degradation rate. The degradability can be tailored for PHA copolymers. All the 
PHAs are degraded enzymatically by microorganisms found in cell and 
environment. Certain enzymes found in the body can also catalyse the 
degradation of certain PHAs. This is in contrast to other synthetic polyesters 
such as PLA. 
Design space Possess the widest array of properties within the polymer family than any other 
synthetic or natural polymeric family. The mechanical properties can be 
tailored from a brittle to a soft polymer within a copolymer (Table 1.12), as well 
as the degradation rate can be controlled. The breadth of properties available 
is more than the polylactide polymeric systems. 
Availability A major obstacle towards application of PHAs. Only handful PHAs are 
commercially available. In contrast most of the synthetic polymers are 
commercially available in large quantities and relatively cheaper than PHAs 
Biocompatibility Since PHAs are produced from microorganisms, extracting a 
pharmacologically pure PHA is a key issue for its use, compared to synthetic 
polymers. Nevertheless, PHAs have been shown to be biocompatible and their 
degradation end products does not affect the surrounding tissues (in contrast 
to acidic end product of PDLLA) 
Processability Can be prepared as films, spheres and scaffolds. However, its solubility in very 
limited solvents restricts its use. Furthermore, its thermal instability might 
restrict the use of thermal manufacturing techniques. 
EM 
LONDON 
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1.5 PHA/bioactive ceramic composites 
Along with developing new polymers in the PHA family, over the years, efforts 
have been made to design PHA composites in combination with inorganic 
phases to further improve the mechanical properties, rate of degradation and 
also to impart bioactivity. P(3HB), P(3HB-co-3HV) and P(3HB-co-3HHx) are the 
polymers that have been studied extensively to fabricate composites in 
combination with hydroxyapatite and other ceramics as fillers and coatings. Since 
this project focuses on the development of novel P(3HB)/Bioglass® composite 
systems, it is crucial to analyze all PHA composite systems that have been 
reported to date. A comparison between different composite systems developed 
in the last few years is presented in this section. Although most of the 
PHA/inorganic phase composites are considered for hard tissue implant 
applications, very limited research has been aimed towards preparing tissue 
scaffolds that can incorporate drug delivery and other applications towards tissue 
regeneration. 
1.5.1 P(3HB)/bioactive ceramics composites 
P(3HB) composites have been prepared by incorporating various bioactive 
ceramics (e. g. HA, TCP, wollastonite) as fillers. Hydroxyapatite, which is similar 
to the principal crystalline constituent of bone providing the bone's compression 
strength, is the most extensively used bioactive ceramics to form composites with 
PHAs. The first attempt to bring these two materials together was performed in 
1991 by Doyle et al. (Doyle C -et a/. 1991) and demonstrated that addition of HA 
particles had a direct positive correlation on the elastic modulus and an inverse 
relationship with the tensile strength of the composite. The compressive elastic 
modulus and the maximum stress of the composite system have also been 
shown to increase due to the addition of HA (10 vol%) (Wang YW et al. 2005a). 
In addition to improvement in mechanical properties, addition of HA has also 
been shown to induce high rate of bioactivity (Ni J et a/. 2002). Dynamic 
mechanical analysis (DMA) experiments carried out by Ni et al. (Ni J et al. 2002) 
showed that the presence of HA increased the storage modulus in the as- 
fabricated composite but the material lost its modulus at a faster rate in the 
biological medium (SBF), compared to the neat polymer (Doyle C et al. 1991). 
P(3HB) on its own has been shown to retain its mechanical and structural 
properties for a longer duration by undergoing slow degradation (Freier T et a/. 
2002a). Over a 4-month period of immersion in SBF the composite recorded a 
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44% reduction in its Young's modulus (9 GPa to 5 GPa), whereas the polymer 
only showed a reduction of 25% (4 GPa to 3 GPa) (Doyle C et al. 1991). 
Luklinska et al. (Luklinska ZB et al. 1997) showed bone apposition occurring 
along the whole length of P(3HB)/hydroxyapatite implant interfaces after one 
month of implantation in rabbits. This was followed by dense bone formation after 
6 months of implantation. Various other in vivo experiments (Shepperd JAN et al. 
2005) have further confirmed the key role played by HA for integration with bone. 
1.5.2 P(3HB-co-3HV)/bioactive ceramics composites 
P(3HB-co-3HV) has been the most extensively used polymer from the PHA 
family for composite development, and fabrication techniques such as 
compression moulding and particulate leaching have been used. Chen et al. 
(Chen U et al. 2002) performed a comparative study using HA and TCP 
(tricalcium phosphate) particulate inclusions and showed that increasing the 
concentration of HA and TCP increased the micro-hardness, Young's modulus 
and dynamic modulus of the composites. However, the presence of HA had more 
influence on the mechanical properties of the composite scaffolds than the 
presence of TCP, as summarised in Table 1.17. This difference is primarily due 
to the differences in the physical properties of HA and TCP. Li et al. (Li H et al. 
2004), showed that the compressive strength of a P(3HB-co-3HV)/wollastonite 
composite scaffold increased from 0.16 MPa to 0.28 MPa on increasing the 
wollastonite content from 0 to 40 wt%. A study carried out by Galego et al. 
(Galego N et al. 2000) showed that increasing the HA content above 40 wt% 
resulted in a sharp decrease in the elastic modulus of the composite. This can be 
explained based on increasing particle-particle contact with increasing HA 
content and possibly due to the lack of sufficient interfacial strength between the 
HA particles and the polymer. These weak interfaces can act as sites of defects 
from which cracks could propagate under tensile loading. Nevertheless, Boeree 
et al. (Boeree NR et al. 1993) showed that the compressive strength of the 
P(3HB-co-3HV)/HA composites has a direct correlation with the concentration of 
HA. The choice of manufacturing'technique for the composite preparation greatly 
affects the mechanical properties, as highlighted in an earlier investigation by 
Knowles et al. (Knowles JC et al. 1992b), Samples of (P(3HB-co-3HV)/HA) 
prepared by injection moulding had greater compressive and tensile strength 
than compression moulded samples. This could be due to the fact that in 
injection moulding full melting of the polymer occurs and as a consequence HA 
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particles can be well dispersed in the matrix. On the contrary, for compression 
moulding only partial melting of the polymer was observed and the samples 
exhibited a porous structure and inhomogeneous distribution of HA inclusions. 
Table 1.17 Effects of incorporating different concentrations of HA and TCP on selected 
properties of P(3HB-co-3HV) composites. 
T,  
(°C) 
Crystallinity 
(%) 
Micro-hardness 
(VHN) 
Td 
(°C) 
(vol%) Sample Sample Sample Sample Sample Sample Sample Sample 
1 2 1 2 12 1 2 
0 137.4 137.4 47.3 47.3 8.6 8.6 279.6 279.6 
10 144.1 137.4 44.6 44.5 10.1 9.3 280.2 277.3 
20 144.7 136.7 41.0 42.6 13.2 9.5 266.9 274.9 
30 142.7 136.7 39.0 40.9 15.7 10.2 252.2 269.7 
Sample 1: P(3HB-co-3HV)/HA 
Sample 2: P(3HB-co-3HV)ITCP 
A detailed in vitro analysis on P(3HB-co-3HV) composites containing wollastonite 
and bioactive glass showed that the presence of these inorganic fillers (LI H et a/. 
2004; Li H et a/. 2005a) helps in neutralising the acidic by-products released from 
the degradation of P(3HB-co-3HV) and aids to stabilise the pH. Adding 
wollastonite in the range of 0-40 wt% also resulted in a decrease of the water 
contact angle from 660 to 160. Similar results were confirmed in P(3HB-co- 
3HV)/bioactive glass composites, wherein the water contact angle reduced from 
65° to 32° upon addition of 0-20 wt% of bioactive glass (Li H et a/. 2005c). 
Addition of bioactive ceramics also resulted in higher water absorption. The 
weight average molecular weight (Mw, ) measurement on the composites showed 
that the MN, of the polymer decreased more than that of the composite upon 
immersion in SBF for 15 weeks (Li H et al. 2005a; Li H et al. 2005c). 
In vivo tests in tibias of rabbits performed using cylindrical specimens of P(3HB- 
co-3HV)/HA (40 vol%) composites revealed a well-developed lamellar bone 
structure around the implant surface after 1 month of implantation, and was 
reported to be preserved after 3 and 6 months of implantation (Luklinska ZB et al. 
2003). It was also reported that new bone formed at the interface followed the 
shape of the implant surface and marrow cells were observed within the bone 
structure. For the P(3HB-co-3HV)/HA (40 vol%) composite, bone formation was 
an ongoing process even after 6 months of implantation. Along with the ability of 
HA to bond with the surrounding tissue, the P(3HB-co-3HV) matrix provided 
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adequate support for cell growth and it was tolerant towards new tissue formation 
(Luklinska ZB et al. 2003). 
1.5.3 P(3HB-co-3HHx)/bioactive ceramics composites 
Addition of 10 vol% of HA particles to P(3HB-co-3HHx) marix, decreased the 
compressive elastic modulus from 0.173 GPa to 0.068 GPa (Wang YW et al. 
2005a). In the same experiment, it was demonstrated that addition of HA had a 
negative effect on osteoblast cell proliferation, confirmed by using MTT assay 
and alkaline phosphatase activity assay. However, P(3HB-co-3HHx)/HA scaffolds 
prepared using thermally induced phase separation technique (Xi J et al. 2008) 
suggested that incorporation of HA resulted in an increase in the modulus and 
compressive stress, increasing the total protein adsorption and improvement of 
the proliferation and ALP activity of MC3T3 osteoprogenitor cells. 
1.6 Aims and objectives of the present project 
The focus of this research project was to produce P(3HB) from a novel species of 
gram-positive bacteria and to use the polymer for preparing multifunctional 
P(3HB)/bioactive glass composites for bone tissue regeneration applications. The 
following tasks were carried out to achieve the project objectives and are 
schematically represented in Figure 1.8. 
characterisation of 
Preparation of 
Characterisation of 
composites 
=stud 
radation 
SBF 
Cytocompatibility 
studies using MG-63 
Improving the 
existing properties 
Antibacterial 
properties 
Improving cell 
attachment and 
cell lines 
In vivo Inducing electrical biocompatibility conductivity 
study (rat model) 
Figure 1.8 Research methodology used in this project 
Multifunctional 
scaffolds 
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" Production, Isolation & characterisation of P(3HB): Production (using 
fermentation culture) and characterisation of P(3HB) from the newly isolated 
strain of Bacillus cereus SPV were carried out. The extraction techniques 
(Soxhlet, Chloroform and Dispersion techniques) for isolating P(3HB) from the 
bacterial cells were optimised. The extracted polymer was then characterised 
using GC-MS, FTIR, NMR and DSC. 
" Preparation & characterisation of P(3HB)lbioactive glass composites: 
P(3HB)/bioactive glass composites with different concentrations of microscale 
and nanoscale bioactive glass particles were prepared using solvent 
casting/pa rticulate leaching for preparation of composite films and foams. The 
effect of bioactive glass particles addition on the thermal, microstructural and 
mechanical properties of the composites was evaluated comprehensively. 
" In vitro simulated body fluid (SBF) and biocompatibility studies: A 
degradation study in SBF medium over short and long period was carried out, 
examining ion release, bioactivity, degradation and water uptake changes within 
the composites. In vitro cell culture studies using MG-63 human osteoblasts 
along with performing a preliminary in vivo study by subcutaneous implantation in 
a rat model. Possible antibacterial properties of P(3HB)/ bioactive glass 
composites were also examined. 
" Functionalisation of P(3HB)/bioactive glass composites: Electrical 
conductivity in P(3HB)/bioactive glass samples was induced by adding different 
concentrations of multiwall carbon nanotubes (MWCNTs). The CNT containing 
composites were fully characterised. The improvement in surface properties 
(hydrophilicity, protein adsorption) and biocompatibility by the addition of natural 
antioxidant i. e. Vitamin E, aimed for better bone-cell response, was also 
examined. 
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2. Production of 
yoIyI3-hydroxvhutvratel 
2.1 Introduction 
Poly(3-hydroxybutyrate), (P(3HB)), a member of the polyhydroxyalkanoate (PHA) 
family, has been extensively investigated for use in packaging and the biomedical 
sector (Chen GQ et al. 2005). P(3HB) is accumulated by many Gram-positive 
(Bacillus spp. Rhodococcus etc. ) and Gram-negative (Pseudomonas spp., E. coli 
etc. ) bacteria, as discrete granules, within their cell (Anderson AJ et al. 1990). 
Generally, P(3HB) producing bacteria starts to accumulate the polymer when 
their cell growth is impaired by the limitation of an essential nutrient (viz. nitrogen, 
phosphorus, magnesium, potassium, oxygen or sulphur) and in the presence of 
excess carbon source (Anderson AJ et al. 1990). The biosynthesis of PHA 
comprises two enzymatic reaction steps: (1) supply of the substrate monomer 
and (2) polymerisation of the generated monomer units. 
The basic reason for the limited availability of PHAs is because the bacteria 
synthesising these PHAs are difficult to cultivate and do not accumulate much 
polymer. The choice of bacteria for cultivation of PHAs is made on its ability to 
cultivate efficiently high cell densities with a high PHA content in a relatively short 
period of time. Also these bacteria have the ability to utilise inexpensive carbon 
source, which is the major contributor to the total substrate cost. The PHA 
content can be considered as the measurement of the cell's ability to accumulate 
PHA in a given condition. High PHA content often results in high PHA yield and is 
beneficial for the recovery process. This chapter explains the identification and 
characterisation of P(3HB) produced from a newly characterised Gram positive 
strain of Bacillus spp. (i. e. Bacillus cereus SPV). P(3HB) production was carried 
out continuously during this project and a schematic representation of the 
processes involved in polymer production is shown in Figure 2.1. This chapter 
also highlights the various protocols involved, starting from growing the polymer 
at smaller scale using shaken flask study to scaling-up the production using 
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fermentation strategy. The range of extraction techniques employed to isolate the 
polymer from the bacterial cells and their effects on the material properties of the 
polymer have also been discussed. Finally, the thermal and structural properties 
of the extracted P(3HB) were compared with the commercially available P(3HB) 
(purchased from Fluka Chemicals, Schnelldorf, Germany). 
2.2 Experimental details 
All chemicals required for the growth of Bacillus cereus SPV and extraction of 
polymer from the bacterial cells were obtained from Sigma-Aldrich Company Ltd., 
and VWR Chemicals (England) except nutrient broth and yeast extract, which 
were obtained from DIFCO (BD UK Ltd., Oxford, UK). Antifoam (FG-10) was 
purchased from Dow corning (Edison, NJ, USA), for fermentation study. For 
comparison purpose, commercial P(3HB) was purchased from Fluka Chemicals 
(Schnelldorf, Germany) and used without further purification. Bacterial cells of 
Bacillus cereus SPV was obtained from The University of Westminster (London, 
UK) culture collection and used for P(3HB) production throughout this study 
(Valappil SP et al. 2007b). 
2.2.1. Production of poly(3-hydroxybutyrate) 
2.2.1.1 Bacterial strain: The Bacillus cereus SPV (Bacillus spp. ) cells 
obtained from the culture collection (Valappil SP et al. 2007b) were grown in an 
incubator (New Brunswick Scientific C25KC Incubator shaker, USA) at 30°C for 
24 h in 30 mL of sterile' nutrient broth. Table 2.1 shows the constituents of 
nutrient broth and nutrient agar. This 24 h grown culture was then streaked on 
sterile nutrient agar plates (30 mL of sterile nutrient agar solution on petri plates) 
in order to obtain single bacterial colonies. The plates were incubated for 48 h at 
30°C and then stored at 4°C. Glycerol (acting as a cryo-preservant) deeps of the 
culture were also prepared for long-term storage by adding 500 pL of the 24 h 
grown culture and 500 pL of sterile 40% glycerol. The mixture was vortexed and 
stored in 1.5 mL eppendorfs at -20°C for further use. 
All media for bacterial growth were sterilised in an autoclave at 121`C for 15 min except medium 
containing glucose which was sterilised at 110`C for 10 min to prevent caramelisation of glucose. 
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2.2.1.2 Shaken flask study: Producing P(3HB) from Bacillus spp. Involved 
two steps: firstly, growing the cells in a nutrient rich medium (nutrient broth) and 
secondly growing the bacterial cells in nitrogen limited production medium for 
polymer accumulation. 30 mL of seed culture was prepared by inoculating a 
single colony of Bacillus spp. to 30 mL of sterile nutrient broth (1.3 wt/vol). The 
seed culture was grown in a benchtop incubator (Stuart Scientific, Orbital 
Incubator S150, UK) in 250 mL Erlenmeyer flasks at 30°C for 24 h and at 200 
rpm. A PHA producing (nitrogen limiting) Kannan and Rehacek medium (Kannan 
LV et al. 1970), was used for the production of P(3HB). The constituents of 
production medium are shown in Table 2.1, and glucose was used as the sole 
carbon source in the medium. 300 mL of sterile production medium was prepared 
and the pH was adjusted to 6.8 before inoculating it with 30 mL of the seed 
culture, which had been grown for 24 h. This culture was further incubated for a 
period of 72 h at 30°C and at 200 rpm. The cells from the shaken flask culture 
were harvested after 72 h by centrifuging (Sorvall Legend RT, Jencons, UK) the 
culture at 4500 rpm for 10 min, and the cells were kept in -80°C for polymer 
extraction (details for polymer extraction are mentioned in Section 2.2.2). 
2.2.1.3 Growth of Bacillus sDD. in ferrnenter. Up-scaling of polymer 
production from 300 mL shaken flask culture was carried out using a 20 L 
fermenter vessel as shown in Figure 2.2, with a working volume of 14 L. The 
basic steps involved in the P(3HB) production using this technique are 
summarised in Figure 2.1. The fermenter vessel containing 12 L of water was 
sterilised (121 °C, 30 min at 1 bar) while containing only the salts of Kannan and 
Rehacek medium except glucose and soybean dialysate. The inoculum required 
for the fermentation process was prepared in two steps. Firstly, 140 mL of the 
inoculum* was prepared in 4x250 mL flasks, each containing 35 mL of sterile 
nutrient broth (grown for 24 h at 30°C, similar to the first step of 300 mL culture 
study). Secondly, 140 mL of this seed culture was transferred to 1.4 L of sterile 
nutrient broth in 4x1 L flasks, and grown for further 24 h at 30°C (until an optical 
density of 0.3 (1: 10 dilution)). Appropriate amount of glucose (280 g) was 
dissolved in 1.4 L of soybean dialysate and autoclaved at 110°C, for 10 min, 
which was then added aseptically to the sterilised fermenter vessel, already 
containing the remaining salts of the production medium. The impeller speed of 
0 Inoculum is nutrient broth with bacterial cells, which have been grown for a specific time period 
and used to initiate bacterial cell growth in the larger volume of production medium 
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the fermenter was set at 250 rpm, while the airflow rate and temperature was set 
at 10 Umin and 30°C, respectively. The pH of the medium was adjusted to 6.8 
before the start of the fermentation. After setting the Initial conditions, 1.4 L of the 
inoculum was added aseptically to the fermenter vessel. At this point the 
dissolved oxygen tension (DOT) in the vessel was set to 100%. 
Table 2.1 Chemicals used to prepare production medium for P(3HB) production and the 
constituents of nutrient broth and nutrient agar for cultivation of Bacillus spp. 
Constituents Quantity (gIL) 
Glucose 20 
Yeast extract 2.5 
PRODUCTION MEDIUM Potassium chloride 3 
Ammonium sulphate 4 
Soybean dialysate§ 100 mL 
Lab-Lemco Powder 1 
NUTRIENT BROTH Yeast extract 2 
Peptone 5 
Sodium chloride 5 
Lab-Lemco Powder 1 
NUTRIENT AGAR Yeast extract 2 
Peptone 5 
Sodium chloride 5 
Mar 15 
§A slurry of 1g of soybean flour in distilled water was poured into dialysis tube- and immersed in a 
flask containing 100 mL of distilled water. The flask was left on magnetic stirrer for 24 h at 4'C. 
Samples from the fermenter were collected in 25 mL sterile bottles at various 
time points to analyse various parameters associated with the growth of the cells. 
The parameters monitored were pH (indicating the growth or bacterial cells) of 
the medium, dissolved oxygen tension levels (showing the activity of the bacterial 
cells) in the vessel, temperature of the culture in the vessel (kept constant at 
30°C), and dry cell weight (measuring the growth of the microorganisms). 
(I) OPTICAL DENSITY (OD): OD of the culture was recorded at different 
time points, in order to measure the bacterial growth. OD readings were taken at 
600 nm (absorbance) in a standard spectrophotometer (Novaspec II Visible 
spectrophotometer, UK) and for all cases nutrient broth was used as blank. 
(ii) TEMPERATURE, PH AND DISSOLVED OXYGEN TENSION (DOT): 
Temperature and DOT levels were monitored online using the temperature and 
DOT probes (polarographic oxygen-sensing probe Ingold, Mettler-Toledo Ltd., 
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Beaumont Leys, Leicester, UK) connected to the fermenter vessel. The pH of the 
production medium was measured offline (Jenway pH meter 3305, UK) by 
collecting samples from the fermenter at regular intervals. 
DRY CELL WEIGHT (DCW) ANALYSIS: 15 mL of the culture from the ON 
fermentation run were taken at different time points to measure the dry cell 
weight. The culture was centrifuged at 4500 rpm for 10 min. and the cells were 
lyophilised before recording the cell mass. 
Prepare Inoculate Prepare 1.4 Wash Add glucose 140 mL the 1.4 L of L of vessel, add to soybean 
of seed nutrient soybean chemicals dialysate 
culture. broth with dialysate (except and sterilise 
Grown for 140 mL of and stir for glucose the solution 
24 h at seed 24 h at TC and separately 
30'C culture. soybean and then 
Grown for dialysate) add to the 
24 h at and fermenter 
30'C sterilise 
D1 D2 D2 D3 D3 
Decrease the temperature of the medium in Inoculate the fermenter with 
the vessel to 30'C using a thermochiller; 1.4 L of culture and grow for 72 
Calibrate pH and DOT level. h at 30'C 
D3 D3-D6 
Harvest the Freeze the Freeze dry Chloroform technique 
cells by extracted the cells for 
centrifuging cells at 
' 
48 h and Soxhlet technique 
at 4500 rpm -80 C for prepare for 
for 10 mins. 24 h. polymer 
extraction Dispersion technique 
D6 D7 D8-D9 
Figure 2.1 A brief schematic representation of the processes involved in production and 
extraction of P(3HB) from Bacillus spp., with an estimation of time duration for the entire process 
(e. g. D3=Day 3) 
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64- r-imý A, ý 
Figure 2.2 20 L fermenter vessel used for the production of P(3HB). 
1- Stirrer, 2- Air inlet, 3- Monitoring unit, 4-Vessel, 5- Sample line 6- Peristaltic pump 
2.2.2 Polymer extraction techniques 
The bacterial cells were harvested from the culture by centrifugation (the 
difference in the optical density of the harvested and non-harvested culture is 
shown in Figure 2.3a), and stored at -80°C for 24 h. The frozen cells were then 
lyophilised (Savant Modulyo D Freeze drier, Thermo electron Corp., UK) for up to 
48 h in a freeze dryer at -47°C and at a pressure of 133 mbar. The freeze-dried 
cells were then weighed and designated as dry cell weight (dcw). Subsequently, 
the polymer was extracted from the cells by using one of the extraction 
techniques mentioned below. 
2.2.2.1 Chloroform technique: The polymer was extracted from the freeze 
dried cells by stirring 1g of freeze dried cell in 50 mL of chloroform for 24 h at 
30°C. The mixture was then centrifuged at 4500 rpm for 10 min and the cell debri 
were removed. The polymer solution in chloroform was precipitated, using ten 
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volumes of ice-cold methanol. The precipitation process was repeated to 
increase the purity of the extracted polymer (Hahn SK et al. 1995). 
2.2.2.2 Soxhlet technique: This procedure employed extensive use of 
organic solvents, such as ethanol, diethyl ether, acetone, chloroform, and 
methanol (Ramsay JA et al. 1994). The freeze-dried cells were treated with a 16 
vol% sodium hypochlorite (NaOCI) solution at 37°C for 12 h and then centrifuged 
at 4500 rpm for 10 min. The supernatant was removed and the residue was 
washed twice with distilled water followed by acetone, ethanol and diethyl ether, 
respectively. The washed cells were left to dry in a fume cupboard for 24 h. 
Finally, the polymer was extracted from the dried cells by refluxing in chloroform 
using the soxhlet apparatus for 24 h. The chloroform containing P(3HB) was then 
subjected to rotary evaporation and precipitated using ten volumes of ice-cold 
methanol. 
2.2.2.3 Dispersion technique: This extraction technique was developed by 
Hahn et al. (Hahn SK et al. 1995) to extract scl-PHAs and is very useful, as it 
does not employ extensive use of organic solvents. According to this method, 15 
g of freeze-dried cells were immersed in a solution containing 100 mL of 
chloroform and 100 mL of (30%) sodium hypochlorite solution in distilled water. 
The mixture was incubated at 37°C for up to 3h and centrifuged. Upon 
centrifugation three separate layers (as shown in Figure 2.3b) are formed in the 
centrifuge tubes. The top part containing hypochlorite and the second layer of the 
cells, which acted as a barrier between the bottom and the top layer was 
discarded. The polymer solution (i. e. bottom layer) was further added drop-wise 
in a beaker containing ice-cold methanol to precipitate the polymer. 
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c 
Figure 2.3 Digital images (i) showing the difference in the optical density of the culture after 
72 h, where WC denotes the culture without the Bacillus spp. cells and C denotes the culture with 
the cells; (ii) formation of three layers after centrifuging the mixture of cells, chloroform and 
hypochlorite solution using Dispersion technique. The phase HY, CD and PS denotes hypochlorite 
solution, cell debris and polymer solution, respectively (iii) precipitation of the polymer in methanol. 
2.2.3 Characterisation of extracted polymer 
The extracted polymer was firstly identified using a range of techniques, such as 
GC-MS, NMR, FTIR and DSC to establish its chemical structure of the polymer. 
Subsequently, the polymer was extensively investigated as reported in Chapters 
3and4. 
2.2.3.1 Solid state 13C nuclear magnetic resonance (NMR): 13C NMR 
cross-polarization with magic-angle sample spinning (CP/MAS) experiments 
were performed at 75.4 MHz on a Varian Unity Inova spectrometer using a 5mm 
magic-angle spinning (MAS) probe with the following acquisition and processing 
parameters: spinning speed 5.11 kHz, number of acquisitions 316, recycle delay 
5s and contact time 1 ms. Selective spectra of the quaternary and methyl 
carbons were obtained using the dipolar dephasing ("non-quaternary 
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suppression") pulse sequence (Opella SJ et al. 1979). This work was carried out 
at the facility of University of Durham, UK. 
2.2.3.2 Gas chromatography mass spectroscopy (GC-MS): GC-MS was 
carried out for identification of PHA. The method used was based on the gas 
chromatographic method of Huijberts et al. (Huijberts GNM et al. 1994). One 
mg/mL of sample and 1 mg/mL of methylbenzoate in chloroform were added to a 
mixture of 2 mL of 15% sulphuric acid in methanol (1: 1). The sample was further 
refluxed for 5h to allow the reaction to take place (i. e. methyl esterification of 3- 
hydroxybutyrate). The tubes were then cooled on ice for 5 min and 1 mL of 
distilled water was added to the tube and vortexed for 1 min. After phase 
separation the organic phase (in the bottom) was collected and dried over 
anhydrous sodium sulphate. The GC-MS analysis was performed using a Trace 
GC-MS (Thermo, San Jose, USA). The Trace2000 gas chromatograph was 
equipped with electron ionisation source and ZB-5MS (Phenomenex, Torrance, 
CA, USA) column, 30 m-length, 0.25 mm-internal diameter, and 0.25 µm-film 
thickness. The sample (1 µL) was injected with helium as the carrier gas. The 
injector temperature was 220°C and the column temperature was increased from 
40 to 320°C at 20°C/min and held at the final temperature for 6 min. GC-MS was 
conducted in collaboration with G. J. Langley from University of Southampton. 
2.2.3.3 Gel permeation chromatography (GPC): Molecular mass analysis 
of the extracted polymer was conducted in collaboration with Dr. Steve Holding 
(RAPRA 'UK) by dissolving the samples 
in chloroform. The solution was heated 
at 50°C and cooled before being filtered through 0.2 pm polyamide membrane 
prior to the chromatography. The GPC system was equipped with PLgel guard 
plus 2x mixed bed-B column (30 cm x10 µm) and a flow rate of 1.0 mUmin was 
used at a temperature of 30°C. The eluted polymer was detected with a 
differential refractometer. The data were collected and analysed using Viscotek 
`Trisec 2000' and 'Trisec 3.0' software. The GPC system was calibrated with 
polystyrene calibrants. 
2.2.3.4 Fourier transform infrared spectroscopy (FTIR): FTIR 
spectroscopy of the as extracted polymer was performed by preparing KBr discs 
(sample: KBr, 1: 100) (Kemp W 1991). An FT-IR 1720x spectrometer (Perkin- 
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Elmer, USA) was used under the following conditions: spectral range, 400-4000 
cm-1; window material, Csl; 16 scans; resolution 4 cm-1; temperature stabilised 
coated FR-DTGS detector. 
2.2.3.5 Differential scanning calorimetry (DSC): Thermal analysis of the 
samples (extracted and commercially available P(3HB)) was performed with a 
Perkin-Elmer Diamond DSC (Perkin-Elmer Instruments, USA). Samples in 
duplicates (4-6 mg) were encapsulated in standard aluminium pans and all tests 
were carried out under inert nitrogen. The samples were heated from -50 to 
200°C at a heating rate of 20°C/min (first heating cycle). The samples were then 
brought to -50°C (cooling rate of 20°C/min) and further heated to 200°C with a 
heating rate of 10°C/min (second heating cycle). 
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2.3 Results and Discussion 
2.3.1 Culturing of Bacillus cereus SPV cells & shaken flask study 
The new strain of bacteria used for polymer production in this study was 
classified as Bacillus cereus SPV (belonging from the Bacillus spp. ) (Valappil SP 
et al. 2007b). The SEM image of the bacterial cells in Figure 2.4 shows the 
micron sized and rod shaped Bacillus spp. cells. The Bacillus spp. cells obtained 
from the University of Westminster culture collection was preserved (i) as glycerol 
deeps (-20°C) and (ii) cultured on agar plates (4°C) 
Figure 2.4 SEM image of a cluster of Bacillus spp. cells, each individual rod corresponds to 
a single bacterial cell 
The production of P(3HB) was firstly carried out in 300 mL shaken flasks to 
identify the processing parameters (pH, temperature, dissolved oxygen tension) 
that affected the growth of the bacteria. The first step of polymer production was 
to grow Bacillus spp. in a nutrient rich medium (nutrient broth), where no nutrient 
limitation is induced and the polymer production is not stimulated. After growing 
the cells for 24 h the culture was inoculated in 300 mL of nitrogen limiting Kannan 
and Rehacek medium (production medium). At this stage the polymer production 
and accumulation is triggered by the absence of nitrogen and the presence of 
excess glucose in the medium. It is important to note that nitrogen is not the only 
limiting nutrient that has been shown to produce P(3HB). There are other 
nutrients such as phosphorus and potassium, whose absence can also trigger 
the production and accumulation of P(3HB) (Dawes EA et al. 1973; Valappil SP 
et al. 2008). PHA accumulation occurs in response to an imbalance in growth, 
brought about by nutrient limitations. The stored PHA constitutes an ideal carbon- 
energy storage material for the bacteria due to its low solubility and high 
molecular weight, which exerts negligible osmotic pressure to the bacterial cell. 
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Since 1987, extensive research has been carried out to understand the metabolic 
synthesis of PHAs (Madison LL et al. 1999). This has provided us with a body of 
information on P(3HB) metabolism, biochemistry, physiology and molecular 
genetic studies. From these studies, it is clear that nature has evolved several 
different pathways for PHA formation, each optimised for the ecological niche of 
the PHA-producing microorganism. Not only have these studies provided a 
fundamental insight into microbial physiology, but also the keys for designing and 
engineering recombinant organisms for PHA production. 
Based on the types of monomer (Steinbüchel A et a!. 1995; Hazer B et a!. 2007) 
incorporated into PHA and organisms used, various metabolic pathways have 
been shown to be involved in the generation of these monomers. Briefly, the 
P(3HB) biosynthetic pathway consists of three enzymatic reactions catalysed by 
three distinct enzymes. The first reaction consists of the condensation of two 
acetyl coenzyme A (acetyl-CoA) molecules into acetoacetyl-CoA by "-ketoacyl- 
CoA thiolase (encoded by phbA). The second reaction is the reduction of 
acetoacetyl-CoA to (R)-3-hydroxybutyryl-CoA by an NADPH-dependent 
acetoacetyl-CoA dehydrogenase (encoded by phbB). Lastly, the (R)-3- 
hydroxybutyryl-CoA monomers are polymerized into poly(3-hydroxybutyrate) by 
P(3HB) polymerase (encoded by phbC) (Madison LL et al. 1999; Steinbüchel A 
2001). The complete pathway involved for P(3HB) production is extensively 
reported in the literature and was not studied in this project (Madison LL et a!. 
1999). 
The first deliverable from the shaken flask study was to examine the effect of 
temperature on the growth of the organism. Figure 2.5 shows the amount of 
Bacillus spp. cells produced from a 300 mL culture, over the 72 h period, when 
grown at various temperature. The amount of cells accumulated from a 300 mL 
culture was found to be the maximum, when grown at around 37°C. Although, 
37°C seems to be the best temperature for bacterial growth, it does not 
necessarily mean that it is also the best temperature for polymer accumulation 
within the cells. Since in our case the polymer accumulation was the driving 
factor, all Bacillus spp. culture was grown at 30°C to ensure maximum PHA 
accumulation. 
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Figure 2.5 Amount of Bacillus cereus SPV cells grown after 72 h at different temperatures, 
using 300 mL shaken flask study. No detectable growth of Bacillus spp. cells at 20 and 50°C. 
The second deliverable from the shaken flask study was to get information about 
the changes in the growth parameters of the culture during the growth period. 
Over the study period, the bacterial cell mass (dry cell weight) increased to a 
maximum within 30 h of cultivation after which there was a gradual decrease, as 
shown in Figure 2.6. In the same study the pH decreased from 7 to 4.3. The 
decrease in pH is primarily because the production medium is an un-buffered 
medium. This low pH has an advantage on its own, as it has been reported to 
inhibit utilisation of the polymer by the bacteria and spore formation (Kominek LA 
et al. 1965). This further helps to retain the P(3HB) content within the cells. This 
trend was also shown by Valappil et al. (Valappil SP et al. 2007a) wherein the 
maximum P(3HB) accumulation in a shaken flask study was found to be around 
60 h and the low pH prevented the consumption of P(3HB) for up to 72 h. This 
was a deciding factor in growing the bacterial cells for a period up to 72 h. 
The bacterial cells produced at the end of the run were then subjected to one of 
the polymer extraction techniques, as discussed in Section 2.3.3. P(3HB) 
produced under nitrogen limitation medium (as in our case), was shown to be 
higher when compared with other reported minimal media such as potassium or 
phosphate deficient production medium (Valappil SP et al. 2008). From a 300 mL 
culture, after 72 h the maximum dry cell weight (dcw) achieved was 1±0.36 g and 
the polymer yield was up to a maximum of 0.25 g (25% dcw in terms of net 
polymer yield). In comparison, it has been shown that polymer accumulation in 
Bacillus cells after 72 h was 34% dcw (estimated using whole cell methanolysis, 
using Gas chromatography) (Valappil SP et a/. 2007a). 
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Figure 2.6 Changes in the pH of the medium and variation of the dry cell weight up to a 
period of 72 h during the growth of Bacillus cereus SPV in shaken flasks using Kannan & Rehacek 
medium. 
2.3.2 Scale up of P(3HB) production using fermentation 
After being able to produce P(3HB) in small quantity using 300 mL shaken flask 
study, a 14 L fermentation strategy was adopted to upscale the polymer 
production. The main production associated parameters monitored over the 
course of the fermentation run are plotted in Figure 2.7. None of the parameters 
were controlled during the fermentation run and hence this shows the possibility 
of optimising the parameters (DOT, pH) to enhance the yield of polymer. 
Microbial growth stages can be broadly categorised into three phases i. e. lag 
phase, log phase and stationary phase, and each of them have their own 
characteristic features. In the lag phase, there was a sudden drop in the DOT 
levels highlighting the consumption of air by the bacteria in order to carry out their 
metabolic activities. During this phase, the optical density of the medium does not 
increase because the bacterial cells adapt to the growth conditions provided to 
them. Dry cell weight, which is a measure of the amount of cells, does not 
considerably increase over the lag phase. During the growth of cells, the pH of 
the medium fell sharply to 6 within the first 10 h and then it gradually decreased 
in the log and stationary phase. This decrease in pH was similar to the one 
observed in the shaken flask study (Figure 2.6) and that reported in earlier 
studies (Valappil SP et al. 2007a). The sharp increase in the bacterial cells 
depicted by an increase in the optical density of the medium and the dry cell 
I 
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weight (dcw) occurs between 10 and 30 h (classified as the log phase). During 
the log phase the OD and dcw increases and indicating the growth of cells. There 
was no significant increase in dcw and OD in the stationary phase, compared to 
the log phase. This phase also coincided with the stabilisation of pH at around 
4.5. During this stage the activity of the bacteria is minimal and their growth is 
impaired because of the depletion of the nutrients from the medium. This phase 
is usually followed by a cell death phase because of lack of nutrients. 
P(3HB) accumulation within the cells is measured using whole cell methanolysis 
(Huijberts GNM et al. 1994) and has been investigated for this organism (Valappil 
SP et al. 2007a). It has been shown in a similar study that P(3HB) production 
during the growth phase was minimal, followed by a steady increase during the 
log phase and saturation at the stationary phase. Cessation of logarithmic growth 
coincided with the approach of the pH minimum and rapid consumption of 
glucose. As expected, P(3HB) production has also been reported to be 
accompanied by a simultaneous decrease in glucose concentration. High initial 
concentration of glucose with a limiting nitrogen medium encourages the bacteria 
to accumulate the excess glucose within them (in the form of P(3HB)). But, on 
depletion of other nutrients including glucose from the medium, the bacteria start 
consuming their stored glucose. In this case it has been shown that the relative 
low pH of the medium (acidic medium) prohibits the sporulation of Bacillus spp. 
cells and prohibits the intracellular degradation of P(3HB), correlated by the 
constant P(3HB) content for up to 72 h (Kominek LA et al. 1965; Valappil SP et 
al. 2007a). 
Since the abundance of glucose acts as a precursor for the accumulation of PHA, 
a co-feeding strategy can be used in this case to further increase the polymer 
content. After growing the culture for 72 h the Bacillus spp. cells were harvested 
by centrifugation and frozen for the isolation of polymer. The weight of the cells 
was recorded, and from a 14 L culture, 32±4 g of cells was produced. A 
comparison of the amount of Bacillus spp. cells and polymer produced from 
shaken flask study and fermentation study is shown in Figure 2.8. 
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Figure 2.7 Growth of Bacillus spp. cells in a 14 L fermentation study and recording of pH 
(ri ), dry cell weight (c), dissolved oxygen tension (DOT, % air saturation) (") and optical density 
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Figure 2.8 Comparison of amount of cells produced (dcw), polymer extracted (g) and 
polymer yield (% dcw) from shaken flask and fermentation study. The polymer content in this case 
was measured using the absolute quantity and not using whole cell methanolysis. 
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2.3.3 Extraction and characterisation of PHA 
2.3.3.1 Extraction of PHA: Isolating the polymer from the bacterial cells is a 
major step in PHA production. In order to get a better recovery a pre-treatment 
step is performed to improve the cell disruption. Moreover, to get a higher purity, 
an additional purification step could also be added to the process, as shown in 
Figure 2.9 (Jacquel N et al. 2008). In this case, after harvesting the Bacillus spp. 
cells, freeze-drying was used as the pre-treatment operation, followed by using 
three different extraction techniques, as explained in Section 2.2.2. Freeze drying 
also helps in releasing PHA granules and aids the cell to be digested during 
extraction. 
Use of solvents to recover PHA is one of the oldest methods. The action of 
solvent can be divided in two, first it modifies the cell membrane permeability and 
then it dissolves PHAs. The chloroform extraction (Hahn SK et al. 1995) method 
relies solely on the solubility of the PHA in chloroform and was the simplest 
method of extraction used for this study. After treating the biomass (cells) in 
chloroform, the cell debris were physically removed and the polymer was 
precipitated out using ice-cold methanol. The advantage of this technique over 
the other methods is the minimal use of organic solvents as well as the absence 
of sodium hypochlorite, which has been shown to have a degrading effect on the 
molecular weight of the polymer (Hahn SK et al. 1994; Hahn SK et al. 1995). But, 
the disadvantage is usually the relative purity of the polymer. Chloroform is not 
the only organic solvent that has been reported for PHA extraction. Vanlautem 
and Gilain (Vanlautem N et a/. 1982), investigated extraction of PHA from R. 
eutropha with liquid halogenated solvents, such as chloroethanes and 
chloropropanes and showed that the best results were obtained for solvents in 
which the functional carbon atoms carry at least one chlorine atom and one 
hydrogen atom. The use of diols (1,2-propandiol: recovery 79%, purity 99.1%, 
140°C), acetalised triols (glycerol formal: recovery 85%, purity 99.7%, 120°C), di- 
or tricarboxylic acid esters (diethyl succinate: recovery 90%, purity 100%, 110°C), 
or butyrolactone (recovery 90%, purity 99.5%, 110°C), as extracting agents was 
studied by Traussnig et al. (Traussnig H et al. 1990). Other solvents like 
tetrahydrofuran, methyl cyanide, ethyl cyanide and acetic anhydride have been 
also tested (Jacquel N et a/. 2008). Whereas these methods do not lead to very 
high recovery, it is possible to obtain a high level of purity (e. g. recovery of 
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P(3HB-co-3HV) from R. eutropha cells using methylene chloride with a purity 
above 98%) (Zinn M et al. 2003). 
The other two methods used for extracting the polymer are the soxhlet (Ramsay 
JA et al. 1990; Ramsay JA of al. 1994) and dispersion techniques (Hahn SK of al. 
1994; Hahn SK et al. 1995), which share a common principle in extracting the 
polymer from the biomass, i. e. the use of the anionic surfactant hypochlorite. 
Sodium hypochlorite is used for differential digestion of non-PHA cellular 
materials and also to break the cell walls and allow the polymer to be dissolved in 
the solvent used. However, the use of sodium hypochiorite is shown to cause 
degradation in the molecular weight of PHAs (Berger E of al. 1989). Native PHA 
granules are susceptible to alkaline hypochlorite and are decomposed into 
soluble products such as monomers and oligomers. However, the soxhlet 
technique employs the washing of the Bacillus spp. cells with acetone, diethyl 
ether and ethanol before the polymer extraction, which helps in removing the 
lipids and other non-PHA matter that are soluble in non polar organic solvents. All 
the extraction techniques used in this study had an effect on the material 
properties of the extracted polymer and this behaviour is discussed in Section 
2.3.4. The extracted polymer was then characterised to identify its chemical 
composition (Section 2.3.3). 
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Figure 2.9 Recovery and extraction of PHAs from bacterial cells (Jacque) N et al. 2008). 
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2.3.3.2 Characterisation of PHA: Extracted PHA was characterised using 
GC-MS, NMR and FTIR for identifying its chemical structure. Results from GC- 
MS analysis of the polymeric samples are shown in Figure 2.10. Methyl benzoate 
was used as the internal standard. All of the GC peaks obtained were further 
subjected to mass spectrometric analysis. The molecular Ion-related mass 
fragments due to the methyl ester of 3HB (M,,, =118) occurred at m/z 117.1. When 
compared to the ones reported in the literature the results obtained clearly 
established the presence of 3HB in the Isolated polymer (Valappil SP et al. 
2007b). 
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Figure 2.10 The total ion current chromatogram of the methanolysis products of the polymer 
and (b) mass spectrum of the methyl ester of 3-hydroxybutyrate. 
The structure of the extracted polymer was further examined using solid-state 13C 
NMR analysis. Four narrow lines appeared (Figure 2.11) with very strong 
intensities, which were identical to the CP/MAS 13C NMR spectra of P(3HB) 
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reported previously (Yoshie N et al. 2002). These four peaks were assignable to 
the methyl (CH3; 21.2 ppm), methylene (CH2; 42.7 ppm), methine (CH; 68.5 ppm) 
and carbonyl (C=O; 169.7 ppm) carbon resonance of P(3HB) (Doi Y et al. 
1989b). This analysis thus confirmed that the polymer extracted is P(3HB). 
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Figure 2.11 13C Solid state NMR plot of the polymeric sample, confirming it to be Poly(3- 
hydroxybutyrate). SSB stands for spinning side bands, which occurs due to the equipment's 
experimentation, set up. 
The FTIR spectrum for the extracted polymer was also analysed to estabilish the 
nature of the polymer. Absorption bands at 1728 cm" corresponding to the ester 
carbonyl group and 1282 cm'' assigned to -CH group are characteristic features 
of P(3HB) that distinguish it from other medium-chain-length and scl-mcl PHAs 
(Hong K et al. 1999). A comparison with the FTIR spectrum of the commercial 
P(3HB) further confirmed the extracted polymer to be a short-chain-length poly(3- 
hydroxybutyrate) (Figure 2.12). FTIR analysis was also used to determine the 
effect of different extraction techniques on the crystallinity index of the polymer 
(discussed in Section 2.3.4) (Galego N et a!. 2000). 
42.7 
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Figure 2.12 FTIR spectrum of P(3HB) in KBr pellet. 
2.3.4 Effect of extraction technique on material properties of 
P(3HB): 
The different extraction techniques employed to isolate P(3HB) were found to 
have an effect on the material properties of P(3HB). The amount of crude yield of 
the polymer extracted from cell biomass was found to be highest for the 
chloroform extraction (31% dcw), followed by the dispersion method (30% dcw) 
and the lowest yield (27% dcw) was obtained using soxhlet extraction (as shown 
in Table 2.2). The yield of the polymer using any of the described techniques is 
low compared to the ones mentioned in the literature and can be improved by 
using fed-batch fermentation technique or even an optimised production medium. 
The high yield of the polymer in the chloroform and dispersion technique can be 
attributed to the presence of some non-PHA (such as, lipids, cell mass etc. ) 
matter that is not filtered out during the extraction process. This led to evaluating 
the purity of the polymer by calculating the total amount of P(3HB) in the isolated 
powder, as determined by Gas chromatography compared to the crude weight of 
polymer powder (Valappil SP et al. 2007a). It was found that the purity of P(3HB) 
extracted was highest for soxhlet extraction (99%), followed by the dispersion 
extraction (95%) and finally the chloroform extraction method (92%). Although all 
the three techniques yielded a pure polymer, it was the soxhlet and dispersion 
techniques that gave polymers of highest purity. The relative high purity in this 
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case can be due to the rigorous washing of the cells with organic solvents and 
the physical separation of the extract from the cellular debris. 
Table 2.2 Thermal and molecular characterisation of P(3HB) samples extracted from the 
Bacillus spp. cells using three different techniques. 
Sample Yield Purity M, PDI Tm To AH, Xe Cl 
(% dcw) (%) (°C) (°C) (J/9) (%) 
Soxhlet 27 99 1,100,000 1.7 169.7 2.1 86.1 57.6 0.76 
Chloroform 31 92 882,000 2.6 160.8 -2.5 81.3 54.4 0.74 
Dispersion 30 95 885,000 3.1 171.7 2.7 95.7 64.1 0.78 
% dcw =% dry cell weight (weight of the dried cells before polymer extraction), M. = Molecular 
Weight, PDI = Polydispersity Index, T, n= Melting Temperature, T9 = Glass Transition temperature, 
AI-If = Heat of Fusion, XX = Crystallinity, Cl = Crystallinity Index 
The effect of extraction method on the thermal properties of the polymer was 
examined by comparing the melting temperature (T. ), glass transition 
temperature (Tg) and enthalpy of fusion. Among the three techniques used, the 
polymer isolated using the soxhlet and the dispersion methods gave similar T. 
values (169.71 °C and 171.71 °C, respectively) as compared to a relatively lower 
Tm (160.83°C) for the polymer obtained using chloroform extraction technique. 
Similarly, the T. of the polymer isolated using the soxhlet and dispersion methods 
were similar (2.04°C and 2.72°C, respectively), compared to a lower value of - 
2.45°C for the polymer extracted using chloroform extraction technique. The 
effect of impurities on T. was not investigated in this study. The reason for such a 
trend can be related to the fact that the chloroform extraction technique uses the 
least amount of solvents during extraction and may allow lipids, fatty acids and 
other hydrophobic cellular materials to be extracted along with P(31-113). The 
presence of such impurities might lead to the slight differences in the thermal 
properties. 
From the DSC measurements the degree of crystallinity of the polymer was also 
determined by measuring the ratio of enthalpy of fusion (AHf) for the extracted 
polymer and AH1 for 100% crystalline P(3HB) (Doyle C et al. 1991), which is 
known to be 149.37 J/g (Equation 2.1). Although PHAs, including P(3HB) are 
present within the bacteria cells as amorphous granules, when isolated from 
bacteria they are known to form crystalline structures due to freeze-drying or 
aqueous solvent treatment employed during the recovery treatment (Jacquel N et 
a/. 2008). In the present study the crystallinity obtained for the P(3HB) extracted 
using the three different methods were found to be similar to the ones reported in 
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the literature (i. e. 55-80%) (Doi Y of al. 2002). Among the three extraction 
techniques used, the dispersion method gave the highest crystallinity value 
(64%) compared to the soxhiet extraction (58%) and the chloroform extraction 
(54%) methods. The results indicate that changing the extraction technique can 
alter the crystallinity of the polymer. 
%Crystallinityv(X, ) _ ýýx 
100 - Equation 2.1 
f (1O(r4cIynalliNe 
Apart from identification of the PHA, FTIR technique can also be used to 
measure the degree of crystallinity (crystallinity Index) of the polymer (Galego N 
et al. 2000). The crystallinity index (CI) is defined as the ratio of the Intensities of 
the bands at 1382 cm" (CH3), which is insensitive to the degree of crystallinity, to 
that at 1185 cm'' (C-O-C), which is sensitive to the amorphous state (Figure 
2.12). The Cl of P(3HB) isolated using all the three techniques was determined to 
be in the range 0.74 - 0.78 (Table 2.2) which was much lower than the previously 
reported value of 0.949 for P(3HB) (Galego N et al. 2000). The results from FTIR 
and DSC on the degree of crystallinity show the ability to alter the crystallinity of 
the polymer for various applications by using the appropriate extraction 
technique. This is particularly important, as the crystallinity of a polymer is known 
to play a major role in the degradation of a polymer. Although the degree of 
crystallinity measured using DSC and FTIR cannot be considered an absolute 
quantity, it provides a measure for relative comparison between materials, in this 
case between the different extraction techniques investigated. The crystallinity 
index calculated using FTIR and the % crystallinity measured using DSC show a 
similar pattern, as highlighted in Table 2.2. 
The molecular weight of the extracted P(3HB) was evaluated using GPC analysis 
and the results showed the ability to isolate the polymer with relatively higher 
molecular weight (-1,000,000). The weight average molecular weight of the 
extracted polymer was highest for soxhlet technique followed by chloroform and 
dispersion technique. This is primarily due to the use of sodium hypochlorite 
during the extraction process (Jacquel N et a/. 2008). Since molecular weight 
plays an important role in not only determining the mechanical properties but also 
in affecting the degradation kinetics of the polymer, it was therefore decided to 
use dispersion technique as the chosen method of polymer extraction from the 
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cells. This is primarily because dispersion technique allows altering the 
concentration of sodium hypochlorite, which in turn affects the molecular weight 
(Hahn SK et al. 1994). The XRD pattern showed in Figure 2.13 also confirms that 
the crystalline morphology developed by freeze-drying and the aqueous solvent 
treatment protected P(3HB) molecules from being further digested by 
hypochlorite. Using 100% concentrated sodium hypochlorite solution resulted in 
extracting P(3HB) with much lower molecular weight of 300,000 (Mw), which 
matched the molecular weight of the commercially available P(3HB) (Section 
2.3.5). 
For this project, the Dispersion technique was used for extracting P(3HB) from 
the bacterial cells as it offers the following advantages: high purity, faster 
extraction time, range of molecular weights achievable, extraction performed at 
room temperature, and finally high yield of polymer extracted from cells. A mass 
of 8±2 g of P(3HB) was extracted from 32±4 g of dried Bacillus cereus SPV cells 
(14 L fermentor) using the dispersion technique. 
2.3.5 Comparison of laboratory produced and commercial 
P(3HB) 
Since P(3HB) is bacterially produced, this polymer is known to exhibit a range of 
properties depending on the differences in the organisms used and the 
production process. Therefore it was in our prime interest to compare the 
laboratory produced and the commercial P(3HB) (Fluka, Schnelldorf, Germany). 
In the next few paragraphs a comparison (processability, purity, adaptability) 
between the commercial and lab produced P(3HB) is laid out. 
The thermal properties and crystalline patterns of the extracted and commercial 
P(3HB) were compared using DSC and XRD measurements, respectively. The 
X-ray diffractograms of the extracted polymer indicated that there was no 
additional crystalline phases present in the lab grown P(3HB) compared to the 
commercial P(3HB), as shown in Figure 2.13. By looking at the X-Ray diffraction 
pattern, the semi crystalline nature of the polymer can be confirmed, which is 
also widely reported in literature (Pouton CW et a/. 1996; Di Lorenzo ML et al. 
2001). 
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Figure 2.13 X-ray diffraction patterns of (a) commercially available P(3HB) and (b) lab grown 
P(3HB). Skrbic Z, et at. (Skrbic Z et al. 1996) calculated unit cell parameters on the basis of the 
positions (2q) of well separated diffraction maxima using the quadratic form of the rhombic cell. 
Figure 2.14 shows a DSC thermograph of commercial and lab grown P(3HB), 
while Table 2.3 presents a comparison of the thermal properties of both 
materials. The thermal measurements in Table 2.3 for both samples are quoted 
from the second heating run of the DSC plot. There were no significant 
differences between the thermographs during the first heating run. Nevertheless, 
values from the second heating are taken in order to obtain a true representation 
of the extracted polymer. The crystallisation temperature and the glass transition 
temperature of the lab produced and commercial P(3HB) were found to be very 
similar, as evident from Figure 2.14 and Table 2.3. However, there was a slight 
decrease in the melting temperature for the lab grown P(3HB) compared to 
commercial P(3HB). The crystallinity for both polymers, determined by measuring 
the enthalpy of fusion (Equation 2.1), suggested both types of P(3HB) to have 
similar degree of crystallinity. 
Table 2.3 Thermal properties of lab grown P(3HB) compared with commercially available 
P(3HB). Data for thermal properties gathered from the second heating curve of DSC. 
Properties Commercial P(3HB) Lab grown P(3HB) 
Tm ('C) 172.2±0.6 169±2 
To ('C) 2.0±0.3 1.9±0.2 
TC ('C) 58.9±0.5 59±2 
OHf (J/g) 70±9 68.5±0.3 
X (%) 47 46 
M. 398,000 300,000 
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Figure 2.14 Normalised DSC heating curves of (a) commercial P(3HB) and (b) laboratory 
grown P(3HB) obtained at a heating rate of 20°C/min. Data taken from the second heating cycle. 
As stated in Section 2.3.4, the advantage of using the dispersion technique was 
to control the molecular weight of the extracted polymer. P(3HB) extracted using 
100% concentrated sodium hypochlorite, instead of diluted sodium hypochiorite, 
resulted in P(3HB) with significantly lower molecular mass, as shown in Table 
2.3. Nevertheless, the M, was found to be very similar to the commercial P(3HB) 
and for further extraction of P(3HB), concentrated sodium hypochlorite was 
always used. One of the advantages of using the lab produced P(3HB) is the 
ability to have a tailored M, -providing a design freedom for any application, as 
opposed to commercial P(3HB) which obviously comes with a fixed M,, value. 
Currently, PHAs are produced at industrial scale using Gram-negative bacteria 
(Wautersia eutropha, Pseudomonas oleovorans, Escherichia coli etc. ). However, 
PHAs isolated from Gram-negative organisms contain the outer membrane 
lipopolysaccharide (LPS) endotoxins, which are pyrogens known to co-purify 
alongwith the PHAs. The presence of LPS induces a strong immunogenic 
reaction and is therefore undesirable in general for the biomedical application of 
the PHAs (Shishatskaya El et al. 2004; Chen GQ et al. 2005). Gram-positive 
bacteria (as in this case Bacillus cereus SPV) lack LPS and are hence potentially 
better sources of PHAs to be used for biomedical applications (Lee SY et al. 
1999a). Although the endotoxin level of the commercial P(3HB) was not 
evaluated, the absence of the LPS endotoxin in the lab produced P(3HB) coupled 
with the use of simple, relatively inexpensive carbon sources, such as glucose, 
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justifies the further consideration of lab produced P(3HB) for biomedical 
applications. 
Another added advantage of using lab P(3HB) Is In its processability. This was 
evidenced in the fact that up to 10 wt% of lab grown P(3HB) solution was easily 
obtainable at room temperature without the need of any external heating. In 
comparison, for commercial P(3HB) heating was required to prepare a polymer 
solution with higher than 2 wt% concentration. This is of great importance in this 
project as the polymer concentration in polymer solution plays an important role 
in determining the microstructure of the final products. For example, the polymer 
concentration can play a vital role in tailoring the microstructure of a polymeric 
scaffold prepared using thermally induced phase separation technique. Similarly, 
if a polymeric scaffold is prepared by the particulate leaching technique using 
sugar or salt, then a hot polymer solution will in effect melt the porogen and thus 
cause a change in the microstructure (porosity, pore size) of the produced 
scaffold. As in our case, we have employed solvent casting and particulate 
leaching techniques to prepare films and scaffolds; therefore using laboratory 
grown P(3HB) instead of commercial P(3HB) had significant advantages. 
On successfully demonstrating the advantages of lab produced P(3HB), films 
were prepared using conventional solvent casting technique. Chloroform was 
used as the solvent to prepare the polymer solution using three different P(3HB) 
concentrations (1,2'and 3 wt%) to get homogenous and microstructurally uniform 
films. The produced films were examined under SEM to investigate their 
microstructure. Figure 2.15 shows SEM images of films produced using 1 and 3 
wt% of P(3HB) in chloroform. It can be seen clearly from the SEM images that 
using 1 wt% polymer concentration resulted in a porous microstructure. Although, 
the pores were homogenously distributed; the presence of porosity will have an 
effect on the measured properties (viz. protein adsorption, mechanical properties, 
etc. ). Hence, a P(3HB) concentration of 3 wt% was used for the preparation films 
(both pure polymers and composites) (See Chapter 3), to ensure less porosity 
and a better homogeneity. The polymer solution was left at room temperature for 
the solvent to evaporate (approx 48-72 h). The films developed were 
characterised to evaluate a range of properties as mentioned, as presented in 
detail in Chapters 3 and 4. 
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Figure 2.15 SEM micrographs of thy: nýýý. ýus; ýu turf: ur iliiw. plus ri.. d by solvent 
casting technique using (a) 1 wt% P(3HB) and (b) 3 wt% P(3HB). 
2.4 Conclusions 
The results obtained in this part of the investigation lead to the following 
conclusions: 
" P(3HB) was produced and extracted from a novel strain of Gram positive 
Bacillus spp. Scaling up the 300 mL shaken flask study to the 14 L fermentation 
process resulted in an increase in dry cell weight (i. e. from 1±0.36 to 32±4 g), 
and an increase in the amount of polymer produced (i. e. from <0.1 to 8±2 g). In 
both cases the % dcw was found to be very similar, highlighting the intrinsic 
ability of Bacillus cereus to produce P(3HB) under similar conditions. 
" The polymer produced was characterised using GC-MS, NMR, FTIR and it 
was confirmed to be a short-chain-length homopolymer of 3-hydroxybutyric acid 
i. e. poly(3-hydroxybutyric acid). 
" P(3HB) was successfully isolated from the Bacillus spp. inclusions by using 
three different extraction techniques. It was found that the molecular weight, 
purity and cost of the polymer can be tailored depending on the extraction 
technique used. 
" The extracted P(3HB) had similar thermal and structural properties to 
commercial P(3HB). However, the lab produced P(3HB) had excellent 
processability compared to commercial P(3HB). 
" The production of endotoxin free P(3HB) further highlights the high potential of 
the polymer for biomedical applications. 
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3. Preparation and characterisation of 
PI3HB1/BiogIass" composites 
3.1 Introduction 
The extracted P(3HB) from Bacillus cereus SPV was used in combination with a 
range of bioactive glass (BG) concentrations to prepare composites. Various 
experiments were conducted to analyse the thermal, mechanical and structural 
properties of the composites, as shown in Figure 3.1. This chapter entails the 
experimental techniques used to analyse the fabricated composites and the 
results obtained from the complete characterisation of the developed P(3HB)/BG 
composite systems. Two different types of bioactive glass particles were used 
(i. e. melt derived microscale (m-BG) and flame spray synthesised nanoscale (n- 
BG) bioactive glass particles) to prepare the composites. The results obtained 
from the characterisation of the composites can be categorised as (i) the effect of 
m-BG particles on physico-mechanical properties of the composite films, (ii) a 
comparative analysis between P(3HB)/m-BG and P(3HB)/n-BG composite films 
and (iii) the results obtained on P(3HB) and P(3HB)/m-BG scaffolds (porous 
foams). 
P(3HB)IBiöglass ; '. _ composites 
Mlc rostructural Thermal Mechanical Stndurai 
SI OSC TS 
Rartmn 
SEM _O CEý: ) 
CýD 
Figure 3.1 Schematic representation of the characterisation techniques used to analyse the 
P(3HB)/Bioglass® composites systems. Abbreviated symbols are mentioned in the list of 
abbreviations 
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3.2 Experimental details 
P(3HB) was produced from Bacillus cereus SPV as mentioned In Chapter 2 and 
chloroform was obtained from Sigma-Aldrich Company Ltd., (UK). Two different 
types of bioactive glass particles i. e. microscale (m-BG) and nanoscale bioactive 
glass (n-BG) were used in this study to prepare the composites. m-BG particles 
used were prepared using melt derived process and provided by Dr. Ian 
Thompson (Kings College, UK) (Sepulveda P et al. 2002). Flame spray synthesis 
was used to prepare nanoscale bioactive glass particles (n-BG), as developed by 
Brunner et al. (Brunner TJ et al. 2006) and was donated by Prof. W. J. Stark (ETH 
Zurich, Switzerland). Both types of Bioglass® particles were used as supplied 
without any further heat treatment or purification. 
3.2.1 Sample preparation 
3.2.1.1 Composite film preparation: P(3HB) and P(3HB)/BG composite 
films were prepared by using conventional solvent casting technique. P(3HB) was 
dissolved in chloroform at room temperature and at a concentration of 3 wt%. 
Appropriate amount of BG particles were added to the polymer solution to yield 
composites with 5,10,20 and 30 wt% BG concentrations. This mixture was 
further sonicated for 1-2 min (Ultrasonic Homogenizers US200, Philip Harris 
Scientific, UK) to improve the dispersion of bioactive glass particles by 
desegregating possible agglomerations. The P(3HB)IBG mixture was poured into 
glass petri-dishes (diameter-5 cm; height-15 mm), and left at room temperature, 
resulting in films with a thickness of the order of 120-170 µm. Once the films were 
cast they were vacuum dried for complete removal of the solvent and stored in 
desiccators for further analysis. 
3.2.1.2 Fabrication of foams (scaffolds): P(3HB) and P(3HB)/BG composite 
foams were prepared using a combination of solvent casting and particulate 
leaching technique. The technique was developed by using commercially 
available sugar cubes as the porogen preform. The sugar cubes used were 
available commercially (Whitworths white sugar cubes, London, UK) in 
dimensions of 1.35x1.2x1.8 cm3. To use the sugar cubes for scaffold 
preparations, they were carefully cut to the sizes of 1 x1 x1 cm3 and 1 xO. 8x0.7 
cm3.3 wt% of P(3HB) was dissolved in 10 mL of chloroform and was 
impregnated into the sugar cubes, and were allowed to dry. This step was 
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repeated till the solidified polymer layer obstructed the flow of the polymer 
solution. On such occasions, neat chloroform was added to unblock the pores 
and effectively allow the polymer solution to flow through the volume of the cube. 
This step was repeated until the entire amount of polymer solution was 
impregnated into the cube (schematically described in Figure 3.2). The porosity 
and pore sizes of the foams were not controlled in this study, but the porosity can 
be tailored by effectively controlling the amount of polymer solution impregnated 
in the sugar preform (Section 3.3.8). The sugar cubes with the polymer solution 
were then left to dry at 30°C for 12 h. To prepare P(3HB)/BG composite foams, 
10 wt% of BG particles (m-BG or n-BG) were added to the polymer solution and 
sonicated prior to impregnating it in the sugar preforms. After drying the sugar 
preform, it was then immersed in 200 mL of deionised water for 90 min. The 
water was replenished after every 30 min to allow a complete dissolution of sugar 
from the porous body and left at 30°C to completely dry out the water from the 
scaffolds. After drying, the foam was sectioned using sharp blades to cut foams 
in the size of 0.5x0.5x0.5 cm3 for further experiments. 
P(3HB) solution Impregnate the 
in chloroform P(3HB)IBG solution 
into the sugar cube 
NO 
Flow 
restricted 
YES 
Impregnate chloroform to 
the preform 
Figure 3.2 Schematic representation of the foam preparation technique, the entire process 
was repeated until the known quantity of polymer was impregnated onto the sugar cube. 
3.2.2 Physical characterisation techniques 
The composites prepared in different form (films and foams) were analysed using 
the techniques mentioned below to determine various physical properties. 
3.2.2.1 Scanning electron microscopy (SEM): Scanning electron 
micrographic analysis of films and foams was performed using a JEOL 5610LV 
microscope (JEOL, USA). The samples were placed on 8mm diameter aluminium 
stubs using a sticky tag to hold the sample. A gold sputtering device (EMITECH- 
K550) was used to coat the samples, operating at a pressure of 7x10-2 bar and 
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deposition current of 20 mA for 2 min. Images were taken at various 
magnifications to analyse the samples. 
3.2.2.2 BET surface area analysis: The specific surface area (SSA) of 
Bioglasso particles (n-BG and m-BG) was measured according to Brunauer- 
Emmett-Teller (BET) method, with nitrogen adsorption at 77 K. After degassing 
for Ih at 150°C the measurement was carried out using a Micromeritics Tristar 
instrument. The particle diameter (dBEr) for n-BG was calculated from the SSA 
value, using Equation 3.1. 
dBET =6 Equation 3.1 
pxSSA 
Where 
p= Density of Bioglass® Le. 2.6 glcm3 
SSA = Specific surface area 
3.2.2.3 White light interferometry: 3D imaging of the surface topography 
was obtained by means of white light interferometry (ZYGOO, New View 200 
OMP 0407C, UK) in order to evaluate the topography and measure the surface 
roughness of the samples. Polymeric and composite samples were analysed at 
10x magnification using a 100 pm bipolar scan. Three analyses per sample were 
performed to get an average RMS measurement. 
3.2.2.4 Water contact angle study: Static contact angle measurements 
were carried out in order to evaluate the wettability of the samples. The 
experiment was carried out on a KSV Cam 200 optical contact angle meter (KSV 
Instruments Ltd., Finland). An equal volume of water (<12 ILL) was placed on 
every sample by means of a gas tight micro-syringe forming a drop. Photos 
(frame interval-1s, number of frames-100) were taken to record the shape of the 
drops. The water contact angles on the specimens were measured by analysing 
the recorded drop images (n=4) using the Windows based KSV-Cam software. 
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3.2.2.5 Differential Scanning Calorimetry (DSC): Thermal properties of the 
samples were measured using DSC analysis, performed with a Perkin-Elmer 
Pyris Diamond DSC (Perkin-Elmer Instruments, USA). The sample mass for 
these measurements were in the range of 4-6 mg. Samples were encapsulated in 
standard aluminium pans and all tests were carried out under nitrogen. The 
samples underwent a thermal cycle of heating-cooling-heating, at a heating and 
cooling rate of 20°C/min between -50°C and 200°C. Analysis was carried out in 
duplicates. 
3.2.2.6 Thermoiravimetric Analysis: Thermogravimetric analyses (TGA) 
were performed on the P(3HB) and P(3HB)Bioglass® foams using a Stanton 
Redcroft STA-780 Series Thermal Analyzer. At least three samples for each 
composite material were analysed and the results averaged to determine the 
degradation profiles and residual mass. Scans were performed In an air 
atmosphere with a temperature range of 35-500°C at a rate of 20°C/min. 
Measurements were taken using a sample mass of 9-10 mg for the foams. 
3.2.2.7 Tensile test on films: Tensile tests were carried out on sheets cut 
out from the samples (films) with a width of 1.4 mm and thickness in the range of 
120-170 pm and 5-6 repeats were tested for each specimens. The tensile tests 
were carried out on Perkin-Elmer Dynamic Mechanical Analyser (DMA 7e) at 
room temperature. The initial load was set to 1 mN and increased to 6N at a rate 
of 200 mN/min. The static modulus, stress and strain were recorded during the 
measurement. 
3.2.2.8 Dynamic Mechanical Analysis (DMA): DMA was carried out on 
composite films with a width of 3 mm and an average thickness in the range 120- 
170 pm. Five specimens per composition were tested in tension under stress 
control mode. The tests were carried out using the Perkin-Elmer Dynamic 
Mechanical Analyser (DMA 7e) apparatus. A temperature scan from -20 to 130°C 
at a heating rate of 4°C/min was applied. Initial static force of 5 mN, dynamic 
force of 4 mN and a frequency of 1 Hz. were applied, with a static tension control 
of 110% and a controlled dynamic strain of 0.2%. Nitrogen was used as purge. 
The viscoelastic parameters of storage modulus (E'), loss modulus (E") and 
mechanical loss tangent (tanb) were recorded as a function of temperature for 
the composites. 
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3.2.2.9 Protein adsorption study: Protein adsorption assay on films and 
foams was carried out using fetal bovine serum (FBS). All measurements were 
carried out in triplicates per sample. The samples were covered with 200 pL of 
undiluted FBS in 1.5 mL eppendorfs and Incubated at 37°C for 24 h. The serum 
was then removed from the samples and the samples were washed three times 
with phosphate buffer saline (PBS). The proteins adsorbed on the samples were 
collected by incubating the samples with 1 mL of 2% sodium dodecyl sulfate 
(SIDS) in PBS for 24 h at room temperature and under vigorous shaking. This 
was done to ensure the adsorbed proteins were re-adsorbed in the PBS (with 
SDS). Amount of total protein adsorbed was measured using a commercial 
protein quantification kit (Pierce, Rockford, IL) based on bicinchoninic acid (BCA) 
calorimetric detection of the cuprous cation obtained by protein Cue' reduction in 
an alkaline medium. The sample optical density was measured 
spectrophotometrically at 562 nm against a calibration curve using bovine serum 
albumin (provided in the kit). 
Statistical Analysis 
All data are expressed as mean i standard deviation. The data were compared 
using Student's t-test and differences were considered significant when *p<0.05, 
**p<0.01 and ***p<0.001. A p-value higher than 0.05 (p>0.05) was taken as 
indicating no significant difference. 
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3.3 Results and discussion 
3.3.1 Microstructural characterisation of P(3HB)lm"BG 
composites 
P(3HB)/microscale-Bioglass® (m-BG) composites were prepared in two forms Le. 
films and porous bodies (scaffolds), and the effect of adding different 
concentration of m-BG particles on the theoretical density and its corresponding 
conversion to vol% is shown in Table 3.1. 
Table 3.1 Conversion of wt% to vol% and the corresponding theoretical density (PC) of the 
composite calculated using rule of mixtures. The density of BG particle is 2.6. 
Bioglasse concentrations 
0 wt% 5 wt% 10 wt% 20 wt% 30 wt% 
Vol% 0 2.17 4.45 9.52 15.29 
pc (g/cm3) 1.12 1.15 1.19 1.27 1.35 
Physical shape Films/foams Films Films/foams Films Films 
The surface morphology of the polymeric and composite films produced was 
observed by SEM and shown in Figure 3.3 (a-f). The presence of m-BG particles 
was not extensive over the surface of the composite, as highlighted in Figure 3.3 
(b-c). The cross sectional microstructure of 10 wt% m-BG composite (Figure 3.3 
(d)) shows a fairly dense and relatively uniform thick film. However, EDX analysis 
of the composites confirmed the presence of Bioglass® particles on the surface. 
Figure 3(d) and (e) shows the elemental surface distribution map generated from 
the carbon (C) and silicon (Si) atoms, respectively. The dots generated from the 
C atoms are contributed from the polymeric phase whereas the dots from the Si 
atom are solely generated by the Bioglass® particles. From the EDX generated 
image in Figure 3 (d-e) it can be said that areas with strong intensity of Si have a 
weak intensity of X-ray dots generated by C atoms. Thus confirming the presence 
of m-BG particles on the surface of the composites. The EDS surface map of Si 
also confirmed the size of the m-BG particles to be <5 pm. 
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Figure 3.3 SEM micrographs of (a) P(3HB) films, (b) P(3HB)/5 wt .% m-BG, 
(c) P(3HB)/10 
wt. % m-BG (d) cross section for P(3HB)/10 wt. % m-BG. Elemental surface mapping generated 
from EDX showing the distribution of (e) carbon and (f) silicon, and thus confirming the presence of 
Bioglass° particles (indicated by arrow) on the surface. The thicknesses of the films were in the 
range 120-170 µm. 
Surface analysis of the composite films was carried out using white light 
interferometry to visualise the surface topography and also measure the surface 
roughness, as illustrated in Figure 3.4 (a-b). The surface roughness of the films 
did not change significantly with addition of 5 wt% m-BG particles. A typical 
surface roughness RMS (root-mean-square-average) value of 2.01,3.05 and 4.6 
pm for P(3HB), P(3HB)/5 wt% m-BG and P(3HB)/20 wt% m-BG films was 
measured, respectively. A similar effect has been also reported for PDLLA/TiO2 
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composites (Boccaccini AR et at. 2005b). One of the reason for not a very high 
increase in the surface roughness for P(3HB)/20 wt% m-BG composites is due to 
the partial embedment of the Bioglass® particles in the polymer matrix, which is 
also confirmed from the SEM images in Figure 3.3. 
Figure 3.4 Surface topography analysis obtained by white light interforemetry (Zygo°) 
showing the surface profile and roughness along the drawn line for (a) P(3HB) film and (b) 
P(3HB)/20 wt% m-BG composite. 
The uniform distribution and exposure of Bioglass® particles is important for 
achieving mechanical reinforcement and bioactivity (i. e. growth of 
hydroxyapatite), respectively. From the microstructural analysis it can be said that 
the presence of m-BG particles was confirmed using EDX, SEM, but the particles 
were not highly exposed on surface of the composites, instead they were partially 
embedded in the polymer matrix. This in turn had a detrimental effect on the 
immediate bioactivity of the composites (Chapter 4) and may lead to a time 
dependent bioactivity due to the progressive exposure of m-BG particles upon 
degradation of the polymeric matrix. This highlights the need for using nanoscale 
bioactive glass particles, which due to their higher surface area and nanometric 
size have a higher surface exposure in composites and will favour bioactivity (as 
analysed in Section 3.3.5 and Chapter 4). 
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3.3.2 Thermal properties of P(3HB)! m-BG composites 
Bioglass® is known to influence the properties of polymer matrix composites by 
altering the thermal, mechanical and degradation properties (Wang Metal. 1998; 
Maquet V et a/. 2003; Blaker JJ et al. 2005). In this section the changes induced 
by the presence of m-BG on the thermal properties is discussed. The DSC 
investigations carried out in this study was performed under a constant heating 
rate (20°C/min) 'to resolve the thermal transitions in P(3HB) and P(3HB)/m-BG 
samples. Typical DSC thermograms of P(3HB)/m-BG composite films is shown in 
Figure 3.5, which outlines the first and second heating curves for the polymer and 
the composites. There was no significant difference in the melting point of the 
polymer by the addition of m-BG particles. But, the emergence of secondary 
melting peak (in the first heating cycle) was prominent on increasing the m-BG 
content in the matrix as shown in Figure 3.5. The emergence of a prominent 
secondary melting peak (152°C) during the first heating for the composite 
samples (Figure 3.5) suggest that addition of m-BG particles may cause the 
formation of primary crystals which melt at a lower temperature. In addition to 
inducing the growth of primary crystals the presence of high concentration of m- 
BG particles can also hinder the growth of these crystallites in the polymer, as a 
consequence the degree of crystallinity for the composite decreases. This is 
verified in Table 3.2, wherein increasing the m-BG content significantly reduced 
the heat of fusion (OHf) of the composite. The measure of heat of fusion is also 
used as an indicator of the degree of crystallinity of a material (Doyle C et al. 
1991) determined using Equation 3.2. 
%Crystallinity(XX) = 
f(samppk) 
x 100 Equation 3.2 
'dHf line) 
AHf for a 100% crystalline P(3HB) is reported to be 149.37 JIg (Doyle C et al. 
1991), and as shown in Table 3.2 the degree of crystallinity significantly reduced 
by the inclusion of BG in the polymeric matrix. A similar decrease in crystallinity 
was also noticed for P(3HB-co-3HV)/hydroxyapatite composite films (Chen U et 
al. 2002). 
Examining the DSC heating curves led to identify a striking difference in the 
absence of a prominent melting peak in the second heating curve for the 
composites as the BG concentration increased from 5 to 20 wt%. This lack of 
melting peak in the second heating run shows that either the polymer has been 
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degraded during the first heating run or the polymer has become amorphous. 
However, the former case is not possible as the degradation temperature of 
P(3HB) is reported at a much higher temperature of 250°C (Kim KJ et al. 2006), 
which leaves the only possibility of the presence of BG prohibiting/retarding the 
re-crystallisation of the polymer during the cooling stage. This is also marked by 
the absence of the crystallisation temperature in the composites (Figure 3.5). 
However, for a lower m-BG content of 5 wt% there was evidence of a small 
melting peak during the second heating run, indicating that the polymer is able to 
re-crystallise after the first heating cycle. This phenomenon was not noticed for 
P(3HB), wherein the melting peaks were prominent in the first and second 
heating cycle. This can in turn have an effect on the degradation temperature of 
the composite system. For example, addition of hydroxyapatite in P(3HB-co-3HV) 
matrix, considerably reduced the degradation temperature of the composite 
(Chen LJ et al. 2002). Such an effect of BG on the composite can cause 
problems when using heat processing techniques (e. g. compression/injection 
molding, extrusion) to prepare P(3HB)/BG composites. 
Table 3.2 The effect of m-BG concentration on the thermal properties. Thermal data were 
recorded from the first heating cycle of DSC runs. 
Properties 0 wt% 5 wt% 20 wt% 
TR, (°C) 172±5 *152/169 *156/172 
AHf (J/g) 73±1 60±4 60±2 
XC (%) 49 41 40 
* Denotes the presence of primary and secondary melting peaks, respectively 
Figure 3.5 First and second normalised DSC heating curves of () P(3HB), (-) P(3HB)/5 
wt% m-BG and () P(3HB)/20 wt% m-BG samples. The units of the Y-axis are arbitrary and 
curves are shifted vertically for clarity. 
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3.3.3 Mechanical and thermo-mechanical properties of P(3HB)/m- 
BG composites 
Static tensile tests showed that the P(3HB) films achieved a Young's modulus of 
1.1±0.3 GPa and a yield strength of 17 MPa. Although the Young's modulus of 
P(3HB) has been reported to be In the range of 3-5 GPa, the value for polymeric 
films obtained by solvent casting technique tend to be lower and in fact similar to 
the values reported in the literature for P(3HB) films (Aoyagi Y et al. 2003). 
The static tensile tests showed that the incorporation of m-BG particles in P(3HB) 
matrix decreased the Young's modulus. The elastic moduli decreased by 27%, 
24% and 36% due to the addition of 10,20, and 30 wt% of m-BG particles, 
respectively. However there was no significant difference observed in the yield 
strength of the composite due to the addition of m-BG particles (Table 3.3). Such 
a decrease in the modulus on increasing the filler content may be due to the 
dewetting effect, in which the adhesion strength between the filler and the matrix 
phases is decreased or even suppressed. The dewetting also reduces the 
surface area in contact with the filler, which reduces the fillers efficiency in 
enhancing the modulus (Nielsen LE et a/. 1994). Another reason for a decrease 
in the modulus of the composite may be the possible presence of agglomerates 
of m-BG particles. Agglomerates act as weak points in the material and break 
easily when stress is applied. Broken agglomerates then act as stress 
concentrators leading to micro-cracking and effectively decreasing the modulus 
of the composites. The experimental Young's modulus is compared with various 
theoretical models in Section 3.3.7. 
Table 3.3 Effect of m-BG concentration on the mechanical properties of the composite 
Properties 0 wt% 5 wt% 20 wt% 
T9 (°C) -6.3±0.6 -5±3 -1.2±0.5 
E (GPa) 1.1±0.3 0.8±0.1 0.84±0.05 
YS (MPa) 16.9±1.1 15.4±2.8 17.2±0.4 
Tg = Glass transition temperature calculated from DMA; E= Young's modulus; YS = Yield strength 
Dynamic mechanical analysis (DMA) has been used to extensively characterise 
particulate reinforced polymer composites (Nazhat SN et al. 2001; Rich J et al. 
2002). P(3HB) being a viscoelastic polymer, the material stores mechanical 
energy without dissipation of it (measured as storage modulus E'), and also 
dissipates energy on deformation (measured as loss modulus E"). In a polymer- 
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matrix composite, the energy dissipation may also come from the filler-matrix 
interface where friction between the two phases occurs. The internal friction can 
be quantified by tan ö, which is the ratio of the energy dissipated per cycle to the 
energy stored during the cycle. DMA results were used to evaluate the 
viscoelastic properties (storage modulus, loss modulus and tan6) of the 
P(3HB)lm-BG composites. The storage modulus and loss modulus were obtained 
in the temperature range of -20°C to 130°C and is plotted in Figure 3.6 and a 
detailed set of data with standard deviation from the measurements Is shown In 
Table 3.4. The storage modulus was found to increase for P(3HB) composites 
containing 20 wt% m-BG particles and decreased with the increase in 
temperature. The glass transition temperature (Ta) defined as the temperature 
where the loss modulus obtained its peak value and also tanb measurement 
results are shown in Figure 3.6 and Table 3.4. 
The three important observations made from the DMA analysis on the P(3HB)/m- 
BG composites can be summarised as follows. Firstly, the increase in m-BG 
concentration effectively increases the T. of the polymer, as can be seen In Table 
3.3. It is possible that the T9 increase was due to the partial immobilisation of the 
polymer chains and the physical blocking of a number of molecular configurations 
as a result of adsorption onto the filler surface. However, there have been reports 
showing that an increase in T. occurs when the adhesion between the polymer 
and the filler has been suppressed (Nielsen LE et al. 1994). Secondly, the 
increase in m-BG content also resulted in an increase in tanb, in other words the 
damping capacity of the material increased. Such behaviour can occur due to the 
introduction of new damping mechanisms that are not present in the neat 
polymer. Some of the possible explanations for this increase are: (a) Bioglass®- 
Bioglass® particle friction where particles touch one another as in weak 
agglomerates, (b) P(3HB)-Bioglass® friction where there is essentially no 
adhesion at the interface, and (c) excess damping in the polymer near the 
interface because of induced thermal stresses or changes in polymer 
conformation or morphology. Finally the storage modulus was found to increase 
by the addition of 20 wt% Bioglass® particles, however on increasing the 
temperature the storage modulus was found to have a similar value compared to 
the neat P(3HB) samples. This further cements the previous observation that 
there might be a weak polymer/Bioglass® interfacial strength. The mechanical 
properties achieved for the P(3HB)/m-BG composites thus indicated the need to 
use finer Bioglass® particles, as it has been shown in literature (Pramanik N et al. 
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2006) that the size of the filler particle influences the mechanical properties of the 
composite. 
Table 3.4 Mean and standard deviation of storage modulus (E'), loss modulus (E") and 
tans for Bioglass® reinforced P(3HB) composites, at various temperatures. 
BG content -20°C 0°C 20°C 50°C 
Storage Modulus 0 2.1±0.3 1.6±0.1 1.3±0.1 0.90±0.04 
(Units-109Pa) 5 1.4±0.2 1.0±0.1 0.8±0.1 0.60±0.1 
20 2.4±0.6 1.8±0.3 1.4±0.3 0.90±0.2 
Loss Modulus 0 9±3 9±2 7±1 5.3±0.7 
(Units-107Pa) 5 10±1 10±2 8±2 6±2 
20 16±5 18±4 13±5 6±1 
TanS 0 0.04±0.01 0.06±0.01 0.05±0.01 0.88±0.04 
5 0.07±0.01 0.10±0.02 0.10±0.02 0.11±0.02 
20 0.06±0.01 0.09±0.03 0.09±0.03 0.11±0.06 
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Figure 3.6 Typical plot of storage modulus (SM) and loss modulus (LM) against temperature 
for P(3HB), P(3HB)/5 Wt% m-BG and P(3HB)/20 wt% m-BG composites. 
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3.3.4 Characterisation of micron sized and nanoscale Bioglass® 
particles 
Inorganic phases can in principle be added to the polymer matrix in their micron- 
or nanometric form. However, for PHA composites mainly microscale bioactive 
ceramic particles have been investigated so far. Therefore comparing the 
differences in the mechanical, structural, in vitro degradation and biological 
properties of the composites, due to the incorporation of micron- sized or 
nanoscale bioactive phase additions is a vital step to enhance the applicability of 
the developed P(3HB)/Bioglass® composite system. The extent of the differences 
in the above mentioned properties has been investigated only in few cases in 
isolation and in this study all the properties (Table 3.5) have been compared in a 
single investigation to determine the impact of using nano-sized particulates as 
fillers. 
Table 3.5 Concentration of Bioglass® particles used in the composites and various 
properties compared in this study. (m-BG=microscale Bioglass®; n-BG=nanoscale Bioglass®) 
Properties compared Discussed Bioglass® concentration 
in 10 wt% 20 wt% 30 wt% 
n-BG m-BG n-BG m-BG n-BG m-BG 
Microstructural analysis Chapter-3       
Thermal & mechanical tests Chapter-3       
Protein adsorption Chapter-3       
In vitro degradation Chapter-4     ----- ----- 
Cell proliferation Chapter-4       
As mentioned in Section 3.2, nanoscale Bioglass® (n-BG) and microscale 
Bioglass® (m-BG) were prepared using flame spray synthesis and melt 
processing, respectively. The chemical composition analysis on both type of 
Bioglass® particles showed that n-BG particles had a very similar composition to 
commercially available m-BG (45S5 Bioglass®) particles, with a slightly lower 
P205 content. The Si02 concentration for the n-BG particles was slightly higher 
than that in m-BG particles, which has been shown to increase the alkalinity of 
the surrounding medium, compared to m-BG particles (Vollenweider M et al. 
2007). 
Table 3.6 Chemical composition (wt%) of n-BG and m-BG particles used in this study 
Si02 Na2O CaO P205 
m-BG 45 
n-BG 46.08 
24.5 
22.96 
24.5 
27.18 
6 
3.77 
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Figure 3.7 SEM images of (a) m-BG particles, (b) n-BG particles and (c) TEM image of n- 
BG particles 
The n-BG particles used in this study had a spherical shape with relatively small 
agglomerate sizes, compared to the irregular shape of the m-BG particles (as 
confirmed in Figure 3.7). The specific surface area (SSA) and the BET equivalent 
diameter (calculated from the SSA, as shown in Equation 3.1) for the n-BG 
particles were 79 m2/g and 29 nm respectively. The particle size obtained from 
the BET analysis was verified using transmission electron microscopy (TEM) 
image in Figure 3.7 (c). In contrast, for the m-BG particles, the SSA was 2-3 m2/g 
and BET equivalent diameter was calculated to be between 12-24 pm. However, 
due to low SSA for m-BG particles, the particle diameter measurement had a 
high standard deviation, and was not deemed to be accurate, also the m-BG 
particles were non spherical in nature as shown in Figure 3.7. Nevertheless, from 
SEM observations the particle size of m-BG particles can be agreed to <10 pm. A 
higher specific surface area of the n-BG particles, compared with the m-BG 
particles, was shown to have a great effect on the bioactivity of the composites 
(Chapter 4) along with enhancing the mechanical reinforcement effect (refer to 
Section 3.3.6). 
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3.3.5 Morphology and microstructural differences between 
P(3HB)/n. BG and P(3HB)/m. BG composites 
The morphology and microstructure of the P(3HB)ln-BG and P(3HB)/m-BG 
composite films, examined using SEM, are shown in Figure 3.8 (planar and cross 
section images of P(3HB)/30 wt% n-BG and m-BG composites). It Is evident from 
the micrographs that addition of n-BG particles changed the surface morphology 
considerably and added a rough nano-topography to the surface, when 
compared to the m-BG composites. The exposure of the n-BG particles on the 
surface of the composites was also found to be considerably higher than that of 
the m-BG particles, which played an important role in making the composites 
highly bioactive (Chapter 4). Although sonicating the P(3HB)/Bioglass® 
suspension allowed a homogenous distribution of Bioglass® particles, 
agglomerations of n-BG particles and its embedment in the polymeric matrix were 
evident, as shown in Figure 3.8 (b) and (d). From the SEM images in Figure 3.8, 
it is evident that addition of n-BG particles caused a reinforcing effect, when 
compared with the m-BG composites. This contrasting difference in the 
microstructure of the two composite systems further affected the mechanical 
properties of the composites, as discussed in Section 3.3.6. 
Based on the clear microstructural differences between P(3HB)/m-BG and 
P(3HB)/n-BG composites, wettability of the composites was measured by 
determining the static water contact angles on the surface. Figure 3.9 shows how 
the water contact angle changed over a time period of 100 sec for the 
composites. Valuable information can be extracted from this plot. Firstly, the 
initial slope of the water contact angle profile over the time period and secondly, 
the time taken for the contact angle to stabilise. The water contact angle for the 
n-BG composites reduced at a steeper rate than the m-BG composites (Figure 
3.9), mainly due to the higher exposure of n-BG particles on the surface. The 
nano-topography of the n-BG composites should, further contribute to the steep 
drop in the water contact angle for the composites. 
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Figure 3.8 SEM micrographs of (a) P(3HB)'30 wt% m-BG (b) P(3HB)/30 wt% n-BG (c) 
magnified image of P(3HB)/10 wt% n-BG (d) magnified image of P(3HB)/20 wt% n-BG (e) cross- 
section of P(3HB)/30 wt% m-BG (f) cross-section of P(3HB)/30 wt% n-BG. 
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Figure 3.9 Change in the water contact angle of the P(3HB)/BG composites over time, 
highlighting the hydrophilicity of the samples. 
Static contact angle measurements on the P(3HB) films gave a value of 87±9°, 
which further confirmed the hydrophobic nature of the polymer that has been 
extensively reported in the literature (Sudesh K et al. 2000). The water contact 
angle determined in this study for P(3HB) films is higher than the reported value 
of 70±5° (Wang YW et al. 2003). Although the water contact angle 
measurements indicate the hydrophilicity of the polymer, determining the surface 
free energy of the samples hold more information about the specific surface 
properties, which have been shown to play a key role in cell attachment (Zhao G 
et al. 2005) and need to be further investigated. The water contact angle for the 
composites in comparison to the neat polymer decreased significantly (n=4, 
**p<0.01) on increasing the Bioglass® concentration, as shown in Table 3.7. The 
decrease in the water contact angle for 10,20 and 30 wt% m-BG composites was 
4% (n=4, p>0.05), 22% (n=4, ***p<0.01) and 17% (n=4, `p<0.05), respectively. In 
contrast, for 10,20 and 30 wt% n-BG composites, the decrease was 22% (n=4, 
**p<0.01), 58% (n=4, `**p<0.01) and 29% (n=4, ***p<0.01), respectively. Water 
contact angle measurements (also an indication of the wettability) showed that 
the reduction in water contact angle was more prominent for n-BG composites 
than in m-BG composites (n=4, `p<0.05). This is primarily due to the 
microstructural differences between the two type of composites that allow a 
higher polymer/Bioglasso interfacial interaction in n-BG composites for adsorption 
of water. A similar effect is reported for P(3HB-co-3HV)/wollastonite composites 
wherein the water contact angle reduced to 33±2° on adding 20 wt% wollastonite 
(Li H et al. 2004). This increase in hydrophilicity for the composites due to 
addition of Bioglass® particles altered the in vitro degradation parameters 
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(Chapter 4) along with enhancing the protein adsorption (Section 3.3.9) of the 
composites, as discussed subsequently. 
Table 3.7 Comparison of water contact angle for P(3HB)/n-BG and P(3HB)/m-BG 
composites 
Bioglass® concentration Water contact angle (°± SD) 
0 87±9 
10 wt% m-BG 83±6 
n-BG 68±1 ** 
20 wt% m-BG 68±6** 
n-BG 55±1 *** 
30 wt% m-BG 71.8±0.3* 
n-BG 62±2*** 
***p<0.001; **p<0.01; *p<0.05 (compared to P(3HB) films) 
3.3.6 Comparison of thermal & mechanical properties between 
P(3HB)/n-BG and P(3HB)fm-BG composites 
The thermal properties (heat of fusion and melting temperature) for both types of 
composites (m-BG and n-BG) were measured using DSC. The addition of n-BG 
particles had a similar effect on the thermal properties of the composite 
compared to m-BG composites, as shown in Table 3.8. The thermograms from 
the first heating cycle for both the composite is shown in Figure 3.10 and the 
observations made from the thermal measurements for both types of composites 
can be summarized as: (i) addition of bioactive glass particles reduced the heat 
of fusion (n=3, **p<0.01) compared to the neat polymer, which can be used as to 
indicate the crystallinity of the material. (ii) Insignificant (n=3, p>0.05) difference 
in the thermal properties (melting temperature, heat of fusion) between n-BG and 
m-BG composites. (iii) Presence of double melting peak as discussed in Section 
3.3.2, (iv) addition of n-BG particles prevented the re-crystallisation of the 
polymer, similar to that observed for m-BG composites, which is evident by the 
absence of the polymer's melting peak during the second DSC heating run 
(Figure 3.10(b)). 
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Figure 3.10 DSC thermograms (a) comparing the n-BG and m-BG composites (first heating 
cycle), and (b) first and second heating cycle for P(3HB)/n-BG composites highlighting the absence 
of melting peak in the second heating cycle. 
Table 3.8 Comparison of thermal properties for P(3HB)/n-BG and P(3HB)/m-BG 
composites 
Bioglass® concentration Tm (°C) OHf (Jig) 
0 172±2 73±1 
10 wt% m-BG 155/171 58±2** 
n-BG 156/172 55±9** 
20 wt% m-BG 156/172 59±2** 
n-BG 157/171 60±4** 
30 wt% m-BG 156/170 57±3** 
n-BG 155/170 55±6** 
***p<0.001; **p<0.01; *p<0.05 (Compared to P(3HB)) 
In contrast to the similarity in thermal properties between m-BG and n-BG 
composites, the static tensile tests showed a very significant difference in the 
Young's modulus of the composites. One of the important reasons for using 
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nanoscale filler particles is their reported success in reinforcing polymers (Wei G 
et al. 2004; Loher S et al. 2006; Pramanik N et al. 2006). The tensile tests and 
DMA results mentioned in Section 3.3.3 highlighted the lack of reinforcement 
achieved by addition of microscale Bioglass® particles in the polymer matrix. In 
contrast, the addition of 10,20 and 30 wt% n-BG particles resulted in a significant 
increase (n=4, *p<0.05) in the Young's modulus compared to the P(3HB) film, 
which was found to be 1.01 GPa. The addition of n-BG particles had a significant 
stiffening effect on the composites as indicated by the stress-strain curve in 
Figure 3.11 for 10 wt% n-BG and m-BG composites (as an example). The slope 
of the stress-strain curve for the n-BG composites was higher than for the m-BG 
composites, thus indicating a higher Young's modulus. 
Figure 3.11 Stress-strain curves for P(3HB)/10 wt% Bioglass° (micro and nano) composites 
highlighting the difference in the slope and thus indicating the higher modulus achieved by n-BG 
composites. Three measurements are shown for each type of composites to get a better 
representation of the difference in the slope. 
The increase in the elastic modulus for the composites (compared to the unfilled 
polymer) due to the addition of 10,20 and 30 wt% of n-BG particles was 57%, 
14% and 20% respectively, as shown in Figure 3.12. The significant increase 
(n=4, **p<0.01) in the Young's modulus of n-BG composites compared to m-BG 
composites can be explained due to the true reinforcement achieved using 
nanoscale bioactive glass particles (Figure 3.12, ). In the case of m-BG 
composites the reduction of modulus is most certainly due to the poor mixing of 
m-BG particles in the polymer matrix, leading to large agglomerations as 
described in Section 3.3.1. Addition of 10 wt% n-BG particles in the polymeric 
matrix also showed to increase the yield strength, compared to the addition of 
same concentration of m-BG particles (Table 3.9). Table 3.9 also shows a 
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comparison of the mechanical properties achieved for the P(3HB)/Bioglasso 
composite system and various types of bones. 
Figure 3.12 Modulus comparison for various concentrations of m-BG and n-BG particles in 
P(3HB)/Bioglass° composites. The data (n= 4; error bars= ±SD) were compared using Student's t- 
test and differences were considered significant when *p<0.05, "p<0.01 and "'p<0.001. 
Table 3.9 Mechanical properties of skeletal tissue and its comparison with the mechanical 
properties achieved for the P(3HB)/BG composites. The mechanical properties of skeletal tissue 
are obtained from Yang S et al. 2001. 
Materials E (GPa) TS (MPa) 
Cancellous bone 0.02-0.5 -na- 
Cortical bone 3-30 60-100 
Cartilage 0.7-15.3 (MPa) 3.7-10.5 
Ligament 0.06-0.54 13-46 
Tendon 0.14-2.31 24-112 
P(3HB) 1.0±0.2 16.9±1.1§ 
10 wt% m-BG 0.8±0.1 12.7±1.1§ 
10 wt% n-BG 1.6±0.2 17.9±0.3§ 
20 wt% m-BG 0.84±0.05 17.2±0.4§ 
20 wt% n-BG 1.1±0.2 11.9±2.6§ 
30 wt% m-BG 0.7±0.1 -na- 
30 wt% n-BG 1.2±0.1 13.5±1.4§ 
§Denotes yield strength 
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3.3.7 Comparison of experimental mechanical properties of 
P(3HB)/BG composites with theoretical models 
For two-phase composites made up of a continuous polymer phase and 
particulate filler, there are numerous theoretical models proposed to predict the 
modulus, tensile strength, and elongation at break as a function of filler volume 
fraction (Nielsen LE et al. 1994). Each of these models has some underlying 
assumptions favouring specific cases (e. g. shape of fillers, porosity, etc. ) (Yan W 
et al. 2006). In the following paragraph the experimental mechanical properties 
determined for the P(3HB)/BG composites is compared with some of the 
theoretical models available. 
A simple model that has been used to investigate adhesion between spherical 
filler and a polymeric matrix is the Einstein equation (Equation 3.3), which is valid 
only at low concentrations of filler particles (Tavman IH 1996; Bliznakov ED et al. 
2000). For the familiar case of perfect adhesion and isolated filler particles, 
Einstein's equation has the form: 
Ec = Em (1 + 2.5 x 0) Equation 3.3 
Where, 
0= Volume fraction of reinforcing particles 
Em= Mechanical moduli of the matrix 
Ec= Mechanical moduli of the composite 
Similarly, Guth model (Guth E 1945) predicts the moduli of a composite system 
by taking into account the shape of the reinforcement phase, as shown in 
Equation 3.4 and 3.5, for spherical and non-spherical particles, respectively. 
Halpin-Tsai-Nielsen model (Nielsen LE et al. 1994) took a step further in 
predicting the modulus of the composite by incorporating the geometry of the 
reinforcing phase, Poisson's ratio of the matrix, relative modulus of the reinforcing 
phase and the matrix, as shown in Equation 3.6. 
Spherical particles: Ec=E, (1+2.5 x 
q+14.1 x O2) Equation 3.4 
Non-spherical Particles: E. = E,  
(1 + 0.67 xýxa+ 14.1 x q2 x a2) Equation 3.5 
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1 ým 
x 
ým 
Where, 
a= Reinforcement aspect ratio. 
Equation 3.6 
yr= A factor depending on the maximum packing fraction of the reinforcement. 
Wn, = maximum packing fraction for spherical fillers is 0.6 and for irregular shapes 
is 0.63. 
u= Poisson's ration of the matrix 
For the case of poor adhesion between the filler and polymeric matrix, i. e. where 
the polymer matrix slips by the filler particles, Sato and Furukawa developed an 
expression for the tensile modulus (Sato Y et a/. 1963; Nielsen LE 1966). This 
model represents the case where the adhesion is so poor that the polymer matrix 
pulls away from the filler surface to give cavities around the filler particles. Their 
equation is shown in Equation 3.7 and ý is the adhesion parameter; i; =1 for poor 
adhesion and ý =0 for perfect adhesion. 
2/3 
X 
ova XKX 
Eý = 1+2-(2xOu3) ýl- Kx ý') -(1-Ou3)X0 Em 
x=-x 
1+ oV, _ 
2/3 
3 1-OU3 +0'/3 
Equation 3.7 
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Table 3.10 Comparison of experimental Young's modulus with various other theoretical 
models developed for particulate filled matrix composites. 
BG content 
(wt%) 
Measured ROM- Einstein Guth & Sato & 
E (GPa) Smallwood furukawa 
0 1.01±0.3 1.01 1.01 1.01 1.01 
10 0.8±0.1 2.5 1.1 1.1 " 0.94§ 
CO 20 0.84±0.05 4.2 1.2 1.3" 0.91§ 
30 0.7±0.1 6.2 1.4 1.6" 0.85§ 
10 1.6±0.2 2.5 1.1 1.2' 1.1§§ 
CO 20 1.1±0.2 4.2 1.2 1.4' 1.2% 
CL 30 1.2±0.1 6.2 1.4 1.7' 1.3§§ 
§ Assuming adhesion parameter C =1 for poor adhesion 
§§ Assuming adhesion parameter C =0 for perfect adhesion 
Using Equation 3.4 
Using Equation 3.5 and a=1.25 
The modulus of Bioglass° is taken as 35 GPa 
ROM= Rule of mixtures 
In the case of P(3HB)/m-BG composites, the experimental tensile modulus 
indicated a similarity with the Sato and Furukawa model, which assumed a poor 
adhesion between the filler and the matrix. The decrease in the tensile modulus 
of the composites on increasing the BG content is evident and discussed in detail 
in Section 3.3.3. However, for P(3HB)/n-BG composites both Einstein equation 
and Sato & Furukawa model agree reasonably well with the experimental result 
and can be hence used to predict the increase in the tensile modulus due to the 
incorporation of nanoscale bioactive glass particles. 
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Figure 3.13 Tensile modulus vs. Bioglasso content when different theoretical models are 
used to compare with the experimental results of (a) P(3HB)/m-BG composites and (b) P(3HB)/n- 
BG composites. 
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3.3.8 Characterisation of P(3HB)/BG composite foams 
P(3HB) and P(3HB)/Bioglass® composite scaffolds (foams) were prepared using 
a slightly modified technique of solvent casting and particulate leaching. The 
modification is in the principle of using this method in which the porogen was 
used not only for inducing porosity but also to provide the 3-D shape of the 
foams. As described in Section 3.2.1, commercially available sugar cubes were 
used in this study as the porogen template. Changing the polymer viscosity 
controls the introduction of a polymeric phase Into the sugar cubes and the whole 
process is done at room temperature. Some of the features of this method are 
discussed in this section. 
  The dimension of the foams (P(3HB) and P(3HB)/Bioglass®) produced using 
this technique is alterable and obviously related to the dimension of the sugar 
cubes (or any other porogen clusters). The sugar cubes were cut down to desired 
sizes and then used as the preform to prepare the scaffolds. The size of the 
polymeric foam formed in this case is limited to the size of the cubes. The foams 
obtained by using the sugar cubes had a close macrostructural and dimensional 
similarity with the sugar cubes, as shown in Figure 3.14 (a). Once the porogen 
(sugar) was dissolved in water, the foams were dried at 37°C and cut to desired 
sizes for further experiments. The technique developed here is very similar to the 
replication techniques used to prepare Bioglass® foams using polyurethane 
foams as the porogen template (Chen QZ et al. 2006). 
  The porosity of the foams was altered by varying the polymer solution 
impregnated into the cubes, as explained in the equations given below. The 
porosity of the foams was calculated using Equation 3.8. The porosity of the 
foams can be significantly reduced by increasing the amount of the polymer 
injected into the sugar cubes, as calculated by Equations 3.8 and 3.9. 
P(3HB)/Bioglass® foams (10 wt% m-BG particles) were prepared in a similar 
manner as P(3HB) foams (Section 3.2.1). The m-BG particles were added to the 
polymeric solution and sonicated prior to impregnation. The theoretical density of 
the composite was calculated using the rule of mixtures formulae (Equation 3.9). 
Using Equation 3.8 the porosities of P(3HB) and P(3HB)/m-BG foams were 
calculated (n=6) to be in the range of 87±4% and 82±5%, respectively. A 
comparison with the theoretical and experimental porosity was not carried out for 
the foams and this needs to be further investigated. 
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The equations used in the calculations are: 
Equation - 3.8 
%Porosity = 1- x 100 ; 
101-"h-l) 
Equation - 3.9 
For composites 
Pth =Pfvf+PmVm 
wf_f 
C 
Where 
%Porosity = 1- 
Mpol 
mer x 100 Vsugar 
cube 
X Pm 
1 
/I 
M- 
Wm 
Mc 
Pe = experimental density 
p1h = theoretical density 
VSgar cube = volume of sugar cube 
M, iyn, er = 
Mass of the polymer 
pf= Density of filler 
pm = Density of matrix 
vf= volume fraction of filler 
um = volume fraction of matrix 
Mf= mass of filler 
Mm = mass of matrix 
Mc = mass of composite 
wf= mass fraction of filler 
wm = mass fraction of matrix 
  The pore morphology of the foams was examined using SEM and typical 
images are shown in Figure 3.14. The surface of the P(3HB) and P(3HB)/m-BG 
foams after cutting them to desired sizes is shown in Figure 3.14 (b-d) and 3.14 
(e-f), respectively. The pores in the foams were of irregular shape and sizes, but 
there was a good pore interconnectivity maintained in the scaffold microstructure. 
From the SEM micrographs, the pore sizes can be deduced to be in the range 
100-200 pm (Figure 3.14). The highly interconnected pore structures were found 
to be present in both foam types (P(3HB) and P(3HB)/m-BG). Although the 
presence of m-BG particles in the foam microstructure caused a partial blockage 
of the pore structure, as shown in Figure 3.14 (e-f), the pore sizes were still 
conducive for bone-tissue engineering. The presence of the interconnected pore 
structures further allowed infiltration of MG-63 bone cells during in vitro 
cytocompatibility studies (Section 4.3.6) and also encouraged vascularisation 
when implanted subcutaneously in rats (Section 4.3.7). 
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Figure 3.14 Images showing the microstructure of foams produced using solvent casting and 
particulate leaching technique developed using sugar cubes. (a) Digital image of the sugar cube 
used for foam preparation and the P(3HB) foam after the dissolution of the sugar from the 
structure. (b) SEM image of P(3HB) foams, (c) magnified image of (b), (d) irregular pore structure 
of P(3HB) foams exhibiting high pore interconnectivity, (e) microstructure of P(3HB)/m-BG foams 
and (f) SEM image highlighting the presence of m-BG particles in the structure of the foams. 
  The porous microstructure achieved using this simple and inexpensive 
technique was comparable and in some cases better than the ones achieved for 
other PHA scaffolds, as reported in the literature (Figure 3.16). However, the 
microstructure of the P(3HB) foams was very similar to the ones achieved for 
other polymers using particulate leaching technique. The use of solvent 
casting/particulate leaching technique to develop the P(3HB) and P(3HB)/m-BG 
foams allowed the incorporation of other components (viz. Vitamin E, multiwall 
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carbon nanotubes (MWCNTs)) in the foam's microstructure enabling the process 
of making multifunctional scaffolds (Section 5.3.8). 
  Thermogravimetric analysis was performed on foams to analyse the residual 
mass of m-BG in the matrix, giving information also on the distribution of m-BG 
particles in the foam microstructure. It can be seen from the TGA profiles in 
Figure 3.15 that the materials did not exhibit any significant mass change beyond 
360°C and hence the residual mass for the foam samples was recorded at 
400°C. It as been reported in the literature (Blaker JJ et al. 2005) that there are 
no thermal events occurring within this temperature range to cause mass loss. 
Therefore the residual mass for the case of P(3HB)/m-BG foams (n=3) arise 
solely from the Bioglass®, which was found to be present in a concentration of 
15±2 wt%. Another important observation from the TGA profile is the reduction in 
the degradation temperature of the foams due to the addition of m-BG particles. 
A similar effect has been also reported for other PHA/HA and PDLLA/Bioglass® 
composites (Chen LJ et al. 2002; Blaker JJ et al. 2005; Xi J et al. 2008). DSC 
thermal scans of P(3HB)/BG films (Section 3.3.2) also suggested a possible 
reduction in the degradation temperature by the addition of Bioglass® particles. 
High temperature FTIR experiments will prove an important tool to determine 
structural changes occurring due to the presence of BG particles, as it has been 
shown that the majority of the bands in the infrared spectra of polymers are 
associated with both the crystalline and amorphous regions and in general, when 
the crystallinity of a polymer is altered, intensities and frequencies of some of the 
IR bands (1185,1278 and 1724 cm-1) also vary (Bayari S et al. 2005). 
Figure 3.15 TGA profile for P(3HB) and P(3HB)/m-BG foams showing the residual weight and 
the shift in the degradation temperature. 
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Figure 3.16 Some of the common scaffold microstructures achieved for (a) P(3HB-co-3HV): 
particulate leaching (Torun Kose G et al. 2003), (b) P(3HB): microemulsion template (Cai Z et al. 
2003), (c) P(3HB-co-3HHx): stereolithography (Wang Z et al. 2006), (d) P(3HB): particulate 
leaching (Deng Y et al. 2002), (e) P(3HB): electrospinning (Ying TH et al. 2008), (f) P(3HB): salt 
leaching (Wang YW et al. 2004), (g) P(3HB-co-3HHx): phase separation (Xi J et al. 2008), (h) 
P(3HB-co-3HHx)/HA: phase separation (Xi J et al. 2008) and (i) PLGA/HA: particulate leaching 
(Kim SS et al. 2006). 
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3.3.9 Protein adsorption study of P(3HB)/BG composites 
Protein adsorption is of importance to evaluate the potential of a biomaterial for 
use as a tissue-engineering implant. It has been shown that most mammalian 
cells are anchorage dependent and need a biocompatible, protein rich surface for 
attachment, differentiation and migration to form new tissue (Webster TJ of al. 
1999; Wei G et al. 2004). It is proposed that cell adhesion takes place In two 
different stages. The first stage consists of the adsorption of a layer of proteins 
that selectively adhere onto the biomaterial surface, mediated by the surface 
properties of the substrate. The second stage involves cell adhesion onto the 
layer of proteins, which is a more complex process, mediated by extracellular 
matrix (ECM) proteins, cell membrane proteins, and cytoskeletal proteins (Luthen 
F et al. 2005; Navarro M et al. 2006). Owing to the importance of protein 
adsorption, a total protein adsorption study was carried out on the P(3HB)/BG 
films and foams using foetal bovine serum (FBS). Although FBS is a mixture of 
complex proteins, it has been shown that the primary protein adsorbed on the 
surface is albumin (Reno F of al. 2005). Albumin is the most abundant plasma 
protein known to be responsible for transport and delivery of a wide variety of 
metabolites, drugs, anionic ligands and cations. Nevertheless, performing a 
protein mass spectrum on the samples can yield a much-detailed composition of 
the proteins that are selectively adsorbed to the composite's surface. 
The protein adsorption study showed that the total amount of protein adsorbed 
on the surface was higher for the composites compared to neat P(3HB) films 
(which was measured to be 171±20 µg/cm). The presence of n-BG particles in 
the composite resulted in higher protein binding compared to the same 
concentration of m-BG particles, as evident from the results shown in Figure 
3.17. For example, 30 wt% n-BG and m-BG particles resulted in 186% and 56% 
increase (n=3, **p<0.01) in total protein adsorption, respectively. P(3HB)/n-BG 
composites adsorbed significantly (n=3, **p<0.01) more protein than P(3HB)/m- 
BG composites at higher bioactive glass content (n=3, *p<0.05). The increase in 
protein adsorption for P(3HB)/Bioglass® composites can be explained from two 
perspectives. Firstly, it has been shown that protein adsorption is higher for 
surfaces having a rougher topography compared to a smooth surface (Dalby MJ 
et al. 2006). In this case addition of n-BG particles induced a structured rough 
topography as shown in Figure 3.8. A rough surface morphology can also relate 
to an increased surface area available for protein adsorption for each of the films. 
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Secondly, a higher albumin adsorption is probably due to wettability modifications 
induced by the addition of Bioglass®. In fact, albumin adsorbs preferably to 
hydrophilic surfaces (Collier TO et al. 1997) and, as deduced by wettability 
measurements, the composites containing n-BG particles are more hydrophilic 
than P(3HB)/m-BG composites. The total protein adsorbed on the P(3HB) and 
P(3HB)/m-BG composite foams (n=3) was measured using the protein 
quantification kit (Section 3.2). The total protein adsorption was significantly 
higher for the 3D-foams than for the films of the same composition (Figure 3.18). 
This was due to the increased surface area available for protein adsorption in the 
case of foams, as evident in their microstructural images shown in Figure 3.14. 
There was also no significant difference in the protein adsorption between the 
P(3HB) and P(3HB)/m-BG foams, as was also evidenced for the P(3HB) and 
P(3HB)/m-BG films (Figure 3.17). The protein adsorption results obtained in this 
study are in agreement with evidence obtained for other nanoscale bioactive 
composites (e. g. nano-hydroxyapatite/PLLA scaffolds, nano-tricalcium 
phosphate/PLGA) (Wei G et al. 2004; Schneider OD et al. 2007), which further 
reflects on the high degree of biocompatibility of the developed P(3HB)/Bioglass® 
composite system. 
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Figure 3.17 Total protein adsorption study on P(3HB)/BG composites films using fetal bovine 
serum. (n=3; error bars= ±SD) *p<0.05, **p<0.01 and ***p<0.001 
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Figure 3.18 Total protein adsorption study on P(3HB) and P(3HB)/m-BG foams using fetal 
bovine serum. (n=3; error bars= ±SD) 
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3.4 Conclusions 
The properties measured in this study have highlighted the advantages of 
incorporating nano-sized bioactive glass particles in the P(3HB) polymeric matrix, 
which are not only related to mechanical reinforcement (up to 50% increase in 
Young's modulus) but also due to the ability of n-BG particles to Induce 
nanotopography, which further regulates the level of surface wettability (up to 
58% decrease in water contact angle) and protein adsorption (up to 186% 
increase). The effects of incorporating nanoscale bioactive glass in the polymer 
matrix are represented schematically in Figure 3.19. All the analyses carried out 
(except for thermal properties) showed a considerable and significant differences 
(**p<0.01) in the properties between the P(3HB)/m-BG and P(3HB)/n-BG 
composites. 
Reinforcing mechanical strength 
n-BG 
Higher specific area, W High surface W Nanotopographical 
nanometric size exposure features 
t*s, Increased protein adsorption Improved wettability 
Figure 3.19 
matrix. 
Consequential effects of adding nanoscale bioactive glass particles in P(3HB) 
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4. BloactiviLy, degradation and 
biocompatibility studies 
4.1 Introduction 
The use of polymer/bioceramic composite systems has seen increasing impetus 
over the last few years due to the ability to tailor composite properties (viz. 
mechanical, structural, degradation kinetics, etc. ) along with inducing the ability 
to develop bioactive hydroxyapatite layers that can interact with the surrounding 
tissues (Rezwan K et al. 2006). The presence of this biologically active 
hydroxyapatite layer seems to be crucial for hard tissue applications and it also 
mimics the inorganic component of bone. Formation of this hydroxyapatite layer 
is a dynamic process and changes over time, which makes it imperative to 
monitor the bioactivity of a composite system by using more than one means of 
measurement over a period of time. The addition of bioceramics has also been 
shown to alter the degradation rate of polymer composite by changing the 
parameters such as water absorption, weight loss and pH (Li H et al. 2005b). For 
use of composites in tissue engineering applications, the biocompatibility of the 
intended materials needs to be extensively investigated. Equally important is to 
determine the effect of adding different concentrations of bioactive ceramics on 
the biocompatibility of the composite system using in vitro cell culture and in vivo 
studies. 
In this chapter, the in vitro degradation behaviour of the P(3HB)/bioactive glass 
composite system, with particular emphasis on evaluating the bioactivity of the 
composites over time, is discussed. Long-term molecular weight degradation 
(-200 days) of the composites in SBF was also monitored. In vitro 
cytocompatibility of the composites was examined using MG-63 human 
osteoblast-like cells by measuring cell proliferation, alkaline phosphatase activity 
and osteocalcin levels for up to 14 days. The possible antibacterial activity of the 
P(3HB)/n-BG composites was also evaluated by measuring the colony forming 
units of Staphylococcus aureus cells. Finally, in vivo biocompatibility of the 
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composites (scaffolds and films) was examined via subcutaneous implants in 
Sprague Dawley rats for up to 2 weeks. The hypotheses guiding the experimental 
work were: 
(i) The presence of bioactive glass changes the surface morphology of the 
composites upon immersion in bodily fluid environment through the formation of 
hydroxyapatite layer. Nanoscale bioactive glass particles will improve the 
bioactivity compared to the micron sized bioactive glass particles. 
(ii) Incorporation of bioactive glass modifies the water uptake, weight loss and 
rate of molecular weight degradation of the composites. 
(iii) Alkalinity induced by the dissolution products of Bioglass® particles triggers a 
strong antimicrobial effect. 
4.2 Experimental details 
4.2.1 Bioactivity & degradation studies 
4.2.1.1 Sample preparation: In vitro bioactivity and degradation studies of the 
P(3HB)/bioactive glass composite films were carried out in simulated body fluid 
(SBF), which has similar ionic concentration to human blood plasma (Kokubo T 
et al. 1990; Kokubo T et al. 1991). The reagents mentioned in Table 4.1 were 
dissolved in deionised water to prepare 2L of final volume and the pH adjusted 
to 7.25. Freshly prepared SBF was used for all the analyses and when needed, 
was stored at 4°C for no more that 14 days. The initial mass of the composite 
samples was recorded and immersed in SBF. The approximate sample to SBF 
ratio for all cases was maintained at 0.2 g/100 mL and the SBF was exchanged 
every 5 days for one month and then once a week. All samples were kept in a 
37°C incubator under static conditions and at desired time points samples were 
collected, gently washed with deionised water and left to dry at 37°C in an 
incubator overnight for further analyses, as mentioned below. 
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Table 4.1 Reagents used for preparation of simulated body fluid (SBF) 
Reagents Formula For 2000 mL 
Ultra pure water 1500 mL 
Sodium Chloride NaCl 15.992 g 
Sodium bicarbonate NaHCO3 0.700 g 
Potassium chloride KCI 0.448 g 
Potassium Phosphate dibasic. trihydrate K2HP04.3H20 0.456 g 
Magnesium chloride hexahydrate MgCI2.6H20 0.610 g 
1 kmol/m3 hydrochloric acid HCI 80 cm3 
Calcium chloride CaCI2 0.556 g 
Sodium sulphate Na2SO4 0.142 g 
TRIZMA® base (CH2OH)3CNH2 12.114 g 
1 kmol/m3 hydrochloric acid Appropriate amount to adjust the pH 
4.2.1.2 Characterisation techniques 
(I) WATER UPTAKE MEASUREMENT: All samples were weighed (Mo, dry) 
before immersion in SBF and incubated at 37°C. At specified time points (5,10 
15,20,30 and 45 days), the films were collected and analysed for water uptake 
(%WA). For measuring the water absorption (%WA), the immersed samples were 
extracted, the surface gently wiped and the weight was measured (M4 , et), 
followed by using Equation 4.1. 
%TVA 
Mt. 
»et - 
Mt. drv X100 Mt. dry 
Equation 4.1 
(11) SEM AND ENERGY DISPERSIVE X-RAY (ED)Q ANALYSIS: Samples for 
SEM observation before and after immersion in SBF were analysed in a similar 
fashion as described in Section 3.2. EDX was carried out on the samples at 
1000x magnification and at 15 kV. For measurements, the samples were carbon 
coated and the images were processed using INCA (Oxford Instruments) 
program to evaluate the formation of hydroxyapatite on samples surface and also 
to determine the change in calcium/phosphorus (Ca/P) ratio. 
ON X-RAY DIFFRACTION: X-ray diffraction (XRD) analysis on samples 
before and after immersion in SBF was performed using two separate 
equipments with details of both diffractometers mentioned below. XRD analysis 
was primarily performed to analyse the bioactivity (level of hydroxyapatite 
formation) of the composites. Samples were analysed on a Brüker D8 Advance 
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diffractometer in flat plate geometry, using Ni filtered Cu Ka, radiation. Data was 
collected from 10 to 100° with a primary beam slit size of 0.6 mm. A Brüker Lynx 
Eye silicon strip detector was used and a step size of 0.02° and a count time of 
0.1 s per step. 
Alternatively, XRD analysis was also conducted using a Phillips PW1700 series 
automated powder diffractometer. Cu I< radiation of 40 kV and 40 mA was 
obtained using a secondary crystal monochromator. The analytical parameters 
used were: step size 0.04°, scan step time of I s, and diffraction range 5-55° 
(20). 
(iv) RAMAN SPEcmoscOPr All Raman spectra were recorded using 
Raman spectrometer (LabRAM HR, HORIBA JOBIN YVON Ltd., UK with 
Labspec software) with 633 nm laser, filter at 100%, hole at 300, slit at 150, 
grating at 1800, microscope objective x50, and acquisition properties of exposure 
time for 10s. Three spectra per location were recorded in the wave number 
interval of 400-1400 cm''. 
(v) ION CHROMATOGRAPHY: For cation (Na*, Ca2`) release, an ICS-1000 
ion chromatography system (Dionex, UK) was used. A 30 mM MSA 
(methanesulfonic acid, BDH, UK) solution was used as the eluent. Cations were 
eluted using a 4x250 mm lonPac® CS12A separator column and auto 
suppression. All results were calculated against a four-point calibration curve 
using the predefined calibration routine. Chromeleon v5.0 software package was 
used for data analysis. Sodium chloride (NaCl) and calcium chloride 
(CaCI2.2H20) were used as reagents. A 100 ppm mixed (sodium and calcium) 
stock solution was made, from which serially diluted 50,25,10 and 1 ppm 
standard solutions were prepared. 
The phosphate anion measurements were carried out using a Dionex ICS-2500 
ion chromatography system (Dionex, UK), consisting of a gradient pump with a 
25 pL sample loop. In this method, polyphosphates were eluted using a 4x250 
mm lonPac AS16 anion exchange column packed with anion exchange resin. A 
Dionex ASRS (anion self regenerating suppressor) was used at 242 mA. The 
Dionex EG40 eluent generator equipped with a KOH (potassium hydroxide) 
cartridge was used in conjunction with the ASRS. The sample run time was set 
for 15 min. The gradient program started from 30 mM KOH, and after 8 min 
increased from 30 to 60 mM KOH up to 10 min, and then reduced to 30 mM KOH 
for up to 15 min. Orthophosphate (PO43") ion release was used as reference for 
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total anion release in this study. A 100 ppm (parts per million) working solution of 
sodium phosphate tribasic (Na3PO4) was made, from which serially diluted 50, 
20,10 and 1 ppm standard solutions were prepared. All the above standards and 
dissolution studies were conducted using high purity water (18.2 MIIcm" 
resistivity), obtained from a PURELAB UHQ-PS system (Elga Labwater, UK). 
The IC study was conducted in collaboration with Dr. S. P. Valappil from Eastman 
Dental Institute (UCL, London). 
(VI) GEL PERMEATION CHROMATOGRAPHY: Molecular mass analysis of the 
degraded samples was conducted by dissolving the samples in chloroform and 
filtering through 0.2 µm polyamide membrane prior to the chromatography. The 
GPC system was equipped with PLgel guard plus 2xmixed bed-B column (30 cm 
x 10 µm) and a flow rate of 1.0 mUmin was used at a temperature of 30°C. The 
eluted polymer was detected with a differential refractometer. The data were 
collected and analysed using Viscotek 'Trisec 2000' and 'Trisec 3.0' software. 
The GPC system was calibrated with polystyrene calibrants. This experiment was 
conducted in collaboration with Dr. Steve Holding (RAPRA, UK) and Prof. Steve 
Howdle (Univ. of Nottingham). 
4.2.2 Cytocompatibility studies 
In vitro cell culture studies were carried out on various samples (Table 4.2) using 
MG-63 human osteosarcoma cell line (Clover J et a/. 1994). A graphical 
representation summarising the work carried out during cell culture analysis 
including the various parameters assessed is shown in Figure 4.1. The cell 
culture experiments were conducted at Eastman Dental Institute (UCL, UK), in 
collaboration with Dr. Vehid Salih. Trypsin, phosphate buffer saline without 
Cat+/Mg2+ (PBS) and low-glucose Dulbecco's modified eagle medium (DMEM) 
was purchased from PAA (UK). Cell culture flasks were procured from BD 
Biosciences (Oxford, UK) and penicillin and streptomycin was purchased from 
Invitrogen (Paisley, UK). 
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Table 4.2 Materials investigated for cytocompatibility studies using MG-63 cell lines, with 
various analyses performed on them. 
Materials Type 
of BG 
Alamar 
blue 
ALP Osteocalcin SEM 
P 3HB     
P(3HB)/10 wt% BG m-BG   
n-BG     Chapter 
4 o P(3HB)/20 wt/o BG m-BG   
n-BG    
P(3HB)/30 wt% BG m-BG   
n-BG   
P 3H6 /2 wt% MWCNT   
Chapter P 3HB /4 wt% MWCNT BG  
 
5 P 3HB /7 wt% MWCNT m-   
P3HBRwt%MWCNT/20wt%BG   
P(3HB)/10 wt% Vit. E   
Chapter p 3HB /10 wt% Vit. E/10 wt% BG m-BG   
Ch ter P 3HB foams   
4 P(3 H B/ 10 wt% BG foams m-BG   
ALP= Alkaline phosphatase activity 
Cell Growth of MG-63 cell lines 
resurrection at 37°C with media changed 
after every 2 days. 
Seeding cells on 
the substrate 
Cell counting 
using a 
haemocytomete 
Taking the samples out at desired time points for 
respective analyses 
Osteocalcin 
assay 
Figure 4.1 
osteoblasts. 
Alamar II ALP 
Blue activity 
Confluent cells were 
then further split from 
one flask to three flasks. 
Yes Start of 
experiment 
No 
Freeze the cells 
SE 
M- 
Summary of steps involved during in vitro cell culture study using MG-63 
4.2.2.1 Culturing and cryo-Dreservation of MG-63 cells: The osteoblast cells 
were resurrected from their frozen state by thawing them and transferring them 
quickly to centrifuge tubes containing 10 mL of Low-glucose Dulbecco's modified 
eagle medium (DMEM) (supplemented with 10% fetal calf serum, 100 U/mL 
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penicillin and 100 fig/mL of streptomycin). The cell suspension was centrifuged at 
room temperature for 3 min. at 1000 rpm. The cell pellet was re-suspended using 
5 mL of DMEM and 2 mL of the re-suspended cell suspension was added in the 
tissue culture flasks (with gas permeable caps and a surface area of 80 cm's), 
followed by 8 mL of fresh DMEM. The flasks were incubated in a humidified 
atmosphere, in 5% CO2 and at 37°C. The spent medium of the flask was 
changed after every 2 days and the flask was checked for contamination using 
an optical microscope. An optical microscopic image of the MG-63 cells grown on 
the cell culture flasks is shown in Figure 4.2. Once the cells were 70-90% 
confluent they were sub-cultured to maintain healthy growth. 
For sub-culture the spent medium was removed from the flask and washed with 5 
mL of PBS followed by adding 2-3 mL (1 mL/cm2) of trypsin/EDTA onto the 
washed cell monolayer and incubated at 37°C for 2 min. The cells were 
examined under inverted phase microscope to observe the detachment of the 
cells and 8 mL (3-4x the volume of trypsin) of fresh DMEM was added to the 
flask. The cell suspension was then centrifuged for 3 min at 1000 rpm. The cell 
pellet was re-suspended using 5 mL of fresh DMEM. 3 mL of the re-suspended 
cell suspension was further divided into three new flasks (1 mL each) and 9 ml 
of fresh DMEM medium was added. The cells were then further allowed to grow 
until the start of new experiments. The cells were not passaged for more than 3-4 
times and were frozen in ampules and stored in liquid nitrogen for further use. 
% 
+I 
. L. 
. r. %' i., 
Figure 4.2 Optical images of MG-63 human osteosarcoma cells grown in tissue culture 
flasks in DMEM medium, highlighting the characteristic spindle-shaped morphology of osteoblasts. 
For cryo-preservation the cell lines were preserved in liquid nitrogen for long 
term-storage. The cells were subjected to trypsinisation and centrifugation as 
mentioned earlier. After centrifugation the cell pellet was re-suspended in 
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freezing medium (70% growth medium, 20% fetal calf serum and 10% dimethyl 
sulfoxide) at a concentration of 0.5-1x106 cells/mL. I mL aliquots were further 
pipetted into cryo-protective vials and stored at -80°C overnight. Frozen vials 
were then transferred to liquid nitrogen storage vessel and preserved until further 
use. 
4.2.2.2 Sample preparation 
(I) STERILISATION OF SAMPLES: All the samples (1 Cm2 films and 
0.25x0.25x0.25 cm3 foams) were sterilised using ultra-violet (UV) light. The 
samples were kept in 24-well microplates and placed under UV for 30 min, for 
each side of the sample. This form of sterilisation was employed, as it has been 
shown to be effective compared to washing with alcohol or autoclaving for PHA 
polymers (Shishatskaya El et a!. 2004). Sterilisation was followed by passivating 
the samples by immersing them in 1 mL of cell culture medium (DMEM) and 
incubating (37°C, 5% C02) for 12 h, followed by cell seeding. 
(ii) CELL SEEDING ON SUBSTRATES: The semi-confluent MG-63 cells were 
released from the flasks by trypsinisation and concentrated to pellet form by 
centrifugation (1000 rpm, 3 min). A cell count was performed using trypan blue 
dye and haemocytometer. A seeding density of 20,000 cells/cm2 and 100,000 
cells/cm3 was used for the films and scaffolds, respectively. The samples were 
seeded with the osteoblast cells and all experiments were performed in 24 well 
microplates. Passivated films were seeded with 1 mL (20,000 cells) of the cell 
containing DMEM medium, whereas, the passivated foams were seeded with 
100 NL (100,000 cells) of cell containing DMEM and left for 3 h; after 3 h, 1 mL of 
fresh DMEM medium was added on to the wells containing the scaffolds. The 
plates were incubated in a humidified environment (37°C, 5% CO2) for a period of 
up to 14 days. The medium of the wells was changed every second day and 
samples were analysed at various time points (1,4,7 and 14 days) to measure 
the cell proliferation, alkaline phosphatase activity, osteocalcin measurements 
and for SEM observation. Standard tissue culture plastic was used as the control 
surface. 
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4.2.2.3 Analysis of cell culture studies 
(i) ALAMAR BLUE ASSAY: MG-63 osteoblast cell proliferation was 
measured using Alamar blue assay (AbD Serotec, UK). Alamar Blue was added 
to the samples (n=3) containing the medium (10% v/v of medium) and left at 
37°C humidified incubator for 4 h. After Incubation, aliquots of 100 pL from each 
well was transferred to a black 96-well plate and the fluorescence of Alamar blue 
was measured using a fluorescence plate reader (Fluoroskan, Lab Systems) at 
absorbance 560 nm (A560) and dmission 590 nm (A590). 
(ii) ALKALINE PHOSPHATES ACTIVITY (ALP): Basal levels of cellular 
alkaline phosphatase activity were measured for the cells after growing them on 
the composites for 1,7 and 14 days. ALP was measured using a commercially 
available SensoLyte pNPP Alkaline Phosphatase Assay kit (AnaSpec, US). The 
kit provides a convenient calorimetric assay for detecting ALP with a 
phosphatase conjugated secondary antibody by using pNPP as a phosphatase 
substrate. Upon de-phosphorylation by phosphatase, pNPP turns yellow and can 
be detected at absorbance 405 nm. Samples (n=3) were prepared as per the 
manufacturer's protocol. 
ON OSTEOCALC1N MEASUREMENT: Osteocalcin is a non-collagenous bone 
matrix protein produced extensively in osteoblasts. The level of osteocalcin is 
used as an indicator of the overall activity of cells during bone (viz. mineral) 
formation. Osteocalcin measurements in the medium was measured (n=2) for 
Day 1,7 and 14 using commercially available Gla-type osteocalcin EIA kit 
(TaKaRa Bio Inc., Japan), as per manufacturer's protocol. The GLA-type 
osteocalcin kit is an in vitro enzyme immunoassay kit for quantitative 
determination of human carboxylated type of osteocalcin (Gla-OC) in medium. 
The standard curve obtained by preparing serial dilutions and reading the 
absorbance at 450 nm, with the curve obtained shown in Figure 4.3. 
Figure 4.3 Osteocalcin standard curve obtained at absorbance 450 nm. 
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(iv) SCANNING ELECTRON MICROSCOPY (SEM): Samples were examined 
under SEM to observe the MG-63 cell attachment and spreading and attachment 
on the surface of the samples. Specimens from Day 1,4 and 7 were fixed in 3% 
glutaraldehyde in 0.1 M cacodylate buffer for 12 h at 4°C. Subsequent 
dehydration using a series of graded ethyl alcohols (50%, 70%, 90% and 100%) 
was performed. Samples were then critical point dried by immersion In 
hexamethyldisilazane for 2 min and left in a fume cupboard for 2 h. The dried 
samples were then attached to aluminium stubs, gold coated and examined 
under SEM (JEOL 5610LV, USA) at various magnifications. 
(v) STATISTICAL ANALYSIS: All data are expressed as mean ± standard 
deviation. The data were compared using Student's t-test and differences were 
considered significant when *p<0.05, very significant **p<0.01 and highly 
significant ***p<0.001, respectively. A p-value higher than 0.05 (p>0.05) was 
taken as indicating no significant difference. 
4.2.3 Biocompatibility studies 
In vivo biocompatibility studies of P(3HB)/Bioglasso composites were performed 
for a period of up to two weeks at Northwick Park Institute of Medical Research 
(London, UK) by Dr. Tahera Ansari and Dr. Paul Sibbons. Experiments were 
performed using Sprague Dawley rats (Harlan ltd. UK). All animals were 
maintained and handled in accordance with the Animals (Scientific procedures) 
Act 1986 and the study performed following guidelines stipulated by the Home 
office. All animals were kept under standard laboratory conditions and fed 
commercial pellet diet. 
Four adult rats weighing 235-280 g were anaesthetised using 0.25 mL IM 
Hypnorm (0.315 mg/mL fentanyl citrate and 10 mg/mL fluanisone) and 1 mg IP 
diazepam. An abdominal midline was incision made through the skin and four 
samples one per animal (0.5x0.5 cm2 and 0.5x0.5x0.5 cm) were implanted into 
subcutaneous pockets formed on the right hand side in all 4 rats. Skin was 
closed with 3/0 Mersilk® sutures (Ethicon, Johnson & Johnson Medical Ltd, UK). 
8 mg/kg IM gentamicin was administered post-operatively. Rats were sacrificed 
by lethal injection of sodium pentobarbitone at desired time points and the 
sample and adjacent associated tissue removed resulting in 2 samples for each 
time point. The samples were fixed in 10% neutral buffered formal saline and 
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allowed to fix for a minimum of one week. Following fixation each sample was cut 
in half before being processed for paraffin/wax embedding. Full-face histological 
sections were cut at 5 Nm and stained with haematoxylin and eosin. 
4.2.4 Antibacterial studies 
Staphylococcus aureus (S. aureus) (NCTC 6571) were inoculated into 10 mL of 
nutrient broth and incubated overnight at 37°C in 50 mL centrifuge tubes, with 
200 rpm agitation in an Orbital Shaker (Stuart Scientific, UK). The overnight 
cultures were further used to inoculate in 6 well plates containing 10 mL of PBS 
to a standardized optical density of 0.03, measured at a wavelength of 600 nm 
(OD600)" 
3D porous P(3HB) and P(3HB)/10 wt% n-BG foams, with dimensions of 
0.5x0.5x0.5 cm3, were UV sterilised and used in triplicate in this study to measure 
the antibacterial properties of the composite foams. S. aureus grown on tissue 
culture plastic (without any samples) was used as the control to assess the 
viability of the bacteria. The samples were kept in 6 well plates and inoculated 
with 10 mL of the overnight cultures and incubated at 37°C. At various time 
intervals (12,24 and 48 h) serial dilutions of the suspensions were carried out in 
PBS and 25 µL of the diluted suspension were spread onto nutrient agar (Oxoid, 
Basingstoke, UK) plates. The plates were then incubated aerobically at 37°C for 
48 h and for each sample viable colony counts (colony forming units; CFUs) were 
conducted. This work was done in collaboration with Dr. Sabeel Valappil 
(Eastman Dental Institute, UCL). SEM analysis (samples prepared as per Section 
4.2.2.2) was performed after 48 h of bacterial growth on the foams to examine 
the attachment of the bacterial cells on the substrate. The foam samples 
(0.5x0.5x0.5 cm3, n=2) were also immersed in 10 mL of PBS for up to 48 h and 
the pH of the medium was evaluated at different intervals. 
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4.3 Results and discussion 
4.3.1 In vitro bioactivity studies 
Bioactive glass particles undergo both structural and chemical changes as a 
function of time upon immersion in an aqueous medium. The dissolution products 
cause a change in the chemical composition and in the pH of the surrounding 
solution. The formation of a hydroxyapatite layer on bioactive glass surfaces and 
the release of soluble silica, calcium and phosphorus to the surrounding tissue 
are key factors in the rapid bonding of these glasses to tissue and the stimulation 
of tissue growth (Hench LL et al. 2004). This bioactive fixation achieved through 
the bioactive bond between the hydroxyapatite and bone has strength equal to or 
greater than bone after 3-6 months. Similarly, the bioactive bond to collagen 
fibrils of soft connective tissues is stronger than the cohesive bond of collagen 
fibres. The high strength of both hard and soft tissue bonding to bioactive 
implants is due to in vivo growth of a dense layer of nanometer-scale hydroxy- 
carbonate apatite (HCA) crystal agglomerates, which bind to collagen fibrils 
(Hench LL 1998). There are altogether 11 stages in the process of complete 
bonding of bioactive glass to bone, as shown in Table 4.3. The solution 
parameters (pH, ionic concentrations, temperature) have a large effect on the 
bio-reactivity and formation of hydroxyapatite. These factors will change as the 
dissolution progresses, which will in turn affect the dissolution rate. Three types 
of media have been mainly used for dissolution experiments and for studying the 
formation of hydroxyapatite layer in vitro: Tris-buffer (simple organic buffer 
solution), simulated body fluid (Tris-buffer containing similar ionic concentration 
to blood plasma) and DMEM (cell culture medium containing inorganic and 
organic components of blood plasma). However, in the present study all 
experiments were performed using simulated body fluid (SBF) medium, prepared 
using Kokubo et al. 's protocol (Kokubo T et a/. 1990), since majority of studies on 
biomaterials for bone implant and bone tissue engineering concentrate on SBF 
as a first assessment of acellular bioactivity. 
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Table 4.3 Sequence of reactions involved in the formation hydroxyapatite and its biological 
interactions with surrounding tissues (Hench LL 1998; Jones JR et al. 2001) 
Stages Key features 
1 Rapid exchange of Na" and Ca2" with H" or H30+from the solution; hydrolysis of 
silica. Causes an increase in the pH of the medium 
°' 2 Increase in hydroxyl concentration, loss of soluble silica through the formation of L Si(OH)4, formation of SiOH 
3 Condensation and repolymerisation of a Si02 rich layer on the surface, formation 
of Si-O-Si L4 Adsorption of Ca2" abd P043- groups to the surface and formation of amorphous 
5 CaO-P205 rich film 
Crystallisation of amorphous CaO-P205 film and formation of hydroxyapatite layer 
(, 6 Adsorption and desorption of biological growth factors in the HA layer r_ 7 Macrophage response to remove debris and promote cell growth 
8 Attachment of stem cells to the bioactive surface 
LD 9 Differentiation of stem cells to form bone growing cells 
10 Generation of extra cellular matrix by the osteoblasts to form bone 
11 Crystallisation of inorganic calcium phosphate matrix to enclose bone cells in a 
living composite structure 
The bioactivity of P(3HB)/bioactive glass composite films (both P(3HB)/m-BG and 
P(3HB)/n-BG) was monitored for up to 45 days, using a range of techniques such 
as, SEM, XRD, Raman spectroscopy and EDX. The surface morphology of the 
composites was examined using SEM at various time points of immersion in 
SBF, as shown in Figure 4.4 (a-f). The nucleation of hydroxyapatite from the 
bioactive glass particles is evident from the SEM micrographs for both type of 
composites (P(3HB)/m-BG and P(3HB)/n-BG). The presence of hydroxyapatite 
on the surface of the composites was also confirmed by XRD measurements at 
different time points, as presented in Figure 4.5. Early levels of bioactivity (after 5 
days of incubation) were confirmed (using SEM, XRD) for both types of 
composites. However, it was found that the level of bioactivity was enhanced for 
composites containing n-BG particles, compared to P(3HB)/m-BG composites. 
This was also confirmed by the lack of prominent hydroxyapatite peaks (20 of 
32°) in the X-ray diffractogram (Figure 4.5) emerging after immersion of the 
P(3HB)/m-BG composites in SBF. On the contrary, there was a strong 
emergence of hydroxyapatite peaks at different time points for P(3HB)/n-BG 
composites. The enhanced bioactivity of the composites containing n-BG 
particles was also verified by SEM micrographs as shown in Figure 4.4. This 
observation can be explained by the fact that bioactive ceramic nanoparticles due 
to their higher surface area are shown to be highly bio-reactive than their 
respective conventional micron-sized bioactive particles (Loher S et al. 2006; 
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Schneider OD et al. 2007; Vollenweider M et al. 2007). The other explanation 
that can be put forward in relation to the bioactivity observation is that there was 
a higher exposure of n-BG particles on the surface of the composites (inducing 
nanotopography features on the surface) compared to m-BG particles (as 
discussed in Section 3.3). Thus the higher number of exposed bioactive glass 
particles were able to come in direct contact with SBF, leading to enhanced 
formation of hydroxyapatite. As a result of their higher bioactivity, in an in vivo 
situation P(3HB)/n-BG composites will be highly beneficial, as there will be a 
gradual increase in the interfacial strength between the composite and the 
surrounding tissues due to increased formation of hydroxyapatite with increasing 
implant time. 
Figure 4.4(b) shows the presence of sub-micron hydroxyapatite crystals 
nucleating from the n-BG particles and it was observed that HA crystals were 
homogenously distributed over the entire surface of the composite. The formation 
of scattered hydroxyapatite crystals over the surface witnessed in Day 5 
transformed to a thick layer of hydroxyapatite by the end of Day 45 (marked by 
the absence of the polymeric background, Figure 4.4(d)). The formation of 
hydroxyapatite crystals was qualitatively proportional to the concentration of 
bioactive glass particles in the composite, demonstrating that it is possible to 
tailor the bioactivity of the composites. Even the addition of 10 wt% n-BG 
particles was sufficient to cause formation of a thick layer of hydroxyapatite over 
the surface after 30 days of immersion in SBF (Figure 4.4(e)). During the entire 
observed duration of 45 days there was no change observed at the surface of the 
pure P(3HB) films indicating no levels of bioactivity, which is expected due to the 
lack of bioactive component in the neat polymer. The cross-section images of 
P(3HB)/10 wt% n-BG and P(3HB)/20 wt% n-BG composites in Figure 4.4(e-f) 
further confirmed the presence of a uniform layer (thickness <10 Nm) of 
hydroxyapatite on the surface. A similar thickness of hydroxyapatite layer has 
been reported for P(3HB)/20 vol% hydroxyapatite composites after 30 days in 
SBF (Ni J et al. 2002). 
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Figure 4.4 SEM micrographs of films after immersion in SBF showing the surface changes 
due to the formation of hydroxyapatite layer in (a) P(3HB)/20 wt% m-BG after 5 days, (b) 
P(3HB)/20 wt% n-BG after 5 days, (c) P(3HB)/20 wt% n-BG after 30 days (d) P(3HB)/20 wt% n-BG 
after 45 days. Cross section SEM showing the presence of hydroxyapatite layer marked by arrow 
for (e) P(3HB)/10 wt% n-BG after 45 days, and (f) P(3HB)/20 wt% n-BG films after 30 days. 
The X-ray diffraction patterns for both type of P(3HB)/BG composites highlighted 
the formation of crystalline hydroxyapatite upon immersion in SBF. Figure 4.5 (a) 
and (b) depict growth of the characteristic crystalline hydroxyapatite peak 
between (20) 31 and 33° over the immersion period in SBF for P(3HB)/m-BG and 
P(3HB)/n-BG composites, respectively. The hydroxyapatite peak was shown to 
increase on prolonging the immersion time, indicating the transformation of 
amorphous (or weakly crystalline) hydroxyapatite to crystalline and also the 
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increase in the extent of growth of hydroxyapatite. The formation of 
hydroxyapatite on the samples can be shown to occur from as early as 5 days In 
SBF, which further confirmed the improved bioactivity of the composites due to 
the addition of the n-BG particles. Although the direct bioactivity comparison of 
the nanoscale and microscale bioactive glass particles on their own was not 
addressed in this study, certainly the high extent of exposure of n-BG particles on 
the surface of the composite was a key factor in making the P(3HB)/n-BG 
composites highly bioactive. 
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Figure 4.5 X-ray diffractograms showing the emergence of crystalline hydroxyapatite peaks 
after immersion in SBF at various time points for (a) P(3HB)/20 wt% m-BG composites and (b) 
P(3HB)/30 wt% n-BG composites. Note the change in the scale for the abscissa in (a) and (b) 
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EDX analysis of the immersed P(3HB)/20 wt% n-BG composites was performed 
to highlight the transition of the bioactive glass particles to calcium phosphate 
layer as well as to detect the Ca/P ratio for the developed hydroxyapatite layer on 
the surface. Figure 4.6 (a), (b) and (c) highlight the EDX dots generated by 
calcium (Ca), phosphorus (P) and silicon (Si), respectively. There is a great 
similarity between Figure 4.6 (a) and (b) indicating that the surface has a rich 
deposit of calcium and phosphorus. Comparing the elemental map of calcium or 
phosphorus with silicon, it is evident that the areas rich in Ca and P have an 
absence of Si, thus indicating that the silica rich bioactive glass particles have 
been leached out and the surface is being transformed to calcium phosphate. 
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Figure 4.6 Results of EDX analysis for P(3HB)/20 wt% n-BG composites after 30 days in 
SBF showing (a) elemental surface mapping of Ca, (b) elemental surface mapping of P, (c) 
elemental surface mapping of Si (surface scanned inset), and (d) change in the Ca/P ratio of the 
hydroxyapatite layer on the composites over the immersion period in SBF, (EDX plot inset). 
The nature of the calcium phosphate quantified by the elemental mapping was 
revealed by the Ca/P ratio of the deposited 
layer over a period of time (45 days). 
Ca/P ratio measured using EDX showed that 
the Ca/P ratio of the apatite layer 
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on the composite surface increased gradually over the time period but it was 
lower than the Ca/P ratio of hydroxyapatite mineral layer present in bone, which 
is 1.67 (Le Geros RZ 1981). The Ca/P ratio stabilised at 1.58 after 30 days. A 
similar observation was made for P(3HB-co-3HV)/ 20 wt% wollastonite composite 
system, wherein a Ca/P ratio of 1.65 was reached by the end of 14 days (LI H et 
a/. 2005a). 
A final verification of the formation and growth of hydroxyapatite on the P(3HB)/n- 
BG composites was performed using Raman spectroscopy after 5,10,30 and 45 
days of immersion in SBF. The spectra of the samples immersed for different 
time points are shown in Figure 4.7(a). The hydroxyapatite characteristic P043" 
peak at 964 cm" (Penel G et aL 1998) corresponding to P-O symmetric 
stretching was found to increase with increasing immersion time in SBF. The 
gradual increase in the PO43- peak corresponds to the appearance of crystalline 
hydroxyapatite and indicates a maturation of the hydroxyapatite layer, in 
agreement with the EDX, SEM and XRD results. Similar observations were made 
in previous studies for PDLLA/Bioglass® composite scaffolds wherein the PO43" 
peak at 964 cm'' was shown to increase over a 30 day period in SBF (Maquet V 
et al. 2004). The Raman imaging method was also used in conjunction to provide 
accurate information about the distribution of hydroxyapatite over the composite's 
surface, which is crucial for understanding its performance when in contact with 
body fluids. The Raman surface map of hydroxyapatite layer (intensity 
distribution of P04 3- peak at 964 cm"') over a surface area of 70x60 pmt for the 
P(3HB)/20 wt% n-BG composite is shown in Figure 4.7(b). A fairly homogenous 
presence of hydroxyapatite on the surface of the composite can be established 
from the Raman mapping. The Raman measurements are particularly significant 
in the field of tissue engineering because they can be used to characterise 
samples while immersed in the biological medium, thus providing in situ 
measurements (Swain RJ et al. 2008). 
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Figure 4.7 (a) Raman spectra of P(3HB)/20 wt% n-BG films following 0-45 days immersion 
in SBF. (b) Raman surface intensity map of P043- peak at 964 cm-1. The bright areas denote high 
intensities whereas black areas denote low intensity of the P043- peak. 
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4.3.2 In vitro degradation studies 
Degradation of a composite involves many aspects such as structural, 
mechanical, physical or chemical degradation. Usually all these forms of 
degradation are interrelated and a composite model can be built to 
mathematically equate and link them (Wu L et a!. 2004). The parameters 
measured in this study to assess the degradation behaviour of the P(3HB)/BG 
composites were: water uptake, ion release, pH changes and molecular weight 
degradation. The duration of the degradation study was also divided as long (>45 
days) and short-term (<45 days) degradation. In the short-term degradation study 
all of the above-mentioned parameters were assessed, whereas for the long term 
study only the molecular weight was monitored. Under all circumstances, the 
degradation study was conducted in simulated body fluid (SBF), unless 
mentioned otherwise. 
It is shown in Figure 4.8(a) that the addition of bioactive glass improved the water 
uptake of the composites, compared to pure P(3HB). P(3HB) being a 
hydrophobic polymer (water contact angle of 88°, Section 3.3), showed a 
maximum of 7% water uptake after 45 days in SBF. In contrast the composites 
showed a highest of 33% water absorption. There was a rapid increase in the 
%WA of the composites within the first ten days, followed by a saturation period. 
The initial %WA for composites containing 10 wt% n-BG particles was higher 
than for the 20 wt% n-BG composites. However, when immersed for longer time, 
the higher bioactive glass content resulted in higher %WA. A comparative study 
between the microscale and nanoscale P(3HB)/BG composites also showed a 
similar trend. Throughout the study period of 45 days it was seen that the 
addition of n-BG particles resulted in significantly (n=3, **p<0.01) higher, water 
absorption than the addition of m-BG particles, as shown in Figure 4.8(b). Similar 
effects have been reported for P(3HB-co-3HV)/wollastonite composite scaffold 
systems, with the water absorption increasing (up to 300%) for the first three 
weeks and thereafter decreasing (Li H et a/. 2005a; Li H et al. 2005c). 
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Figure 4.8 Water absorption measurement after immersion in SBF for (a) P(3HB)/n-BG 
composites, and (b) comparison of P(3HB)/m-BG and P(3HB)/n-BG composites. 
It has been suggested that acidic degradation product of polymers (e. g. PLA 
degrading to lactic acid and P(3HB) to hydroxybutyric acid) results in a pH 
decrease in the vicinity of the material which may cause a concern regarding the 
material biocompatibility and also alter its rate of degradation (Knowles JC et al. 
1992a). Therefore, the pH of the surrounding SBF was measured over a 45 day 
period to analyse the changes induced by the immersion of P(3HB)/m-BG 
composites. For this experiment (n=2), the medium was not replenished. Over 
the entire duration the pH of the medium did not change significantly for the 
P(3HB) samples, which confirmed that the polymer undergoes slow degradation. 
However, it was found that the addition of m-BG particles in the composites 
resulted in a rapid increase of the pH of the medium. This was primarily due to 
the hydrolysis of the silica causing an increase in the hydroxyl radicals (Hench LL 
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et al. 1993). This increase in pH was directly proportional to the m-BG 
concentration in the composite, as shown in Figure 4.9, with the highest pH of 7.8 
attained after 45 days. However, the pH measurements carried out in SBF do not 
represent the true alkaline nature of the composites because SBF is a buffered 
medium that resists the change in the pH. Nevertheless, the presence of 
bioactive inorganic particles has been frequently shown to increase the pH of the 
medium (Li H et a/. 2005b) and the magnitude of this increase depends on the 
medium (PBS, water, Tris buffer, cell culture medium, etc. ) in which the tests are 
carried out. pH measurements in water were not conducted in this study to 
maintain consistency, as for all the analysis SBF has been the immersion 
medium. 
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Figure 4.9 Change in pH of SBF with incubation time, due to the immersion of P(3HB)/m-BG 
composites 
The temporal variation in the weight average molecular weight (MW) of P(3HB)/m- 
BG composites is shown in Figure 4.10. The MM, of P(3HB) in all materials 
showed a decrease during the whole incubation experiment. However, the rate of 
decrease was different between the groups. During the entire duration, the 
decrease in MN, was higher for neat P(3HB) than for P(3HB)/m-BG composites. A 
continuous drop in the molecular weight was observed without the characteristic 
induction period described by Doi et a/. (Doi Y et al. 1989). The overall change in 
M, for the composites followed first order kinetics (exponential relationship 
between molecular weight and degradation time), with a half-life of 18 weeks for 
the polymer. The molecular weight distribution of samples was unimodal over the 
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whole degradation time, which together with the observed first-order kinetics 
indicates a random chain scission both in the crystalline and amorphous regions 
of P(3HB). However, the half life observed here is much less than the 56 weeks 
reported in the literature (Doi Y et al. 1989; Freier T et at. 2002) and therefore a 
more detailed molecular weigh degradation study needs to be conducted to 
examine the true half life of the composites. The MW analysis of the polymer 
further indicates the slow degradation of P(3HB), compared to other synthetic 
polymers such as PDLLA, which has a half-life of 10 weeks (Wu L et al. 2004). 
A possible reason for slowing the decrease of M,, for P(3HB)/m-BG composites 
is the increased pH obtained by the addition of m-BG (Figure 4.9) that can 
compensate the acidification of the medium due to acidic products of the P(3HB) 
degradation. P(3HB) undergoes random chain scission by ester hydrolysis in a 
process auto-catalysed by the generation of carboxylic acid end groups. 
Gopferich (Gopferich A 1996) has reported that the pH is one of the factors that 
influence the velocity of the hydrolysis through catalysis. Because the acidic 
products generated from the degradation of the polyester could accelerate 
polymer degradation by lowering the pH (Knowles JC et al. 1992a), the alkalinity 
induced by the inorganic particles could prevent this acceleration because the 
autocatalytic effect associated with the acidic products of the polymer is hindered 
by the buffering effect. A similar trend has been shown for PLGA/Bioglass® (Li H 
et al. 2005b) scaffolds and P(3HB-co-3HV)/wollastonite scaffolds (Li H et al. 
2005a). 
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Figure 4.10 Changes in weight average molecular weight (MW) of P(3HB)/m-BG samples 
immersed in SBF for up to 200 days. 
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The presence of bioactive glass particles in the composite considerably changes 
the ion concentration of the surrounding medium through the exchange of ions 
from the bioactive glass particles structure to the medium. Therefore an ion 
dissolution study was conducted for the composites in deionised water using ion 
chromatography. The change in the ion concentration for Cat+, P043, and Na2* 
was monitored over a period of 45 days in water, as shown In Figure 4.11. The 
ion release for all three functional groups in deionised water was higher for 20 
wt% n-BG composites, followed by 10 wt% n-BG composites. In comparison, 
there was no change induced by the addition of the polymer on its own. There 
was a sharp increase in the Na 2+ concentration in water due to its release from 
the glass composition, followed by a saturation phase after 5-10 days. However, 
the release of Ca 2+ and P04 3- groups had a very similar and gradual pattern, with 
the cumulative release of Cat' greater than P043" ions, as shown in Figure 4.11 
(a-b). Although the concentration of Si was not determined in this study, it has 
been shown that the Si and Na concentrations follow a similar trend (Cerruti M et 
al. 2005). The dissolution studies of the composites also need to be carried out in 
SBF environment as it has been reported that in such environments there is an 
increased release of Si and Na ions but a decrease in the Ca and P ions 
concentration due to their adsorption on the composite's surface, aiding in the 
formation of calcium phosphates and hydroxyapatite surface layers (Leonor IB et 
al. 2002). 
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Figure 4.11 Cumulative ion release from P(3HB)/n-BG composites in water over a 45 day 
period for (a) Caz+, (b) P043-, and (c) Na+. 
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4.3.3 Cytocompatibility study using MG-63 osteoblast-like cell 
lines 
Cell proliferation study using MG-63 cell lines on P(3HB)/BG composites was 
carried out using Alamar blue assay. The proliferation assay showed the extent 
of cell growth to be higher on the neat polymeric samples than on the composite 
samples (n=3, **p<0.01) and it was comparable to the cell growth on tissue 
culture plastic (n=3, p>0.05), as shown in Figure 4.12(a-c). However, there 
seemed to be a decrease in cell growth with increasing bioactive glass 
concentration. This trend was similar for both microscale and nanoscale bioactive 
glass composites. Nevertheless, the composites as well as the neat polymer 
samples showed an increase in cell proliferation during the 7 day period, 
following the same trend as the control (tissue culture plastic) (Figure 4.12). 
Since the P(3HB)/n-BG and P(3HB)/m-BG composites were tested in separate 
batches, the results obtained are not directly comparable. Therefore, Figure 
4.12(c) shows the cell proliferation results of all the samples compared to the 
control (control normalised to 100%) and it can be concluded that the MG-63 
osteoblast proliferation was in all cases >65% of the control surface. There were 
also no significant differences in the proliferation results between P(3HB)/m-BG 
and P(3HB)/n-BG composites. A possible reason for the decrease in cell number 
on the composites containing higher concentration of bioactive glass particles 
can be the high alkalinity induced by the dissolution of the particles. This could 
indicate that for this particular material, i. e., P(3HB)/BG composite, the size of the 
inclusion particles on direct cell response might be a secondary factor in 
comparison with the effect of the chemistry, e. g., surface reactivity and 
dissolution products. The reasons for these effects on cell proliferation are not 
clear, but they are undoubtedly associated with the differential influence of the 
various ion species released from the glass into the culture media and possibly 
also with material-induced pH differences between the composites. The present 
results demonstrate that these factors, arising from differences in the 
concentration and differential dissolution of the bioactive glass containing P(3HB) 
composites, have an important impact on cell growth and function. 
The cell proliferation results coupled with an encouraging value of protein 
adsorption (Section 3.3) showed good cytocompatibility of the composites 
towards MG-63 osteoblasts. Although the presence of high concentration of 
bioactive glass particles in the composites significantly increased protein 
142 
Chapter 4: Bioactivity and biocompatibility studies 
adsorption (Section 3.3), these composites had reduced cell proliferation values 
(Figure 4.12). This inverse relationship may be explained by conformational 
changes in the proteins in thicker layers. Thus composites with increased glass 
concentration, and their subsequent rapid development of a biological apatite 
surface layer, may cause the reduction in specific surface reactions and cell 
responses. This effect is supported by the fact that adsorption of proteins from 
serum can have an inhibitory effect on apatite formation (Kaufmann EABE et al. 
2000) and therefore this effect can slightly delay or reduce the proliferative 
capacity of the cells on these surfaces. 
In order to reveal the morphology of cells cultured on the P(3HB)/BG composites, 
Day 4 and Day 7 surfaces were examined by SEM and typical images are shown 
in Figure 4.13. The well-spread morphology showing attachment of the 
osteoblasts on composite samples, and the intracellular communication of cells 
with one another were evident on all examined samples. The cells had a more 
flattened and stretched morphology on the substrates at Day 7 compared to the 
Day 4 (Figure 4.13). 
The proliferation results and SEM images confirm also published results 
(discussed in Chapter 1) that show P(3HB) to have excellent biocompatibility and 
lack of toxicity towards osteoblasts as well as fibroblasts and chondrocytes. 
Similarly, other polymers from the PHA family (P(3HB-3HV), P(3HB-3HHx)) have 
also shown cytocompatible response to various other osteoblast cell lines 
(Kumarasuriyar A et aL 2005; Wang YW et al. 2005a). 
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Figure 4.12 Cell proliferation study for 1,4 and 7 days, using Alamar blue assay on (a) 
P(3HB)/m-BG composites, (b) P(3HB)/n-BG composites, (c) all tested samples relative to the 
control (control set to 100%). n=3; error bars =±SD; *p<0.05, "p<0.01, "'p<0.001 
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Figure 4.13 SEM micrographs of MG-63 cells grown on (a) P(3HB) at day 4, (b) P(3HB) at 
day 7, (c) P(3HB)/30 wt% m-BG at day 4, (d) P(3HB)/30 wt% m-BG at day 7, (e) P(3HB)/30 wt% n- 
BG at day 4, (f) P(3HB)/30 wt% n-BG composite at day 7 showing cells communicating through 
their filopodia. Cells on image (b) are enhanced by artificial colouring. 
ALP and osteocalcin measurements for a period of 14 days were carried out on 
P(3HB)/10 wt% and P(3HB)/20 wt% n-BG films to evaluate osteoblast activation 
and differentiation. These bone-associated proteins are typical markers for 
osteoblast characterization. ALP activity is an early marker of osteoblast 
differentiation, and its increased expression is associated to the progressive 
differentiation of cultured osteoblasts (Malaval L et al. 1999), whereas 
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osteocalcin is a late marker of osteoblast differentiation (Cowles EA et al. 1998). 
Therefore the change in ALP activity is implicated in a variety of physiological 
events such as bone development and liver diseases. The effect of bioactive 
glass content on the differentiation of MG-63 cells on the P(3HB)/n-BG 
composites are presented in Figure 4.14. The ALP activity for all samples peaked 
at Day 14 with a relatively lower growth at Day 1. In terms of osteoblastic 
response to the composite surface as a function of BG content, it was found that 
the ALP activity of MG-63 cells in the P(3HB)/n-BG group was significantly higher 
than for the control surface for Day 7 and Day 14. 
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Figure 4.14 ALP activity for osteoblastic phenotype expression of MG-63 cells grown on 
P(3HB)/n-BG samples. A significantly higher activity is measured on Day 14, with significantly 
higher ALP activity of cells on P(3HB)/n-BG samples than for the control surface. (n=3, error bars= 
±SD) 
Ishaug et al. (Ishaug SL et al. 1994) investigated the interactions between 
osteoblasts and various poly(a-hydroxy esters) (viz. PLLA, PLGA and PGA) and 
found that the ALP activities expressed by osteoblasts cultured on the samples 
did not significantly increase during the 14 day incubation period, with only 75: 25 
PLGA showing a substantial increase in ALP activity over time. In comparison, 
there was a significant increase in the ALP activity of cells grown on the P(3HB) 
substrate at Day 14. Multiple studies have suggested that ALP activity is 
enhanced when osteoblasts are grown on bioactive glass substrates (Loty C et 
al. 2001; Bosetti M et al. 2005). This fact is further strengthened by the positive 
effect of BG on bone apposition in both animal studies (Livingston T et al. 2002; 
Yang XB et al. 2006) and clinical trials (Trombelli L et al. 2002). A possible 
reason for the increased bone formation around bioactive glass implants is (i) 
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attachment to the bioactive glass or, (ii) exposure to its dissolution products 
enhances osteoblastic differentiation and affects cellular gene expression (Xynos 
ID et al. 2001; Bosetti M et al. 2005). Similar results using mesenchymal stem 
cells have been reported for PLGA foams containing bioactive glass particles, 
wherein the composite foams exhibited higher ALP activity than pure PLGA 
foams (Reilly GC et al. 2007). Yang et al. (Yang XB et al. 2006) also showed that 
PDLLA foams containing 5 wt% BG were much more effective in increasing 
alkaline phosphatase activity than the PDLLA foams containing 40 wt% BG 
particles. The results obtained here indicate that there should be an optimal 
concentration of BG leading to enhanced osteoblast response. 
Osteocalcin, also known as bone y-carboxylglutamic acid protein, is a vitamin K- 
dependent Caz+ binding protein carrying carboxylated glutamic acid residues 
(Gla), which are known to mediate strong binding of osteocalcin to hydroxyapatite 
(Poser JW et al. 1980). Osteocalcin constitutes about 15% of the non- 
collagenous bone matrix proteins and is produced exclusively in osteoblasts and 
odontoblasts (Price PA 1989). Due to this tissue specific expression, the level of 
osteocalcin is considered an indicator of the overall activity of cells operating in 
bone formation. It is thus suggested that when there is increased bone formation, 
the serum osteocalcin concentration also increases (Deftos LJ et al. 1982). 
Therefore in this study the Gla-osteocalcin EIA kit (TaKaRa Bio Inc., Japan) was 
used to quantify the carboxylated-type of osteocalcin (Gla-OC) produced by the 
MG-63 osteoblasts when grown on the P(3HB)/BG composite substrates. 
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Figure 4.15 Osteocalcin (Gla-OC) content of culture medium of MG-63 osteoblasts grown on 
the P(3HB)/n-BG composites as a function of time. Measurements correspond to osteocalcin levels 
on Day 1, Day 7 and Day 14. (n=2; error bars =±SD) 
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On culture-Day 1, expression of osteocalcin at low levels was found in all groups 
with an average value of 15±1.2 ng (Figure 4.15). There was no significant 
difference in the levels of osteocalcin between all the samples at Day 1 and Day 
7. However, there was a significant (n=2; *p<0.05) difference in the osteocalcin 
expression between the control and P(3HB)/n-BG composite samples. At all 
time-points no significant difference between the control and the P(3HB) samples 
was observed, thus proving the cytocompatibility of the polymer. However, on 
Day 14 there was a significant increase in the levels of osteocalcin for all 
samples (57% increase in the average) without any significant difference 
occurring between the samples. Similar levels of osteocalcin were also 
expressed by mouse osteoblast cell lines when grown in collagen foams 
(Arpornmaeklong P et a!. 2007) and in P(3HB-co-3HV) substrates (Kose GT et a!. 
2003). The increase in osteocalcin as observed in Figure 4.15 is indicative of the 
maturation of the cells and their osteoblastic phenotype and also complements 
the increased ALP activity of the MG-63 cells on Day 14. 
4.3.4 In vivo biocompatibility evaluation 
After examining the in vitro cytocompatibility of the P(3HB)/BG composites using 
bone forming MG-63 osteoblast cells, a preliminary in vivo biocompatibility study 
(subcutaneous implants in rats) was performed for a period of 3 weeks to 
examine the tissue response triggered by the newly isolated polymer. Histological 
examination of the P(3HB) film after two weeks showed a thin fibrous layer 
consisting of fibroblasts, vasculature consisting of small capillaries and a few 
inflammatory cells encapsulating each film (Figure 4.16). The underlying muscle 
showed no signs of any inflammatory response. At a higher magnification no 
cellular penetration of the film was observed due to their non-porous nature. A 
thick tissue capsule, consisting mainly of web-like fibres and elongated 
fibroblasts orientated along the length of the film, surrounded the implanted 
P(3HB) film after 2 weeks. In addition, a small number of blood vessels were 
present in the capsule, fibre bundles were organized in an extremely loose 
manner and the vasculature was better defined. Typical lymphocytes and 
vascularisation were clearly observed in the tissue around the implant. P(3HB) 
films elicited a mild tissue response throughout the course of the study. However, 
no inflammatory response was noted in the underlying muscle and a fibrous 
capsule encapsulated the film. The implantation of the film did not result in any 
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toxicity to the tissue but represented a foreign body response rather than an 
immunogenic response and the film was therefore considered to be 
biocompatible. In previous studies it was clearly found that increasing numbers of 
neutrophils were attracted to the implant sites as certain cytotoxic substances 
were released from the biomaterials (Pol BJM et al. 1996; Qu XH et al. 2006). In 
this study, however, no neutrophils were observed in any of the capsules, 
suggesting that the tested materials were non-cytotoxic. The P(3HB) implants 
were observed to be very inert and films were readily removed as only little tissue 
was found to be adherent to them. Based on these encouraging results, P(3HB) 
and P(3HB)/m-BG porous scaffolds were subcutaneously implanted to examine 
the vascularisation and biocompatibility of the foams (results are discussed in 
Section 4.3.7). 
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Figure 4.16 Histological examination of P(3HB) films implanted subcutaneously in rats after 2 
weeks. Figure (a) shows a bi-rifringent image using polarized light of the film (x200), with both 
sides attaching to the surrounding tissues. A high density of cells is evident from this image (b) 
Histological image showing the presence of a fibrous capsule surrounding the film and the adjacent 
muscles (x200). Figure (c) shows the presence of well-developed blood vessels were evident 
(marked by arrow) (x400). The results indicate a mild response, predominantly a foreign body 
response by the P(3HB) implant. In all the images, no penetration or growth of the cells through the 
substrate was observed considering that films were non-porous. 
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Numerous examples of PHA biocompatibility have been cited In the literature 
(Valappil SP et al. 2006) as well as discussed in Section 1.4.6. As an example, 
for P(3HB)/hydroxyapatite composites it has been shown by Interfacial shear 
strength that both hard as well as soft tissue can attach on the surface (Knowles 
JC et al. 1992b). Luklinska et al. (Luklinska ZB et al. 1997) studied the interface 
between P(3HB)/hydroxyapatite composites and bone when implanted in vivo In 
rabbits and found that, after one month of implantation, bone apposition occurred 
along the whole length of the implant interface. Three months after implantation, 
bone was found to form an interlocking structure on the exposed hydroxyapatite 
particles at the interface, followed by dense bone formation after six months of 
implantation. Despite the well documented biocompatibility of P(3HB), there are 
reports of P(3HB) inducing some level of inflammatory response, as shown by 
Löbler et al. (Lobler M et al. 2002) and Unverdorben et al. (Unverdorben M et al. 
2002). Although the signs of inflammation were not observed macroscopically, 
the implantation of P(3HB) into the gastrointestinal tract of rats provoked a tissue 
response. However, other PHAs, i. e. P(3HB-co-3HHx), have shown a better 
biocompatible response than PLA, which exhibited more significant acute 
inflammatory response when implanted in rabbits for up to 6 months (Qu XH et 
al. 2006). This could be attributed to the released chemicals from the degradation 
process of PLA that has been also shown to induce cell death in vitro (van 
Sliedregt A et al. 1994). 
It is important to note that most of the reported in vivo P(3HB) studies have been 
performed on industrial rather than medical grade polymers and hence pyrogenic 
contaminants co purified with P(3HB) might have been the cause of adverse 
tissue responses as opposed to the monomeric composition of P(3HB). 
Currently, P(3HB) is produced at an industrial scale using exclusively Gram 
negative bacteria (R. eutropha, E. coli, Pseudomonas spp. ), and all these 
organisms contain the outer membrane lipopolysaccharide (LPS) endotoxins, 
which are pyrogens known to co-purify with the polymer. The presence of LPS 
induces a strong immunogenic reaction and is therefore undesirable for 
biomedical applications (Chen GQ et al. 2005). However, in our case, P(3HB) 
was produced from a Gram positive species of Bacillus spp. and hence the 
production process does not have the possibility of introducing LPS endotoxins. 
The lab produced P(3HB) is therefore a good candidate for biomedical 
applications, as demonstrated by the biocompatibility studies presented in this 
chapter. 
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4.3.5 Bioactivity of P(3HB)/m"BG foams 
Based on the encouraging bioactivity and biocompatibility results achieved by the 
addition of 10 wt% bioactive glass particles in P(3HB) (as presented in previous 
sections), P(3HB)/10 wt% bioactive glass foams were prepared by a sugar 
leaching method and characterised. This section covers the bioactivity, 
biocompatibility and antibacterial activity of P(3HB) and P(3HB)/BG foams. 
Although experimental results discussed so far have Indicated that P(3HB)/n-BG 
composites could be potentially more suitable for scaffolds for hard tissue 
regeneration, in this investigation P(3HB)/BG foams were made using microscale 
Bioglass® particles. The reason for using m-BG was to primarily check the 
efficacy of incorporating the m-BG particles in the foam's microstructure and also 
to gain a basic understanding of the composite's behaviour. In contrast, the 
foams used for evaluating the antibacterial activity had n-BG particles. This was 
due to published reports of n-BG having a greater antibacterial activity than the 
conventional m-BG particles (Waltimo T et al. 2007). The scaffold fabrication 
technique is described in Section 3.2. For the investigation described here foams 
of 85-90% porosity and physical dimensions of 0.5x0.5x0.5 cm3 were used. 
SEM and EDX analyses were used to identify the bioactivity of the composite 
foams after 10 days of immersion in SBF and Figure 4.17 (a-c) shows the 
microstructure of the foams covered by hydroxyapatite crystals after 10 days in 
SBF. EDX analysis confirmed the presence of calcium and phosphorus and the 
Ca/P ratio was found to be 1.57. The formation of hydroxyapatite throughout the 
foams is highlighted in Figure 4.17 (c), denoting the difference in the scale of 
magnification. The observation made is consistent with the P(3HB)/m-BG films 
(results in Section 4.3.1) and demonstrates the success of the methodology used 
to prepare the composite foams and the ability of the composites to introduce 
bioactivity. However, in this case the characterisation (especially the crystallinity 
of the developed calcium phosphate layer) was not extensive and only 
preliminary SEM and EDX was performed to examine the bioactivity of the foams 
after 10 days of immersion in SBF. The P(3HB)/m-BG scaffolds were extremely 
brittle after the 10 days incubation period compared to the neat P(3HB) foams. 
This observation however is only a manual qualitative assessment and needs to 
be validated by mechanical tests, remaining as an important task for future 
research. 
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Figure 4.17 SEM micrographs at different magnifications (a-c) showing the in vitro bioactivity 
of P(3HB)/10 wt% m-BG foams (e. g. formation of hydroxyapatite-marked by arrows) and, (d) EDX 
spectrum performed on the composite scaffolds. 
4.3.6 Cytocompatibility study of P(3HB)/m-BG foams 
Cytocompatibility of the foams were also demonstrated using MG-63 osteoblasts 
on P(3HB) and P(3HB)/m-BG foams, by measuring the cell proliferation and 
examining the attachment and distribution of MG-63 cells in the scaffold through 
SEM. Figure 4.18 (a) shows the cell proliferation results highlighting the 
significant increase in the growth of the MG-63 cells between Day 1 and Day 4 
for all samples. There was however no significant increase in the growth of the 
cells between Day 4 and Day 7 for the P(3HB) foams. This could be due to the 
lack of nutrients, as the scaffolds were seeded with a much higher cell density 
than the films (100,000 cells for foams and 20,000 cells for films). The 
proliferation of cells in P(3HB)/m-BG foams was lower (13% less in Day 1 and 
15% less on Day 4) than in P(3HB) foams and followed a similar trend as shown 
for P(3HB)/m-BG films. This observation is however in contrast with the data 
reported in literature, wherein the presence of Bioglass® in PDLLA foams 
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increases significantly the cell proliferation (Blaker JJ et al. 2003). The effect of 
lower BG concentration i. e. <10 wt% on the cell proliferation was not evaluated 
and it remains an area that needs to be investigated. The outcome of this 
experiment was to demonstrate that the P(3HB) and P(3HB)/m-BG scaffolds 
prepared using solvent casting and particulate sugar leaching technique were 
appropriates substrate allowing cell proliferation. 
A qualitative analysis of cell adhesion and distribution was carried out by SEM 
observation of samples at Day 7 of cell culture. The SEM study confirmed the 
infiltration and migration of osteoblasts deep into the porous network of the 
foams. In both the samples, MG-63 cells were more evident on the highly porous 
surface of the foams and showed that the cell seeding method allowed the cells 
to be well distributed throughout the foam structure. For example, Figure 4.18 (b) 
shows a thick layer of MG-63 cells adhering to the surface of a P(3HB) foam after 
7 days of culture. On closer examination of the surface at higher magnification it 
was confirmed that the P(3HB) foam surface allowed MG-63 cell attachment, 
cellular communication as well as cell division (indicated by cell couplets), as 
shown in Figure 4.18 (c). A well-spread and flattened morphology of MG-63 cells 
is also evident from Figure 4.18 (c). Cells can be seen attaching to the walls of a 
pore of P(3HB)/m-BG scaffolds in Figure 4.18(d). An interesting feature was 
observed in Figure 4.18 (e), wherein the MG-63 cells aligned themselves to the 
physical shape of the scaffold, as shown by the curved shape of the MG-63 cells 
as opposed to a flattened morphology seen in P(3HB)/m-BG films (Figure 4.13). 
The cell attachment identified on the foams further suggests the fact that the 
surface morphology and microstructure of the foam plays an important role in cell 
spreading and attachment. The SEM results further prove that the P(3HB)/BG 
foams being a cytocompatible and osteoconductive substrates provide structural 
cues for the cells to take up the desired shape and morphology. 
4.3.7 In vivo study of P(3HB)lm-BG foams 
For biocompatibility studies, scaffolds were implanted subcutaneously in the 
abdominal region of rats (n=2) (Figure 4.19(a)). Each animal received 2 scaffolds, 
i. e., P(3HB) and P(3HB)/BG scaffold having a porosity of -85-90% and pore 
sizes of 100-200 µm. The micrographs in Figure 4.19 (b-d) were taken from the 
samples 1 week after subcutaneous implantation. The in vivo response of 
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P(3HB) foams was comparable to the P(3HB)/BG foams, as both implants were 
surrounded by a thin capsule containing proliferating fibroblasts, collagen fibres, 
newly formed capillary sprouts and some macrophages. Attachment of cells to 
the foams outer structure is clearly shown in Figure 4.19 (c). From this capsule, 
endothelial cells, fibroblasts and inflammatory cells penetrated into the porous 
cavities of the scaffold. Some giant cells (multinucleated macrophages) were also 
observed at the border of the scaffold. However, a striking difference between the 
P(3HB) and P(3HB)/BG foams was that the P(3HB) foams were able to maintain 
their structural shape throughout the study, whereas, the P(3HB)/BG foams 
seems to break up, as shown in Figure 4.19 (c-d) and (e-f). However, it is 
important to note that the addition of n-BG particles, instead of m-BG particles 
may improve the physical and structural integrity of the foams, as n-BG have 
been shown to reinforce the mechanical properties, as shown in Chapter 3. The 
irregular shape of the pores in P(3HB) foams, shown in Figure 4.19 ((a)-inset) is 
maintained after implantation and can be seen in Figure 4.19 (c-d). Additionally, 
there were numerous macrophages around the scaffold, but more were observed 
in the P(3HB)/BG foams than in the P(3HB) foams, perhaps due to the structural 
degradation occurring in the foams. Since the in vivo study was done in a non- 
osteo model and in a movable environment, the non-matching mechanical 
properties can also be a cause for the structural disintegration of the scaffolds 
and hence occurrence of a foreign body reaction. The interconnected pore 
structure helped to promote vascularisation in all the samples, the formation of 
small capillaries was observed and would help to increase the supply of nutrients, 
and the efflux of waste products from the surrounding cells. These observations 
highlight the biocompatibility of the scaffolds and their ability to allow cell 
penetration and vascularisation (as shown in the cytocompatibility studies, Figure 
4.19). Only very few giant cells were seen in the P(3HB) samples and in contrast 
to the P(3HB)/BG samples a foreign body reaction was observed. Giant cells 
were observed between a network of fibroblasts, collagen and newly formed 
capillaries. After 1 week of implantation mineralization was seen to occur in 
P(3HB)/BG foams, as shown in the bi-rifringed image of the foams in Figure 
4.19(f). This however was not confirmed using von-kossa or any other stains and 
needs to be examined. Overall, the animal study of the P(3HB) and P(3HB)/BG 
foams revealed them to be biocompatible without any toxic or inflammatory 
response. The results achieved also highlight that the method adopted to prepare 
the foams allows for the growth, penetration and vascularisation of the cells. The 
incorporation of nanoscale bioactive glass particles along with bioactive growth 
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actors renders a possibility of testing these scaffolds for bone regenerative 
applications. 
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Figure 4.18 (a) Cell proliferation study using Alamar blue assay for P(3HB) and P(3HB)/m-BG 
composite scaffolds on day 1,4 and 7. SEM micrographs of MG-63 cells grown for 7 days, (b) 
P(3HB) foams (arrow marks the MG-63 cell layer) , (c) higher magnification image of 
(b) showing 
cell attachment and division, (d) P(3HB)/m-BG foams highlighting the spread of the cells and 
bridging the pores (image enhanced by artificial colours) and, (e) P(3HB) foams demonstrating the 
ability of the cells to bridge the pores and also to take up the contours of the substrate (marked by 
arrows). 
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Figure 4.19 Digital image of (a) foams after 7 days subcutaneous implantation in rats SD. 7 
Days haematoxylin/eosin stained sections showing the biological response of (b) P(3HB) foams 
(x200), (c-d) P(3HB) foams (x100), and (e-f) P(3HB)/BG foams (x100). 
NOTES: 1-formation of blood capillaries denoting vascularisation, 2- Fibrous tissue surrounding 
around the scaffolds and attachment of the tissues to the periphery of the scaffolds, 3-penetration 
of the cells through the pores of the scaffolds, 4-Foam area denoting the structural homogeneity 
maintained after 7 days of implanation, 5- macrophages, and 6- bi-rifringent image using polarized 
light highlighting mineralised bone i. e. hydroxyapatite arising from the bioactive glass component in 
the matrix. 
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4.3.8 Antibacterial properties of P(3HB)/n-BG foams 
Implanted biomaterials usually suffer from bacterial colonization (also known as 
biofilm formation) (Costerton B et al. 2004), and Staphylococcus aureus (S. 
aureus) is a major pathogen, associated with medical device related Infections 
(Stickler DJ of al. 1995; Francois P et al. 1996). Once biomaterials are implanted 
they are coated immediately with host plasma constituents, including extracellular 
matrix, and, eventually host cells. It is well established that if host cells such as 
fibroblasts arrive at the biomaterial surface and secured bonds are established, 
bacteria are confronted by a living integrated cellular surface (Costerton JW of al. 
1999). Such an integrated viable cell layer with a functional host defence 
mechanism can resist colonization from bacteria such as S. aureus (Gristina AG 
1987). However, this principle only works under the assumption that the host 
cells attach to the surface faster and earlier than the bacterial cells, which is not 
always the case. The bacterial cells after attachment to the surface start forming 
colonies, which lead to the formation of thick layers (usually of several microns), 
known as biofilms. Biofilms start with the adhesion of bacteria to a surface, 
followed by bacterial cell-cell adhesion and formation of multiple layers of 
bacteria (Cramton SE et al. 1999). The biofilms associated bacteria (viz. 
Pseudomonas spp., S. aureus) show decreased susceptibilities to antibiotics, 
disinfectants and phagocytosis, and pose a threat to the biocompatibility of the 
implant area. 
Therefore it is essential that when a biomaterial is introduced into the body it 
does not preferentially favour bacterial adhesion/colonization. In most 
cases this is achieved by the addition of antimicrobial agents, viz. addition of 
specific drugs (gentamicin, chiorhexidine, tetracycline etc) (Koller G et al. 2008; 
Virto MR et al. 2007) or doping with metal ions (silver, gallium, zinc, boron etc. ) 
(Bellantone M et al. 2002). Another approach is to alter the surface topography 
by making the surface smoother to prevent the bacterial adhesion (commonly 
used in metal implants) (Hallab NJ et al. 2001). However, this will also have a 
negative effect on the attachment of the host cells, which is not desirable. Hence, 
the battle to prevent bacterial growth and promote host cell attachment is a 
complicated clinical problem. 
The primary aim of this microbial growth study was to investigate whether the 
P(3HB)/BG composite on its own, without addition of any antibacterial drug, had 
any prohibiting effect on the growth of S. aureus. P(3HB) and P(3HB)/n-BG 
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foams with 10 wt% n-BG particles were used in this study as it was shown to be 
the optimum n-BG concentration for mechanical reinforcement (Chapter 3) as 
well as for inducing favourable cell growth (Section 4.3.3). It is important to note 
that the true bactericidal effect of the P(3HB)/BG composite cannot be confirmed 
using one strain of bacteria only and other bacterial strains (Pseudomonas spp. ) 
needs to be used, as a part of further studies. 
Viable count experiments conducted on S. aureus showed that there was no 
significant difference (n=3, p>0.05) between the P(3HB) foams and the control 
(cells grown on tissue culture plastic in PBS without any sample). Although the 
comparison with the control surface is not ideal, due to the increased surface 
area of the 3-D foams for bacterial cell attachment compared to the control 
surface (tissue culture plastic), it nevertheless provides a reference to test the 
validity of the experiment. It was shown that the log10 of the mean number of 
viable cells in P(3HB)/10 wt% n-BG composites was reduced and followed the 
same trend throughout the study period. This effect occurred solely due to the 
presence of Bioglass® in the composite, as shown through the log10 of the mean 
number of viable cells in the presence of n-BG particles on its own 
(corresponding to 10% of the weight of the foams). The decrease in the amount 
of viable bacterial cells in the presence of n-BG particles was highly significant 
(n=3, **p<0.01) compared to the control or the pure P(3HB) foams. Also, as 
shown in Figure 4.20, the presence of n-BG particles on their own reduced the 
colony forming units of S. aureus cells on prolonging the time period (up to 48 h). 
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Figure 4.20 Colony forming unit (CFU) study of S. aureus when grown in PBS medium, for 
various foams samples and for n-BG samples suspended in PBS. Each point represents the logic 
of the mean number of viable counts. (n=3; error bars = ±SD). Tissue culture plastic with the PBS 
medium is used as the control surface. 
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A clear difference (qualitative) in the number of cells attaching to the surface of 
P(3HB) and P(3HB)/10 wt% n-BG foams can be seen through the SEM Images in 
Figure 4.21. The presence of spherical S. aureus cells on the surface evidenced 
their attachment and colonisation on the substrates. It Is worth noting the 
difference in the spherical shape of the bacterial cells compared to the more 
flattened and spread morphology of MG-63 cells, as shown in Section 4.3.3. On 
allowing the bacterial cells to grow freely on the surface they start colonising and 
forming a thick layer, as described extensively in the literature (Costerton JW et 
al. 1987). This SEM observation coupled with the reduction in the log10 of the 
mean number of viable cells observed due to the presence of n-BG particles in 
the P(3HB) foams suggest the possible antimicrobial effect of the developed 
P(3HB)/10 wt% n-BG composite foams. 
A possible explanation for the antimicrobial effect of Bioglass® particles is the 
relatively higher alkaline effect, which resulted due to the release of ionic 
products of the dissolution of the Bioglass® particles in vitro (Allan I et al. 2001). It 
has been shown that the optimum pH for the growth of S. aureus cells is between 
7 and 7.5 and in our case, the pH of the medium increased from 7.4 to 8.4 (n=3, 
***p<0.0001) over the 48 h period as a result of the immersion of P(3HB)/10 wt% 
n-BG composites (Figure 4.22). In comparison, the pH of the medium remained 
at 7.4 throughout the time period for pure P(3HB) foams, thus allowing a 
favourable environment for the bacterial cells to colonise and grow. Therefore, 
having higher concentration of bioactive glass particles in the composite will have 
an increased pH effect resulting in a prominent reduction in bacterial colonisation. 
But, in doing so, the compatibility towards the host cells (fibroblast, osteoblasts, 
etc) could also be compromised. Therefore an optimal concentration of bioactive 
glass particles should be used in the composite to ensure a biocompatible 
surface with enhanced antimicrobial properties. In such circumstances the use of 
n-BG particles can play a vital role in imparting the desired antimicrobial activity, 
because it has been shown to have a higher alkaline effect than the conventional 
melt processed microscale Bioglass® particles (Waltimo T et al. 2007). The 
higher surface area of n-BG particles enhances the dissolution and release of the 
ionic products. The difference in the extent of colony forming units between 
P(3HB)/n-BG and free n-BG samples is primarily due to the fact that all of the n- 
BG particles are not exposed in the composite because they are either 
completely or partially embedded in the polymeric matrix. 
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Attempts have also been made to dope Bioglass® with silver to increase the 
antimicrobial efficacy (Bellantone M et al. 2002). The obvious question of the 
effect of Ag' ions on the host cells remains a matter of further investigation. The 
experiments conducted here demonstrate that no direct contact between 
bioactive glass particles and bacterial cells is required for the antibacterial effect. 
The alkalinity of the solution due to the presence of n-BG particles was able to 
prevent the bacterial adhesion, in-effect sterilising the implant site. 
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Figure 4.21 SEM micrographs of S aureus attachment after 48 h on (a, b, c, e) P(3HB) 
foams and (d, f) P(3HB)/n-BG composite foams. A decrease in S. aureus cells on the surface of the 
P(3HB)110 wt% n-BG foams is evident in (d) and (f) in comparison to (c) and (e), respectively. 
Bacterial cells are artificially coloured in (e) and (f) to improve visualisation. 
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Figure 4.22 Change in the pH of the medium over the 48 h period, due to the immersion of 
P(3HB) and P(3HB)110 wt% n-BG foams. The medium used was phosphate buffer saline with a pH 
of 7.4 that remained unchanged over the period of study. (n=3, error bars = ±SD) 
4.4 Conclusions 
The mechanical and structural properties (as discussed in Chapter 3) in 
combination with the degradation and detailed biocompatibility studies discussed 
in this chapter provided a better understanding of the effect of Bioglass® on the 
composite's properties. The various results obtained in this chapter can be 
summarized in two sections. 
4.4.1 Bioactivity and degradation studies 
" The bioactivity of the P(3HB)/bioactive glass composites was confirmed by 
the formation of crystalline hydroxyapatite on the composites' surfaces after 5 
days of immersion in SBF. Various techniques confirmed that the calcium 
phosphate layer grown on the surface to be weakly crystalline hydroxyapatite. 
" In vitro degradation studies confirmed that the addition of bioactive glass to 
the polymeric matrix significantly increased the water uptake, the pH of the 
surrounding medium and slowed the molecular weight degradation (with a 
reported half life of approx 120 days and 140 days for P(3HB) and P(3HB)/m-BG 
composites, respectively). 
" Inclusion of nanosized bioactive glass (n-BG) particles significantly improved 
the bioactivity and water absorption of the composites more than the microscale 
bioactive glass composites and at the same time provided a surface 
nanotopography. 
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" Bioglass® particles (both m-BG and n-BG) were successfully incorporated in 
the structure of P(3HB) foams and preliminary acellular bioactivity for P(3HB)/10 
wt% m-BG was confirmed after 10 days of immersion in SBF. 
4.4.2 Biocompatibility studies 
" No significant differences in cell proliferation, ALP activity and osteocalcin 
expression between the P(3HB) samples and the control surface (tissue culture 
plastic) were found. 
" Increase in bioactive glass concentration decreased the cell proliferation, 
without affecting the ALP and osteocalcin measurements. P(3HB) composites 
with 10 wt% n-BG showed a significant improvement in cell proliferation, 
compared to higher bioactive glass concentration (i. e. 20 and 30 wt%). No 
significant difference in cell proliferation between n-BG and m-BG composites 
was observed for concentrations of 20 and 30 wt%. 
" ALP activity and osteocalcin measurements demonstrated that the P(3HB)/n- 
BG substrates provided a cytocompatible surface for MG-63 osteoblasts 
attachment, differentiation and expression of bone binding proteins. 
" P(3HB) and P(3HB)/m-BG foams showed highly compatible surfaces for 
proliferation and attachment of the MG-63 bone cells. The large pore sizes (80- 
100 µm) and porosity (<90%) allowed infiltration and migration of MG-63 
osteoblasts deep into the porous network of the foams. 
" In vivo studies of P(3HB) and P(3HB)/BG foams showed a non-inflammatory 
and foreign body response induced. Vascularisation was achieved in the 
scaffolds and growth of blood capillaries and fibroblasts was present throughout 
the foams. 
" Antibacterial studies demonstrated that pure P(3HB) foams do not prohibit 
the bacterial (S. aureus) adhesion and colonization on the substrates. Whereas 
the presence of bioactive glass in the foams significantly reduced the growth of 
bacteria for the first 24 h. 
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5. Functiona1istion of 
PE3HBI/BiOuIass® com'LltDSites 
5.1 Introduction 
Tissue repair strategies using a resorbable scaffold have been traditionally 
intended towards providing a template for adequate mechanical stability and 
desired cellular response, e. g. cell proliferation and cell attachment. However, as 
the field of tissue engineering advances, there is a growing need for stretching 
the functions of scaffolds, encompassing delivery of suitable signalling 
molecules, e. g. growth factors and drugs, addition of functional properties and 
even considering their function as biosensors. Functionalising the 
polymeric/composite substrates can be multifaceted, viz. improving surface 
topography to enhance cell attachment and proliferation, using the substrate as a 
delivery vehicle for a controlled or sudden release of drugs or growth factors. 
That being the case, in the present chapter, the results of a series of experiments 
designed to provide extra functionalities to the basic P(3HB)/Bioglass® composite 
system are presented and discussed. Firstly; the cell supporting function of the 
composites has been enhanced by improving the surface properties for better 
cell attachment by adding Vitamin E. Secondly; the possibility of achieving 
electrical conductivity in the composite by adding multiwall carbon nanotubes 
(MWCNTs) was investigated. In the subsequent paragraphs the rationale for 
using Vitamin E and MWCNTs is presented. 
5.1.1 Rationale for incorporating Vitamin E 
The presence of oxygen-derived free radicals can lead to a gradual decrease in 
bone formation (Garrett IR et al. 1990; Key Jr. LL et al. 1990). The decrease in 
number and activity of osteoblasts responsible for synthesizing new bone matrix 
is an important factor to the development of osteoporosis. Such cases have been 
usually linked with the increased presence of oxygen radicals and decreased 
levels of antioxidants (Arjmandi BH et al. 2002). Accumulation of such free 
radicals is associated with the bone resorption activity of osteoclasts (bone eating 
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cells) and has shown to be toxic towards osteoblasts (Garrett IR et al. 1990). It is 
thus of considerable interest to introduce antioxidants In the biological systems 
through tissue engineering scaffolds. The incorporation of such antioxidant 
systems will not only allow a suitable substrate for the growth of osteoblasts but 
will also undermine the activity of osteoclasts. 
Among the various antioxidants available, Vitamin E (C29H50O2) Is a natural 
biological antioxidant that is biocompatible and does not have undesirable 
toxicological effects (Lucy JA et al. 1964; Crary EJ 1984). Vitamin E is a well- 
documented lipid soluble antioxidant in biological systems that protect structures 
and functions of cell membranes from free radical damage (Lucy JA et al. 1964; 
Brigelius FR et al. 2002). In vivo and in vitro results have shown the presence of 
Vitamin E to act as free radical scavenger and suppress bone resorption while 
stimulating bone formation (Xu H et a/. 1995). Vitamin E deficiency has also been 
revealed to cause a decrease in the mechanical strength of bone (Melhus H et a/. 
1999; Arjmandi BH et al. 2002). Moreover, Vitamin E being a natural product has 
been tested positive for the biocompatibility of its degradation products and has 
hence been approved by the FDA to be used in food and contact applications 
(Reno F et al. 2004). Apart from being a strong antioxidant, Vitamin E also aids 
towards the optimal development and maintenance of human nervous system 
and skeletal muscle, acts as anti-inflammatory agent (Devaraj S et al. 1996) and 
is reported to help in preventing heart diseases (Pryor WA 2000). Apart from the 
biological significance of Vitamin E, it has also been used to increase the bio- 
stability of poly(etherurethane urea) (PEUU) elastomers and ultra high molecular 
weight polyethylene (UHMWPE), by inhibiting oxidation and crosslinking of the 
polyether soft segments (Reno F et al. 2004; Reno F et a/. 2006). Due to the 
reported importance of Vitamin E in hard tissue applications, it was envisaged as 
a part of this project to explore the possibility of incorporating Vitamin E into the 
P(3HB)/Bioglass® composites. The effect of incorporating Vitamin E on the 
surface properties and on the growth and attachment of osteoblasts cells (MG-63 
human osteoblasts) was examined in this study. No previous work has 
investigated the addition of Vitamin E to scaffolds intended for hard tissue 
regeneration. 
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5.1.2 Rationale for adding multiwall carbon nanotubes 
(MWCNTs) 
Conventional scaffolds often allow no means of in-situ monitoring the status of 
new tissue growth or the scaffold conditions (e. g. degradation, bioactivity, etc. ). 
Hence it is recognised that the ability to in-situ monitor the scaffold's performance 
(bioactivity, degradation etc. ) while it is implanted can provide valuable 
information about the scaffold's interaction with the surrounding biological 
environment. To achieve a sensing function based on electrical signals, it is 
necessary to incorporate an electrically conducting material within the scaffold 
structure (Huang JE et al. 2003). Carbon nanotubes (CNTs) are one of the 
materials of choice for this application due to their excellent chemical stability 
along with their electrical and mechanical properties (Baxendale M 2003). CNTs 
are being investigated for biomedical applications and several investigations 
have led to several proposed applications in the biomedical field, including 
biosensors, drug/vaccine delivery, conductive polymer nano-composites and 
scaffolds for cell attachment (Correra Duarte MA et a!. 2004; Grunlan JC et a!. 
2004; Lin Y et a!. 2004; Zhao L et a!. 2004; Sinha N et a!. 2005). The high aspect 
ratio and high electrical conductivity of CNTs make them excellent elements for 
use in conductive composites. The possibility of placing sensing elements in 
flexible biocompatible substrates is also appealing for devices with in vivo 
sensing function. For instance, free cholesterol in blood was measured using 
MWCNT electrodes (Tan X et a!. 2005) and polyaniline/nanotube composites 
have shown to be flexible pH sensors (Kaempgen M et a!. 2006). If successful, 
the incorporation of MWCNTs in tissue engineering scaffolds can possibly render 
scaffolds capable of transmitting information (e. g. pH, and glucosefinsulin levels) 
extracorporeally. Equally important is the recent experimental demonstration that 
biological and bioactive species such as proteins, carbohydrates, and nucleic 
acids can be conjugated with carbon nanotubes (Smart SK et al. 2005). 
Although CNTs have various favourable properties but the lack of understanding 
of CNT toxicity has been an impediment towards its wider applicability. Various 
biocompatibility tests have been carried out on CNTs using in vitro and in vivo 
techniques to understand their interaction with biological systems (Elias KL et al. 
2002; Webster TJ et al. 2004). Attempts have also been made to investigate the 
suitability of CNT containing materials as bone substitute biomaterials, by 
examining the adhesion and behaviour of bone forming osteoblast cells 
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(MacDonald RA et al. 2005; Zanello LP et al. 2006). There are reports concluding 
that carbon nanofibres induce no cytotoxic response to osteoblasts cells, 
indicating that they can be used as potential orthopaedic materials (Elias KL et al. 
2002). However, the positive impact of carbon nanotubes for biomedical 
applications does not balance the concerns related to their possible cytotoxicity 
(Hurt RH et al. 2006; Harrison BS et al. 2007). There are reports also showing 
that CNTs enter through the cellular membrane and get accumulated in the cell 
cytoplasm (Monteiro-Riviere NA et al. 2005). It has also been shown that the 
presence of nanoparticles including CNTs can induce or increase oxidative stress 
levels in the human body (Shvedova A et al. 2003). Overall, the recent 
developments constitute only limited research about carbon nanotubes and their 
effect on the various aspects of toxicity, thus the findings are still inconclusive 
and in some cases even contradictory (Hurt RH et al. 2006). Therefore in this 
study we aim to examine the effect of MWCNT concentration on electrical 
properties, bioactivity and biocompatibility of the P(3HB)/Bioglass® composite 
system with potential applications in bone tissue engineering. 
5.2 Experimental Details 
5.2.1 Materials 
Functionalisation of P(3HB)/Bioglass® composites was achieved by the addition 
of Vitamin E and multiwall carbon nanotubes. Vitamin E ((t)-a-tocopherol) was 
purchased from Sigma Aldrich Chemicals (UK) and multiwall carbon nanotubes 
(MWCNTs) were donated by Prof. Ravi P. Silva (Advanced Technology Institute, 
University of Surrey, Guildford, UK). The average tube diameter of the highly 
entangle CNTs were ca. 40 nm. Bioglass® powder - used for producing 
P(3HB)/Bioglasso composites for Vitamin E and MWCNT studies was donated by 
Dr. Ian Thompson (Kings College, London). The Bioglass® particles utilized were 
of 45S5 type (Hench LL 1998b) (composition given in Chapter 3) and exhibited 
irregular shape with mean particle size <5 µm. Nanoscale bioactive glass 
particles (<50 nm) were used in this study to prepare functionalised 3-D foams 
(details of the composition mentioned in Chapter 3). 
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5.2.2 Sample preparation 
5.2.2.1 Incorporation of Vitamin E: Vitamin E loaded P(3HB) and P(3HB)/ 
(20 wt%) Bioglass® films (Table 5.1) were prepared using solvent casting 
technique, as described in Section 3.2. The 10 wt% concentration was used In 
this study in relation to the favourable results reported in the literature (Reno F et 
al. 2005). Vitamin E was added to the polymer solution (3 wt%) and sonicated for 
1 min. For P(3HB)/Bioglass® films, appropriate amounts of Bioglass® particles 
were added prior to the addition of Vitamin E and then sonicated. The mixture 
was then poured in petri plates and left to dry in a dark room at room 
temperature. Upon solidification the films were stored at 4°C for no more than a 
week before further characterisation. 
5.2.2.2 Addition of multiwall carbon nanotubes (MWCNTs): P(3HB) and 
P(3HB)/20 wt% Bioglass® films containing various concentrations of MWCNTs 
(Table 5.2) were prepared using solvent casting technique. The required 
concentrations of MWCNT and Bioglass® were added to the polymer solution (2- 
3 wt%) and sonicated for 2-3 min. Sonication was performed to achieve a 
homogeneous dispersion of MWCNT in the polymer solution by breaking the 
possible agglomerates. The films were cast onto glass petri dishes at room 
temperature and upon solidification were stored in desiccators for further 
analysis. 
Table 5.1 Sample descriptions for Vitamin E loaded polymeric and composite films. 
Samples Bioglasss (wt%) Vitamin E (wt%) 
Sample A00 
Sample B 20 0 
Sample C0 10 
Sample D 20 10 
Table 5.2 Samples prepared with various concentrations of Bioglass® and MWCNTs in 
P(3HB) matrix. 
Samples Bioglass® content (wt%) MWCNT content (wt%) 
Sample 100 
Sample 2 20 0 
Sample 302 
Sample 404 
Sample 507 
Sample 6 20 7 
Sample 7 20 2 
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5.2.2.3 Functionalised foams: Functionalised P(3HB)/Bioglass® scaffolds 
were prepared by incorporating 10 wt% Vitamin E and 2 wt% MWCNTs using 
solvent casting and particulate leaching technique, as described In Section 3.2. 
Details of the samples prepared are given in Table 5.3. The additives (i. e. 
MWCNT and Vitamin E) were sonicated regularly prior to impregnating the 
mixture onto the sugar preforms, which were used as porogens to fabricate the 
scaffolds. 
Table 5.3 Description of the foams prepared containing bioactive glass, MWCNT and 
Vitamin E. 
Samples Bioglass® (wt%) Vitamin E (wt%) MWCNT (wt%) 
Foam 1 0 0 0 
Foam 2 10 0 0 
Foam 3 0 10 0 
Foam 4 10 10 0 
Foam 5 0 0 2 
5.2.3 Characterisation techniques 
The physical characterisation techniques employed were chosen to highlight the 
functionalisation aspect provided by the addition of Vitamin E and MWCNTs in 
the composites, i. e. cell attachment and current conducting capacity, 
respectively. The tests carried out on the different composites are listed in Table 
5.4. 
Table 5.4 Various physical techniques employed to characterise the Vitamin E and 
MWCNT containing P(3HB)/BG composites. 
Samples Tests 
Vitamin E samples Contact angle; protein adsorption; cytocompatibility 
MWCNT samples In vitro bioactivity, thermal and mechanical properties; 
cytocompatibility; surface roughness, current-voltage measurements 
5.2.3.1 Surface analysis: SEM analysis was performed using JEOL 5610 LV 
and ESEM FEI Quanta 200 F instruments. Wherever needed, the samples were 
gold coated and looked at various magnifications to analyse the microstructure. 
Contact angles measurements (five repeats) were performed on the Vitamin E 
samples using the protocol developed for composites mentioned in Section 3.2. 
The influence of MWCNT on surface roughness (i. e. RMS value) of the 
jai 
1.1 1 
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composites was investigated using surface interferometry measurements, Zygoo 
(Section 3.2). Samples were analysed in duplicate with each sample scanned 
three times. 
5.2.3.2 Mechanical properties: Static tensile tests (five repeats) were 
conducted on the MWCNT containing films in a Perkin Elmer Dynamic 
Mechanical analyser (DMA 7e) at room temperature (Section 3.2). 
5.2.3.3 Protein adsorption study: Protein adsorption was investigated on 
the films containing Vitamin E, employing the protocol described in Section 3.2. 
Analyses were carried out in triplicates. 
5.2.3.4 In vitro bioactivity study: P(3HB) and P(3 H B)/Biog lasso samples 
containing MWCNTs were immersed in SBF to assess the formation of 
hydroxyapatite and to monitor the change in the electrical conductivity of the 
composites upon different days of immersion in SBF. The formation of 
hydroxyapatite was examined using SEM and confirmed by X-ray diffraction 
analysis (experimental parameters mentioned in Section 4.2). Samples at 
different time points of immersion in SBF (15,30 and 45 days) were analysed to 
monitor the differences in the current-voltage (I-V) behaviour of the samples. 
5.2.3.5 Current-voltage (I-V) measurements: IN measurements were 
carried out on MWCNT containing samples to determine the electrical 
characteristics of the samples. Four and two probe dc IN measurements were 
carried out using a picoammeter/voltage source (Keithley 487). Four sharpened 
gold probes were contacted to the composite films. The probe separation 
distance was 5 mm. The IN data were recorded directly via a computer program 
in the voltage range of -0.01 to +0.01 V (step size of 0.002 V). Triplicate samples 
were examined and each sample was tested six times to get a representative IN 
curve from 18 measurements. 
5.2.3.6 In vitro cell culture studies: Cell culture studies were performed on 
the Vitamin E and MWCNT containing composites using the method described in 
Section 4.2. Cell proliferation study using Alamar blue assay and SEM 
observations were carried out for the composites. 
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5.3 Results and discussion 
5.3.1 Protein adsorption and contact angle study of Vitamin E 
loaded P(3HB)/BG samples 
This section discusses the results (i. e. analysis of wettability and protein 
adsorption) obtained on P(3HB)/Bioglasso composites with Vitamin E addition. It 
has been shown that adding Vitamin E (10 wt%) in a polymeric matrix does have 
a significant impact on the surface properties of the samples, when compared 
with low quantity (1-5 wt%) of Vitamin E addition (Reno F et al. 2005). Hence, for 
this investigation only one fixed concentration of Vitamin E (i. e. 10 wt%) was 
added to test the efficacy of its addition on the P(3HB)/Bioglass® system. The 
addition of Vitamin E had no visible impact on the microstructure of the films 
when examined under SEM, as shown in Figure 5.1. However, the effect of 
adding Vitamin E was highlighted through the wettability and protein adsorption 
experiments. Addition of Vitamin E led to a significant increase in the wettability 
of the composites by lowering the water contact angle, as highlighted in Figure 
5.2. The water contact angle for the P(3HB) film reduced from 8614° to 63±2° 
(decrease of 27%, n=5, **p<0.01) as a result of the inclusion of Vitamin E in the 
polymer matrix. A similar trend was recorded for the P(3HB)/20 wt% Bioglass® 
films, wherein the contact angle decreased from 68±6° to 63±3° (7% reduction, 
n=4, p>0.05). It can be thus concluded that the Vitamin E enriched surfaces of 
P(3HB) and P(3HB)/20 wt% Bioglasso composite films were more easily wetted 
than those of the non enriched films of the same kind. The decrease in the 
hydrophobicity of the polymer in turn had a significant effect on protein adsorption 
and cell proliferation behaviour, as discussed in the subsequent sections. Since 
Vitamin E was not coated on the samples and was instead used while making the 
films, there is a high chance that Vitamin E will be present throughout the 
polymeric matrix, which will indeed slow down its diffusion from the composite 
matrix (not evaluated in this project). 
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Figure 5.1 Scanning electron micrographs of (a) P(3HB)/10 wt% Vitamin E film surface and 
(b) P(3HB)/20 wt% Bioglass, 1/10 wt% Vitamin E film surface. 
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Figure 5.2 Water contact angle value as a measure of hydrophobicity for the Vitamin E 
loaded P(3HB) and P(3HB)/Bioglass° composite systems. 
The protein adsorption study using a commercial kit (described in Section 3.2) 
evidenced that the addition of Vitamin E induced statistically higher total protein 
binding capability compared to the samples not containing Vitamin E, as shown 
in Figure 5.3. The amount of total protein adsorbed on P(3HB) and P(3HB)/20 
wt% Bioglass® surfaces was 171±21 FLg/cm2 and 182±20 Etg/cm2, respectively. 
On addition of 10 wt% Vitamin E, the total protein adsorption on the sample 
surface increased to 693±50 pg/cm` (increase of 300 %) and 485±70 pg/cm2 
(increase of 165 %) for P(3HB) and P(3HB)/20wt% Bioglass® composites, 
respectively. Since foetal bovine serum contains a mixture of proteins, it is 
difficult at this stage to quantify each type of protein adsorbed on the surface and 
to identify the affinity of a specific type of protein to the particular surfaces 
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investigated here. A similar experiment conducted on PDLLA/ Vitamin E films by 
Reno et al. (Reno F et al. 2005) demonstrated and that the adsorbed protein is 
albumin, which is also the most abundant plasma protein known to be 
responsible for transport of a wide variety of metabolites, drugs, anionic ligands 
and cations. As stated in Chapter 3, the increase in the protein adsorption may 
arise due to both micro/nano-structural surface changes and due to the increase 
in the hydrophilicity of the surface. In our case, since there were no significant 
microstructural changes induced by Vitamin E addition, the increase of wettability 
(Figure 5.2) seems to be the reason behind the increase in protein adsorption. A 
direct effect of the presence of Vitamin E on the total albumin adsorption cannot 
be excluded, as it has been shown earlier that afamin (one of the four 
constituents of albumin gene family) is a specific binding protein to Vitamin E 
(Voegele AF et al. 2002; Jerkovic L et al. 2005). 
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Figure 5.3 Differences in total protein adsorption on the surface of P(3HB) and 
P(3HB)/Bioglass° films induced by the addition of Vitamin E. 
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5.3.2 Cytocompatibility study of Vitamin E loaded P(3HB)/BG 
samples 
Cell proliferation studies using MG-63 human osteoblast cells were carried out to 
investigate the biocompatibility of the P(3HB)/Bioglass®Nitamin E substrates. 
The trend of the MG-63 cell proliferation over the 7-day period of study is shown 
in Figure 5.4(a). The growth of MG-63 cells on all substrates Increased over the 
observed duration of the study. In Figure 5.4(b), the relative cell proliferation 
(control surface normalised to 100%) of all the samples is presented. The 
conclusions drawn from the cell proliferation results can be summarised as 
follows. (i) There was no significant difference between the control surface 
(standard tissue culture plastic) and the P(3HB) surface, thus indicating the 
suitability of the polymer for hard tissue applications. (ii) Addition of 20 wt% 
Bioglass® to the polymer significantly (n=3, *'p<0.01) reduces the cell 
proliferation when compared with the control surface. This behaviour could be 
attributed to the high alkalinity in the surrounding medium induced by the relative 
high concentration of Bioglass® particles. (iii) Incorporation of Vitamin E in the 
polymeric matrix does not have a significant effect on the cell proliferation, except 
for Day 4 where P(3HB)/10 wt% Vitamin E samples exhibited higher cell growth, 
compared with the control surface (n=3, **p<0.01). Finally, the presence of 
Vitamin E in P(3HB)/20 wt% Bioglass® composites had a positive effect on cell 
proliferation when compared with the P(3HB)/20 wt% Bioglass® composite 
system (n=3, *p<0.05). Examining the surfaces of the samples under SEM for 
cell attachment further validated the quantitative cell proliferation results. In 
Figure 5.5, SEM micrographs highlight the spreading and attachment of the MG- 
63 cells on the surfaces after Day 7, and confirmed the biocompatible nature of 
the Vitamin E loaded composite system. There was no difference observed in the 
cell attachment and spreading between Vitamin E loaded samples and the 
unloaded composite films. There are a few cell culture and biocompatibility 
studies performed on Vitamin E composites (Schubert MA et al. 1996; Sasaki M 
et al. 2000; Mendez JA et al. 2002; Reno F et al. 2004; Reno F et al. 2005), but 
none for Vitamin E containing polymer/bioceramic composite systems. Our 
investigation is the first in this field. Therefore no comparison of our data with 
relevant values by other investigators is possible, which highlights the need of 
future detailed studies exploring the behaviour of such composites in contact with 
relevant cells including the investigation of Vitamin E on angiogenesis. The 
release rate and kinetics of Vitamin E release from the composite also needs to 
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be examined as it might have a profound effect on the initial tissue response to 
the composite (McNally AK et al. 2003). 
Figure 5.4 Cell proliferation study on (a) samples with and without Vitamin E, (b) all tested 
samples relative to the control (control set to 100%). (n=3, *p<0.05, "p<0.01 and "'p<0.001) 
Figure 5.5 SEM micrographs of MG-63 cells grown on (a) P(3HB) (b) P(3HB)/10 wt% 
Vitamin E/20 wt% Bioglass® specimens at day 7 highlighting spreading, attaching and division of 
MG-63 cells. Images of cell growth on P(3HB) and P(3HB)/Bioglass® is shown in Chapter 4. 
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5.3.3 Microstructural examination of MWCNT containing 
P(3HB)/BG samples 
The characterisation of the P(3HB)/Bioglasso composites containing multiwall 
carbon nanotubes (MWCNTs) is presented in this section. As mentioned earlier 
in this chapter, the emphasis was to investigate the electrical properties, 
bioactivity and the biocompatibility aspect of the composites In relation to the 
concentration of MWCNTs. 
The distribution of the fillers, i. e. Bioglass® particles and MWCNTs, is of 
paramount importance not only for improved bioactive behaviour (as discussed in 
Chapter 4), but also for improved electrical conductivity induced by MWCNTs. In 
this case, the sonication method, i. e. using a sonicating probe, was used to 
prepare a stable and well dispersed suspension of MWCNTs (in 
P(3HB)/chloroform solution) (Pirlot C et a!. 2002; Safadi B et a!. 2002; Hilding J et 
a!. 2003). The surface morphology, microstructure homogeneity and uniformity in 
the distribution of Bioglass® particles and MWCNT were evaluated using SEM 
and white light surface interferometry (Zygo®). SEM micrographs showing the 
microstructures of composites with varying concentrations of Bioglass® particles 
and MWCNTs are presented in Figure 5.6. In Figure 5.6(a) the surface 
morphology of P(3HB) films (Sample 1) is shown, followed by the TEM image 
(Figure 5.6(b)) confirming the long entangled and tubular morphology of the 
MWCNTs used in this study. On increasing the MWCNT concentration in the 
polymer matrix the surface appearance of the composite became rougher, 
compared to Sample 1. Bioglass® particles are found to be present on the 
surface of the P(3HB)/Bioglass® composites, without MWCNTs addition, as 
discussed in Chapter 3. However, due to the addition of MWCNTs, the 
concentration of Bioglass® particles on the surface was found to increase, as 
shown in Figure 5.6(e). Although MWCNTs were fairly well distributed throughout 
the matrix, there were also sites of high agglomerations of MWCNTs (Figure 
5.6(d)). 
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Figure 5.6 Scanning electron micrographs of (a) P(3HB) film, (b) MWCNTs used in this 
study, (c) P(3HB)/4 wt% MWCNT, (d) P(3HB)/7 wt% MWCNT, (e) P(3HB)/20 wt% Bioglass®/7 wt% 
MWCNT, (f) interaction of MWCNT and Bioglassc particle for P(3HB)/20 wt% Bioglass®a/7 wt% 
MWCNT, (g) cross section of P(3HB)/20 wt% Bioglass®/7 wt% MWCNT. 
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The addition of MWCNTs played a vital role In Increasing the surface roughness 
of the composites. The RMS value quantifying surface roughness was measured 
using white light interferometry technique (data shown in Table 5.5). In Figure 5.7 
(a-b), the surface roughness map is shown for Sample 5 and Sample 6, along 
with their corresponding 3D profiles. The addition of MWCNTs Increased the 
surface roughness as shown in the Zygo® profile, and this increase in roughness 
is more homogenous over the entire surface. In comparison, for Sample 6 (i. e. In 
presence of Bioglass®) the surface roughness is not homogenous and areas with 
higher relative roughness than other areas on the surface can be seen. The 
increase in surface roughness for the composites was in the order of Sample 
1<Sample 2<Sample 3<Sample 4<Sample 5<Sample 7<Sample 6 f0000t° The 
relative high surface roughness of the MWCNTs containing P(3HB)/Bioglass® 
films can be attributed due to the presence of Bioglass® particles on the surface 
and the direct interaction between the MWCNTs and Bioglass® particles. This is 
further confirmed in SEM observations, particularly in Figure 5.6(f), which 
illustrates the attachment of MWCNTs to the surface of Bioglass® particles within 
the composite. This interaction could be due to the physical interlocking of the 
MWCNTs onto the Bioglasse particles surface, arising due to the irregular 
Bioglass® particle shape and size and their rough surface, thus causing a partial 
enveloping of the Bioglass® particles by MWCNTs. Another reason for the 
increase in the surface roughness might be the potential agglomeration of both 
bioactive glass particles and MWCNTs. Although by sonicating a fairly 
homogenous dispersion of MWCNTs is achieved, it is possible that by allowing 
the films to cast at room temperature for a period of more than 72 hrs the 
MWCNTs start agglomerating in the polymer solution. Therefore, a faster 
evaporation of solvent, for example by using vacuum or higher temperatures, 
could reduce the agglomeration of MWCNTs, as shown in the literature (Wang 
SF et al. 2005). Another way of assessing the distribution of MWCNTs in the 
films is to examine film cross-sections. Figure 5.6 (g) shows the cross-section of 
Sample 6, confirming the embedment of Bioglass® particles in the polymeric 
matrix along with the presence of MWCNTs. 
footnote 
Sample 1: P(3HB) 
Sample 3: P(3HB)/2 wt% MWCNT 
Sample 5: P(3HB)17 wt% MWCNT 
Sample 6: P(3HB) 120 wt% BG /7 wt% MWCNT 
Sample 7: P(3HB) /20 wt% BG /2 wt% MWCNT 
Sample 2: P(3HB)/20 wt% BG 
Sample 4: P(3HBY4 wt% MWCNT 
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Figure 5.7 2D and 3D surface roughness map by white light interferometry (Zygo`) for (a) 
Sample 3 and (b) Sample 6 
5.3.4 Mechanical properties of MWCNT containing P(3HB)/BG 
samples 
MWCNTs have been reported to be useful as reinforcing elements for structural 
support (Cadek M et al. 2004) in composites with both polymers (such as, 
polysulfone, collagen, chitin, PMMA) (Chlopek J et al. 2003; MacDonald RA et al. 
2005; Wang SF et al. 2005; Yang Z et al. 2005; Chlopek J et al. 2006) and 
ceramic matrices (Wood A 2003; Zhao L et al. 2004; White AA et al. 2007). This 
is primarily because CNTs have exceptionally superior mechanical properties, 
e. g. Young's modulus of SWCNTs can be as high as 5 TPa, measured Young's 
moduli of MWCNTs are as high as 1.8 TPa and bending strength can be as high 
as 14.2 GPa (Treacy MMJ et al, 1996; Wong EW et al. 1997). However, to 
achieve effective reinforcing effect by addition of CNTs, these must be well 
dispersed in the matrix and agglomerates must be avoided. The mechanical 
properties of the P(3HB) and P(3HB)/Bioglass"' samples containing MWCNT 
were evaluated through static tensile tests. The presence of MWCNTs in the 
P(3HB) polymeric matrix significantly reduced the Young's modulus (E) of the 
composites, and the decrease in E was directly proportional to the increase in 
MWCNT loading. As can be seen from Table 5.5, the presence of even the 
lowest concentration of MWCNT (i. e. 2 wt%) was enough to reduce the modulus 
(24% reduction) of the composite. The maximum reduction in the Young's 
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modulus was for Sample 6 that contained both MWCNT and Bioglass® particles. 
Increasing the MWCNT concentration in the P(3HB) films also reduced the yield 
strength of the samples (Figure 5.8). However, the drawback in the present case 
has been the reduction in the stiffness of the polymer (marked by the decrease in 
the strain to failure) meaning that the composites are also in fact more brittle than 
the un-reinforced matrix (Wang SF et al. 2005). 
Table 5.5 Mechanical properties, electrical resistance and surface roughness 
measurements for MWCNT containing P(3HB)/Bioglasse composites. 
Samples Bioglass® MWCNT R RMS E 
(wt%) (wt%) (n) (µm) (GPa) 
Sample 1 0 0 >7.5x109 1.7±0.1 1.1±0.3 
Sample 2 0 2 3500 6±2 0.8±0.1 
Sample 3 0 4 1550 7±2 0.77±0.03 
Sample 4 0 7 500 10±2 0.5±0.1 
Sample 5 20 0 >7.5x109 5±1 0.84±0.01 
Sample 6 20 7 -na- 11±2 0.4±0.1 
Sample 7 20 2 -na- -na- -na- 
R= electrical resistance measured in ghms; RMS = root mean square value of the roughness; 
E=Young's modulus 
This behaviour can be explained by the agglomeration of MWCNTs in the 
polymeric matrix, which increases with MWCNT concentration. Agglomerates can 
act as weak interfaces and they represent internal flaws in the material. It can be 
deduced from the mechanical analysis that the possibility of adding less than 2 
wt% MWCNTs can be favourable from the mechanical strength perspective (not 
tested within this framework) and there is a critical value above which the 
MWCNT concentration has a detrimental effect on the mechanical properties of 
the composite films when prepared using solvent casting technique. 
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Figure 5.8 Stress-strain curves for samples 2,3 and 4 highlighting the change in the slope 
of the curves along with the tensile strength of the different samples detailed in Table 5.5. Repeats 
of each sample are shown in same colour. 
A similar observation was made by Wang et al. (Wang SF et al. 2005), showing 
that by dispersing a small fraction of CNTs into a polymer (chitosan), significant 
improvements in the mechanical strength of the composite can be achieved. For 
example, addition of a low quantity of MWCNTs (0.4 wt%) increased the tensile 
modulus and strength by 78% and 94% respectively, compared with the pure 
chitosan films. It was shown in their study that due to the agglomeration effect, 
the increase in the mechanical properties was the maximum for a MWCNT 
loading of up to 0.4 wt% and beyond that the changes were minor (Wang SF et 
al. 2005). Similarly the critical concentration of CNT loading in PMMA matrix was 
shown to be 1 wt%, beyond which the increase in micro-hardness and decrease 
in friction coefficient was minimal (Yang Z et al. 2005). Cadek et al. (Cadek M et 
al. 2004) studied the effect of surface area of SWCNTs on the mechanical 
properties of polymer/SWCNT composites and showed that the increase in 
mechanical property depends on the average diameter of CNTs. 
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5.3.5 Current-voltage (I-V) measurements of MWCNT containing 
P(3HB)/BG samples 
Four point contact current-voltage measurements were carried out on the 
composites to determine their electrical behaviour. It was anticipated that the 
MWCNTs in the polymer matrix would form a conducting network, Imparting 
electric conductivity to the composite. This function should enable contact with 
acquisition electronics for monitoring purposes in an advanced tissue- 
engineering scaffold with sensing function. Figure 5.9(a) shows the resulting IN 
graph indicating that increase in MWCNT loading had a positive effect on the 
amount of electric current that can flow through the composite material. As 
expected, in the absence of MWCNTs, P(3HB) and P(3HB)/Bioglass® films are 
electrically insulating (as confirmed by the straight horizontal line in Figure 
5.9(a)). Moreover the linear IN relationship indicates that the composites with 
MWCNTs are classic ohmic conductors. Increasing the MWCNT loading from 2 
to 7 wt% resulted in a significant decrease in the composite's electrical 
resistance, as shown in Figure 5.9(b). The lowest resistance was measured for 
the composites containing the highest amount of MWCNT, as expected. 
However, the resistance decreases non-linearly with increasing MWCNT loading, 
implying that the conducting network goes through a transition from low 
concentrations to high concentrations. Previously, it has been shown that 
nanotube-polymer composites with a low CNT content exhibit a resistivity 
equivalent to CNTs connected in a series array, whereas in high concentration 
CNT loaded composites the CNTs can be considered to be connected in parallel 
and result in a non-proportionally low resistivity (Watts PCP et al. 2002). This 
behaviour is reflected in our materials as shown in Figure 5.9(b), where the non- 
linearity of the relationship between resistivity and CNT content is manifested. 
Finally, the interaction between MWCNTs and Bioglass® plays an important role 
in the electrical conductivity of the composites. At high concentration of 
MWCNTs, the amount of current flowing is increased in the presence of 
Bioglass®, as evident from Figure 5.9(a). Addition of more MWCNTs obviously 
leads to lower resistance but it might also cause aggregation of MWCNTs in 
large bundles due to attraction forces between tubes (both Van der Waal and 
electrostatic forces), which is not desirable. 
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Figure 5.9 (a) Four-point current-voltage measurements on P(3HB) and P(3HB) based 
composites. (b) Graph showing the decrease in electrical resistance as a function of MWCNT 
content. 
For the developed P(3HB) composites containing MWCNTs, 2 wt% MWCNT was 
found to be well above the critical CNT concentration needed to achieve true 
electrical conductivity (Stauffer D et al. 1992). Although the MWCNT 
concentration required to achieve percolation threshold in the composites was 
not evaluated in this study, but reports on other composite systems have 
achieved the threshold for as low as 0.04 wt% (Grunlan JC et al. 2004) and this 
was raised to 0.3 wt% for CNT containing composites prepared using solvent 
based solution or polymer melt (Kymakis E et al. 2002; Landi BJ et al. 2002). 
5.3.6 Cytocompatibility study of MWCNT containing P(3HB)/BG 
samples 
The ability to induce electrical conductivity in the P(3HB)/Bioglass" composite 
would be of no great significance without examining the biocompatibility of these 
composites. Therefore, a cell proliferation study (Figure 5.10) was conducted on 
all samples (except Sample 7) for a period of up to 7 days, using MG-63 human 
osteoblasts. MG-63 cell attachment and cell spreading was also observed on the 
constructs by examining scanning electron micrographs (Figure 5.11). The cell 
proliferation study shows that MG-63 cells found all the substrates conducive for 
growth. However, some surfaces were relatively "better" as denoted by the cell 
proliferation data. It is well documented (Luthen F et al. 2005; Hansen JC et al. 
2007) that nanotopography plays a major role in cell attachment to the substrate. 
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The increase in the surface area due to the addition of MWCNTs influences cell 
behaviour by utilising the nano-topographical cues. Although MWCNTs are 
hydrophobic and the effect they had on the overall hydrophobicity of the 
composites was not investigated, the increase in roughness due to their addition 
might affect the overall protein adsorption (Webster TJ et al. 1999). The outcome 
of the cell culture study on MWCNT containing materials can be summarised as 
follows. 
(i) The growth of osteoblast cells was observed over the seven-day period of 
study with the maximum cell growth on Day 7 (as Indicated by the pattern of cell 
growth from Figure 5.10(a)). 
(ii) After the initial cell seeding, Day I measurements showed that the cells 
initially did not favour the samples with higher concentration of MWCNTs (n=3, 
**p<0.01) when compared with the control. This result can be possibly due to the 
initial toxic response of the MWCNT (above 2 wt%) containing constructs. 
However, there was no significant difference between the control and Samples I 
and 2 for Day I and Day 4. 
(iii) At Day 4, there was no significant difference between the samples, apart from 
Sample 5 and the control surface. Nevertheless, there was an interesting pattern 
starting to emerge in the proliferation results, i. e. samples containing 2 wt% 
MWCNTs were allowing better cell proliferation compared to samples containing 
higher concentration of MWCNTs. This fact was further cemented by the results 
at Day 7. 
(iv) At Day 7, results showed that there were significantly (n=3, **p<0.01) more 
cells proliferating on Sample 2 compared to the control and on the polymeric 
sample. Whereas for all other samples containing higher amount of MWCNTs, 
there was a significant reduction in cell proliferation compared to the control 
surface (depicted in Figure 5.10(b)). Nevertheless, it can be seen that the overall 
decrease in cell proliferation at any given point of time was not less than 65% of 
the control surface, thus indicating the biocompatibility aspect of the developed 
composites. 
From the cell culture experiments it can be said that there is a MWCNT threshold 
concentration, below which the surface roughness feature dominates over the 
possible toxicity of MWCNTs and above which the toxicity could be predominant 
over the positive influence of nano-structural surface roughness. This fact 
explains the higher cell proliferation results for Sample 2. It should be pointed out 
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however that the results do not allow to infer that 2 wt% is the threshold MWCNT 
concentration because concentrations below 2 wt% were not tested in this study. 
Finally, the experimental results obtained here do not test for the biocompatibility 
or possible cytotoxicity of MWCNTs but on the efficacy of their use in making 
composites. The results do hint however that MWCNTs (in the form of filler) at 
large concentration have detrimental effect on cell growth, a fact also reported in 
the literature for other composite systems (Jia G et al. 2005; Muller J et al. 2005; 
Smart SK et al. 2005). 
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Figure 5.10 Cell proliferation study for 1,4 and 7 days, using Alamar Blue assay on (a) 
P(3HB)/m-BG composites containing different concentrations of MWCNTs, (b) all tested samples 
relative to the control (control set to 100%). The data (n=3; error bars= ±SD) were compared using 
Student's t-test and differences were considered significant when *p<0.05, "p<0.01 and "'p<0.001 
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Cytocompatibility studies (using of fibroblasts and osteoblasts) of CNT reinforced 
polysulfone composites also showed a similar behaviour, wherein a decrease In 
the viability of cells in the presence of CNT was observed (Chlopek J at al. 2006). 
It was also shown in the same study that in the presence of nanotubes there was 
a lack of pro-inflammatory IL-6 cytokine as well as free radicals Induction, 
unchanged release of osteocalcin from osteoblasts and a slight increase in 
collagen (Type I) production. Human osteoblasts when grown on MWCNT 
constructs showed higher metabolic activity compared to the control and the 
metabolic activity negatively correlating with nanotubes diameter (Mwenifumbo S 
at al. 2007). Elias et al. (Elias KL et al. 2002) demonstrated an increase in bone 
cell proliferation, alkaline phosphatse activity and extra cellular deposition of 
calcium for smaller diameter (<100 nm) of carbon nanofibers. Various other in 
vitro investigations have shown that several different cells types can be 
successfully grown on carbon nanotubes or nanocomposites, including blends of 
SWNT with collagen, which were shown to support smooth muscle cell growth 
(MacDonald RA et al. 2005). L929 mouse fibroblasts have been successfully 
grown on carbon nanotube scaffolds (Correra Duarte MA et a/. 2004). The 
nanometric size of MWCNTs has also prompted their use for neuronal growth 
(Hu H at al. 2004; Gabay T at al. 2005) and preferential adhesion of neurons and 
glia cells to the CNT-coated regions (Gabay T et al. 2005) was shown. The 
biocompatibility of CNTs can be further improved by either purifying the CNTs 
(Dillon AC at al. 1999; Andrews R at al. 2001) or by functionalizing the CNTs for 
better cell recognition and used as a growth factor delivery (Lin Y et al. 2004). As 
mentioned above, the literature on CNT compatibility is not one sided and in fact 
there are plenty of reports that show the inflammatory and cytotoxic response 
induced by CNTs (Shvedova A et a/. 2003; Jia G et a/. 2005; Monteiro-Riviere NA 
at al: 2005; Muller J et al. 2005; Smart SK at al. 2005). The above cited examples 
highlight the need to research the cytocompatibility of the P(3HB)/BG/MWCNT 
composites further, by examining the ALP activity, gene expression and collagen 
expression. 
The electrical conductivity of carbon nanotubes may also contribute to directed 
and enhanced cell growth. For example, when an alternating current is applied to 
a polymer (PLA)/MWCNT composite substrate, there has been a 46% increase in 
osteoblast proliferation and >300% increase in calcium production (Supronowicz 
PR et a!. 2002). Also, the up-regulation of Type-I collagen, osteonectin and 
osteocalcin was observed, suggesting the use of these nanocomposites to 
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stimulate bone formation. A similar effect was seen for neurons deposited on 
CNTs that showed a significant increase in network activity in the frequency of 
spontaneous postsynaptic currents (Lovat V et a/. 2005). This aspect of cell 
growth using induced current was not investigated in this project and is set as 
further work to determine the potential of our electrically conducting composite 
system for a wide range of biomedical applications. 
In the midst of debatable tissue response to MWCNTs, one factor that is widely 
accepted is the non-degradability of CNTs, which makes it imperative to look into 
the in vivo effect and transportation of CNTs within the biological system. Singh 
et a!. (Singh R et a!. 2006), used radioactive tracing to monitor the transportation 
of functionalized water-soluble SWCNT labelled with indium and showed that 
SWCNTs are not retained in any of the reticulo-endothelial system organs (liver 
or spleen) in a mice model, and are rapidly cleared from systemic blood 
circulation through the renal excretion route. Moreover, urine excretion studies 
using functionalized SWCNT and MWCNTs followed by electron microscopy 
analysis of urine samples revealed that both types of nanotubes were excreted 
as intact nanotubes. This is a very important finding, which means that MWCNTs 
used in tissue engineering could be removed from the body upon the degradation 
of the scaffold. 
In our investigation, SEM imaging (Figure 5.11 (a-f)), was used to reveal the cell- 
surface interactions and to evaluate the morphological appearance of MG-63 
cells. The cells had a well spread arid flattened morphology for all samples. 
Figure 5.11 (b), (c) and (f) highlight the division of MG-63 cells taking place on 
the substrates (depicted by the globular morphology attached with other cells). 
No significant differences between samples were observed from the cell 
attachment point of view as primarily the cell lines are the same and also 
considering that the MWCNTs are in all cases embedded in the polymeric matrix. 
This is different for the case when cell culture studies are directly on MWCNT 
substrates (Mwenifumbo S et al. 2007). Another feature observed on the SEM 
micrographs is the cell interaction between each other through their filopodia 
(http: //www. answers. com/topic/filopodia), i. e. the cytoplasmic projections 
containing proteins that help them to attach to the surface. 
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Figure 5.11 SEM micrographs highlighting the spreading, attaching, dividing and 
communicating of MG-63 osteoblasts on the substrates after Day 7 when grown on (a) Sample 1, 
(b) Sample 2, (c) Sample 3, (d) Sample 4, (e) Sample 5 and (f) Sample 6. 
For samples key, see footnote' 
Sample 1: P(3HB) 
Sample 3: P(3HB)/2 wt% MWCNT 
Sample 5: P(3HB)/7 wt% MWCNT 
Sample 6: P(3HB) /20 wt% BG /7 wt% MWCNT 
Sample 7: P(3HB) /20 wt% BG /2 wt% MWCNT 
Sample 2: P(3HB)/20 wt% BG 
Sample 4: P(3HB)/4 wt% MWCNT 
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5.3.7 In vitro bioactivity and IN study of MWCNT containing 
P(3HB)/BG samples 
Based on the current-voltage and cell culture studies two different groups of 
composites were immersed in simulated body fluid (SBF) to determine the in vitro 
bioactivity (Sample 6) as well as the changes in the IN characteristics of the 
composites (Sample 2 and 7; Sample 4 and 6). The most important contributing 
factor of Bioglass® to a composite system, apart from the reinforcing effect 
(Chapter 3), is to impart bioactive behaviour (Chapter 4), i. e. to induce the 
formation of a hydroxyapatite layer on the sample, surfaces upon immersion in 
SBF or in actual in vivo situations. Therefore it was important to examine whether 
the addition of MWCNTs had any prohibiting/contributing effect on the bioactivity 
of the composites. 
SEM images of the films after immersion in SBF for 2 months are shown in 
Figure 5.12. The differences in surface morphology of sample 6 before (Figure 
5.12(a)) and after immersion (Figure 5.12(b)) in SBF can be attributed to the 
formation of hydroxyapatite crystals on the surface. EDX analysis of the 
composites surface showed that the composition of the crystals on the surface 
was similar to hydroxyapatite (Figure 5.12(d)). The Ca/P ratio of the layer was 
measured to be 1.5, which is very similar to the value of hydroxyapatite found in 
human bone, i. e. 1.67. Figure 5.12 confirmed thus that the presence of MWCNTs 
did not hinder the bioactivity of the composites, marked by a uniform and 
homogeneous hydroxyapatite formation after immersion in SBF. This is a very 
important finding, if these composites are to find application for development of 
bone tissue engineering scaffolds. Formation of HA crystals on the composite 
surface will eventually induce a strong adhesion strength between the scaffold 
and the surrounding tissue. It is worth mentioning that for the case of Sample 4 
(i. e. P(3HB)/7% MWCNT) there was no bioactivity and structural degradation 
observed over the degradation period. The use of P(3HB) as the polymeric matrix 
is useful in some applications requiring the mechanical competence of the 
scaffold to last long due to the slower rate of degradation of P(3HB) in 
comparison with other synthetic polymers such as PLGA and PDLLA, which have 
been proposed for bone tissue engineering (Rezwan K et al. 2006). This 
behaviour will allow the composite to have a structurally competent matrix for the 
formation of the HA layer and for the incorporated MWCNTs to conduct the 
electric signals. 
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Figure 5.12 SEM micrographs of (a) sample 6 before immersion in SBF, arrow mark 
highlighting the Bioglass® particles and (b) showing the formation of a homogeneous 
hydroxyapatite layer on the surface of the composite after two months of immersion in SBF, (c) 
Sample 4 after 45 days in SBF with MWCNTs marked by arrow and (d) EDX spectrum of sample 6 
after two months, confirming the presence of calcium and phosphorus rich layer on the surface. 
Figure 5.13 illustrates the XRD patterns of the neat polymeric matrix (Sample 1), 
and of the P(3HB)/Bioglassc/MWCNT composite (Sample 6) before and after 
immersion in SBF. It can be noticed that incorporation of MWCNTs does not 
significantly affect the crystalline structure of P(3HB), as supported by the 
observation that the XRD pattern of the P(3HB)/Bioglass°/MWCNTs composite 
keeps the characteristic peaks of neat P(3HB). The formation of HA after 
immersion in SBF can be confirmed from the XRD pattern of sample 6 after 2 
months of immersion, as shown in Figure 5.13. The HA peaks were not observed 
in samples 1,3,4 and 5 due to the absence of Bioglass`. Although the bioactivity 
was not measured during the initial days of the study, but the XRD pattern of 
sample 6 after 2 months strengthens the argument that the presence of 
MWCNTs does not prohibit the bioactivity induced by Bioglass®. This observation 
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confirms the hypothesis tested in this investigation of having an electrically 
conducting MWCNTs containing composite that is able to maintain its bioactivity 
for bone tissue engineering applications. 
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Figure 5.13 XRD patterns of (a) Sample 1 (b) Sample 6 (c) Sample 6 immersed in SBF for 
two months, showing the emergence of hydroxyapatite peaks marked by the arrow and the 
hydroxyapatite markers (vertical lines) 
After confirming the bioactivity, another aspect examined by the in vitro 
degradation study was the change in the IN characteristics of the composite with 
increasing immersion time in SBF. A preliminary attempt was made to examine 
the change in the resistivity of the composites by immersing Sample 4 and 
Sample 6 in SBF for up to 30 days. It was observed that for Sample 4 
(P(3HB)/7% MWCNT) the resistivity of the composites decreased (i. e. the 
substrate proved to be a conducive substrate for flow of current) on increasing 
the immersion time in SBF (Figure 5.14). In contrast, the electrical resistance of 
the Bioglass® containing sample, i. e. Sample 6, increased on prolonging the 
immersion time (marked by the slope of the line i. e. higher slope means less 
resistance). 
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Figure 5.14 IN plot for (a) Sample 4 and (b) Sample 6 after immersion in SBF for 0,15 and 
30 days, indicating the change in the electrical conductivity of the composites. 
Although the results look promising, it must be pointed out that different samples 
were tested at each time point. Hence, the variation in the results could be due to 
intrinsic differences in the samples, and not a consequence of the in vitro 
degradation study in SBF. Therefore, a new method was employed to study the 
change in the IN behaviour of the composites and this time Sample 2 and 
Sample 7 were used. The low MWCNT concentration of 2 wt% was chosen as it 
was found to be enough to induce electrical conductivity and also gave a 
favourable cellular response (cell proliferation), as shown in the cell culture study 
(i. e. Section 5.3.6). 
For this analysis triplicates of Sample 2 and 7 were immersed in SBF for a period 
of 45 days and the samples were unchanged throughout the period of the study. 
The hypothesis tested in this experiment was that the resistivity of the 
composites would increase if the current flow path of the CNT is obstructed either 
by the loss of MWCNTs from the surface or by the blockage of the conducting 
path by formation of HA crystals. Two-point contact I-V analysis of the samples is 
shown in Figure 5.15. The observations from this experiment are as follows. (i) 
There were no significant changes in IN plot for Sample 2, as seen by the 
unchanged slope in Figure 5.15 of the IN graph for the entire study period. This 
gives an indication that there was no obstruction in the electrical flow path by the 
loss of MWCNTs, which further agrees with the fact that P(3HB) degrades very 
slowly in SBF. (ii) In comparison, the I-V plot for Sample 7 changed significantly 
throughout the study period, especially from Day 0 to Day 30. The slope of the I- 
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V data was found to decrease over the time indicating the increase in resistance 
of the composites over time. The explanation for this behaviour can be obtained 
by analysing the microstructure of the films after immersion in SBF (Figure 5.12 
and Figure 5.15). On immersion of the Bioglass' containing composite in SBF, a 
layer of hydroxyapatite grows (as discussed in Chapter 4) on the surface and 
spreads over the surface. HA acts as an insulating path for the flow of the current 
and consequentially envelops the MWCNTs in contact with the surface of 
Bioglass® and the composite. The decrease in the slope indicating the increase in 
resistance over the study period also corresponds to the increase in the level of 
bioactivity (i. e. hydroxyapatite formation) of the Bioglass® composite. Hence, IN 
data can be used to indicate the growth of the hydroxyapatite layer. This finding 
highlights the possibilities to examine this effect in vivo and in real-time. For 
example, the growth of new tissues in vivo could be monitored by the 
measurement of the electrical resistance of the MWCNT containing scaffold, 
while the samples act as a sensor extra corporeally. 
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Figure 5.15 Change in the current-voltage plot over the 45-day period in SBF for (a) Sample 
2 and (b) Sample 6. The change in the slope of the I-V plot for Sample 6 clearly denotes the 
change in the resistivity of the samples, in comparison to Sample 2, which remains unchanged 
over the 45-day period. The IN graph is an average of 18 measurements over triplicates per 
samples. 
Corresponding images of (c) Sample 2 and (d) Sample 6 showing the unchanged surface of 
Sample 2 and the development of hydroxyapatite layer on the surface of Sample 6. (d) Schematic 
diagram showing the enveloping of MWCNTs by growing hydroxyapatite layer 
5.3.8 Multifunctional scaffolds 
After testing the efficacy of adding Vitamin E and MWCNTs to P(3HB)/Bioglass" 
composites in the form of films. P(3HB)/Bioglass® composite foams were 
prepared with 10 wt% Vitamin E and 2 wt% MWCNTs. P(3HB)/ (10 wt%) 
Bioglass® foams were shown to be biocompatible, bioactive and allow 
vascularisation when implanted in vivo (Chapter 4). The composite scaffolds also 
delivered antimicrobial properties, as highlighted in Chapter 4. From the various 
results achieved in this study, the effect of incorporating each additive, viz. 
Bioglass® particles, Vitamin E, and MWCNT has been discussed either in 
isolation or combined in part. It is clear from the results achieved that each 
additive is able to contribute significantly to the overall properties of the 
composite, i. e. Bioglass® particles imparting bioactivity, Vitamin E improving the 
surface wettability and protein adsorption and finally MWCNT inducing electrical 
properties. Therefore in this section preliminary results will be presented on the 
attempt of making 3-D porous scaffolds with all the above-mentioned 
functionalities. The experiments were not designed to show all three functions, 
but they were focussed on investigating the combination of materials to develop 
the concept of "multifunctional scaffolds" for bone tissue engineering. 
5.3.8.1 P(3HB)Nitamin E/Bioglass® foams: P(3HB) and P(3HB)/Bioglass® 
(10 wt%) 3D foams with 10 wt% Vitamin E were prepared by particulate leaching 
method (details in Chapter 3) and the total protein adsorption was measured to 
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examine whether the developed system emulates the observation made on 
P(3HB)/Bioglass°Nitamin E (2-D) films. It was found that there was a significantly 
higher protein adsorption in the foams, e. g. P(3HB) foams=510±210 Eºg/cm3; 
P(3HB)/Bioglasso foams=581±182 ýLg/cm3, as opposed to films, e. g. P(3HB) 
film=171±21 ELg/cm2; P(3HB)/Bioglasso films= 182±20 tag/cm2. This was thought 
to be primarily because of the higher surface area available in the 3-D foams that 
allows higher protein binding/adsorption. Addition of 10 wt% Vitamin E 
significantly increased the total protein adsorption in the foams (n=3; *p<0.05) as 
shown in Figure 5.16, which also correlates to the observation for films (Figure 
5.3). Also by adding Vitamin E the standard deviation of the measurements 
reduced, denoting a uniform distribution of Vitamin E throughout the scaffold 
microstructure. This experiment highlights the possibility of including Vitamin E in 
a 3-D porous composite system and demonstrates for the first time the 
preparation of P(3HB)/Bioglasso composite foams with added antioxidants. 
Figure 5.16 Total protein adsorption for P(3HB) and P(3HB)/Bioglass° foams, with and 
without addition of 10 wt% Vitamin E. 
5.3.8.1 P(3HB)/MWCNT/Bioglassc foams: MWCNTs have been used 
as a coating scaffolds (Boccaccini AR et al. 2007), as a reinforcing agent in 
polystyrene and polyurethane electrospun membranes (Sen R et al. 2003), as 
well as used as porous thin films (Correra Duarte MA et al. 2004). In this study 
P(3HB) foams with MWCNTs (2 wt%) were prepared using solvent 
casting/particulate leaching and the microstructure was examined using SEM. 
The SEM micrographs revealed a rough surface with uneven pore sizes (Figure 
5.17 (a)). However, there was a better degree of pore interconnectivity, which 
should allow for vascularisation and cell proliferation, as shown in Chapter 4. The 
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presence of MWCNTs in the foams is evident from Figure 5.17 (b) and (c), 
wherein the MWCNTs are seen to be present as aggregated bundles. The 
presence of MWCNTs should also reinforce the foam structure, by being properly 
embedded in the polymer struts of the foams, as evident in Figure 5.17 (d). The 
ability to successfully introduce MWCNTs in the foam microstructure highlights 
the potential of using these scaffolds for bone tissue engineering (as verified by 
the MWCNT reinforced P(3HB) films discussed in earlier sections). Preliminary I- 
V studies on the foams also indicated the foams to be electrically conducting. 
However, an optimised distribution of Bioglass"' particles and MWCNTs within the 
scaffolds and their influence on the mechanical, structural and electrical 
properties needs to be investigated. 
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Figure 5.17 SEM micrographs of P(3HB)/MWCNT foams highlighting (a) the microstructure, 
(b) agglomeration of MWCNTs, (c) polymeric phase and MWCNTs agglomeration, and (d) the 
reinforcement achieved by MWCNTs in the polymer. 
The electrically conductive property provided by MWCNTs is advantageous, 
however the use of MWCNTs has to be weighed against the drawback that they 
are not degradable and they could be toxic. Therefore the optimum concentration 
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of MWCNTs in a matrix system has to consider the critical concentration required 
for minimal possible toxicity towards cells, minimal concentration for the 
percolation threshold for electrical conductivity and the lowest possible 
concentration for achieving mechanical reinforcement, as schematically shown in 
Figure 5.18. For biological applications, the concentration of MWCNT should riot 
exceed the threshold concentration above which they may cause damage to 
cells, although the true cytotoxic potential of MWCNT is still being highly debated 
in the literature (Section 5.3.6). 
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Figure 5.18 Graphical representation of the parameters affecting the desired concentration of 
MWCNTs in a polymer matrix system, and possible optimisation of MWCNT loading. 
Cm*= Critical concentration beyond which there is no significant improvement on the achieved 
mechanical properties. 
Ce*= Threshold value of CNT concentration below which there is no significant electrical 
conductivity achieved in the sample. 
Cb*= Critical concentration of CNTs above which there is a toxic response to the surrounding cells 
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5.4 Conclusions 
The results obtained in this chapter highlighted for the first time the efficacy of 
using Vitamin E in a P(3HB)/Bioglass® composite system aimed towards the 
development of improved material system for hard tissue regeneration. The 
results achieved also showed the prospects of combining three materials 
(P(3HB), MWCNTs and Bioglass®) and optimising their concentrations in these 
multifunctional biomaterials for tailored bioactivity, structural and mechanical 
integrity, electrical conductivity and biocompatibility. 
5.4.1 Addition of Vitamin E In P(3HB)/Bioglass® composites: 
The successful results obtained regarding the use of Vitamin E in orthopaedic 
applications were the motivation for the experiments reported In this chapter on 
Vitamin E loaded P(3HB) and P(3HB)/Bioglass® composites. 
" The static contact angle measurements suggested that the incorporation of 
Vitamin E improves the wettability of the samples. 
" Inclusion of Vitamin E in the P(3HB)/Bioglass® samples significantly 
increased the total protein adsorption. 
" The conducive MG-63 cell proliferation results on samples containing Vitamin 
E further confirmed the prospect of using Vitamin E in tissue engineering 
scaffolds. 
5.4.1 Addition of MWCNTs in P(3HB)IBioglass® composites: 
The results highlight the possibility of incorporating electrically conducting 
MWCNTs in a degradable and bioactive P(3HB)/Bioglass® composite system. 
" The electrical properties of the composites improved proportionally to the 
MWCNT content, possibly by producing a three-dimensional electrical conducting 
network. However, the resistance was shown to decrease non-linearly with 
increasing MWCNT content. 
" The presence of MWCNTs in low concentration improved MG-63 osteoblast 
cell proliferation, whereas increasing the MWCNT concentration had an opposite 
effect and caused cell death. 
. The electrical resistivity of the MWCNTs containing polymeric films remains 
unchanged over a 45-day period in SBF. In comparison, the resistivity for the 
samples with MWCNT and Bioglass® increased over the study period 
predominantly due to the growth of hydroxyapatite layer on the surface with 
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increasing time in SBF. The results obtained indicate the suitability of using IN 
measurements as a marker for assessments of polymer's structural degradation 
and bioactivity. 
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6. Conclusions 
6.1 Summary 
The degradable and bioactive P(3HB)/BG composites developed in this research 
have shown the potential to be used in bone tissue engineering applications. This 
multidisciplinary project encompassed a wide range of techniques ranging from 
microbiology and materials science to cell biology. The inclusion of bioactive glass 
nanoparticles into the biopolymer matrix served the dual objective of Improving the 
mechanical properties and inducing nanotopographic surface features. This study 
also showed the possibility of enhancing the existing surface properties of the 
composite materials by incorporation of Vitamin E and inducing electrically 
conducting properties by the addition of MWCNTs. The results highlight the potential 
of developing multifunctional scaffolds capable of providing chemical and physical 
signals to guide cell attachment and spreading, as well as being an electrically 
conducting substrate for monitoring purposes. The most important conclusions from 
each chapter are summarised here along with some recommendations for future 
investigations that will expand the applicability of the P(3HB)/BG composites as 
tissue engineering scaffolds. 
Chapter 1 reviewed the strategy of using a composite approach, based on polymers 
and bioactive inorganic phases, for hard tissue regeneration. A comprehensive 
description of the polyhydroxyalkanoate polymer family and its comparison with other 
synthetic polyesters are presented in this chapter. This chapter also introduced the 
alms and objectives of this research project. 
In Chapter 2 production of P(3HB) from Bacillus cereus SPV using a simple glucose 
feeding strategy is discussed. Upscaling the bacterial growth from 1.0±0.3 to 32±4 g 
was achieved using a 14 L fermentation vessel, which led to an increase in polymer 
production (i. e. from <0.1 to 8±2 g). The study confirmed the potential of B. cereus 
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SPV cells to produce P(3HB) in large scale, with a good volumetric yield. P(3HB) 
was extracted using any of the three investigated techniques and all of them 
produced highly pure polymer enabling a degree of tailorability of its properties (e. g. 
molecular weight). 
The lab produced P(3HB) was further used to prepare composite films with a range 
of different concentration of bioactive glass particles (5-30 wt%) In microscale (<5 
pm) (m-BG) and nanoscale sizes (<50 nm) (n-BG). In Chapter 3, the changes In 
structural, thermal, and mechanical properties induced by the systematic addition of 
n-BG and m-BG particles are presented. Various analyses concluded that addition of 
n-BG particles had an improved effect on the mechanical properties and 
microstructural homogeneity of the composites compared to the addition of m-BG 
particles. For example, addition of n-BG particles increased (up to 57%) the Young's 
modulus, increased the hydrophilicity (up to 58% max. ), improved the total protein 
adsorption (up to 186%), reduced the heat of fusion (up to 25%) and induced 
nanostructured surface topography when compared to the addition of m-BG particles. 
Finally, the preliminary investigation on the microstructure of P(3HB)/bioactive glass 
foams prepared using solvent casting/particulate leaching highlighted the 
interconnected porous network achieved, a high degree of porosity and the ability to 
incorporate bioactive glass particles within the foam's architecture. 
Chapter 4 addressed the bulk of this research study covering the bioactivity and 
biocompatibility of the P(3HB)/BG composite system. The addition of bioactive glass 
particles enhanced the %WA and bioactivity of the composites. The presence of BG 
particles also helped in reducing the molecular weight degradation compared to neat 
P(3HB). The bioactive crystalline hydroxyapatite (HA) layer formation- (<10 µm 
thickness) was confirmed on the composites at an early stage of immersion in SBF. 
The in vitro bioactivity of P(3HB)/BG foams was also confirmed within 10 days of 
immersion in SBF. Cytocompatibility studies highlighted that MG-63 osteoblast-like 
cells can attach, proliferate and differentiate on all P(3HB)/BG substrates 
investigated. P(3HB)/BG foams also showed a highly compatible surface for MG-63 
bone cells proliferation and attachment by allowing the infiltration and migration of 
MG-63 osteoblasts deep into the porous network of the foams. In vivo studies of 
P(3HB) and P(3HB)/BG foams showed a non-inflammatory, non toxic response and 
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confirmed a foreign body reaction when used as subcutaneous implants. 
Vascularisation was achieved in the scaffolds and growth of blood capillaries and 
fibroblasts was present throughout the foams after 7 days of subcutaneous 
implantation. Finally, antimicrobial studies demonstrated that the presence of 
bioactive glass particles in P(3HB) foams significantly reduced the bacterial growth 
and adhesion of Staphylococcus aureus cells on the substrates for the first 24 h. The 
observations made in this chapter highlighted that the advantages of Incorporating 
bioactive glass nanoparticles in a degradable P(3HB) matrix are not only related to 
mechanical reinforcement but also to the ability of n-BG particles to Induce surface 
nanotopography, which can regulate the level of bioactivity and other important 
surface parameters relevant for bone tissue engineering. 
Certain aspects of the relevant properties such as surface and electrical properties, 
surface roughness and protein adsorption of the P(3HB)/BG system were further 
investigated in Chapter 5. The wettability (up to 27% increase) and protein 
adsorption (up to 300% increase) of P(3HB)/BG composites were significantly 
improved by the incorporation of Vitamin E (i. e. a strong natural antioxidant). 
Addition of Vitamin E also improved the MG-63 cell proliferation on P(3HB)/BG 
samples, suggesting that the substrates are conducive for bone tissue regeneration. 
Furthermore, in Chapter 5 the analyses showed the prospects of combining three 
materials (P(3HB), MWCNTs, Bioglass®) in a multi-component scaffold and the 
optimization of MWCNT loading in these multifunctional biomaterials for tailored 
bioactivity, mechanical integrity and electrical conductivity. The electrical conductivity 
and surface roughness of the composites increased proportionally to the MWCNT 
content in the matrix. It was also shown that the bioactivity of the composites was 
maintained upon MWCNT addition. The presence of low concentration of MWCNTs 
improved MG-63 cell proliferation, whereas higher (>2 wt%) MWCNT concentration 
had an opposite effect and caused cell death. The results obtained in Chapter 5 also 
indicate the prospect of using IN measurements as a marker for the assessment of 
P(3H B)/Biog lass" composite's structural degradation and bioactivity. Finally, the 
possibility of incorporating Vitamin E and MWCNTs in the P(3HB)/BG foams system 
was demonstrated in this chapter. 
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6.2 Further work 
On the basis of the achieved results and knowledge gained during this project, it is 
possible to identify potential areas of further research that will provide a 
complete/better understanding of the P(3HB)/bioactive glass composite system. 
1. P(3HB) production: Evaluating the level of endotoxin and comparing it with 
commercial P(3HB). Use of fed-batch culture and optimized fermentation parameters 
to increase polymer yield. Utilising other members of PHA family (mcl-PHA and scl- 
mcl PHA) to prepare composites with wide-ranging mechanical and biological 
properties for tissue regenerative applications. 
2. P(3HB)IBG characterisation: Characterisation (structural and mechanical 
properties) of P(3HB)/BG foams and surface energy measurements. Evaluating the 
effect of porosity on microstructure and mechanical properties of the foams. 
3. Degradation study: Ion dissolution study of P(3HB)/BG composites in SBF 
using ICP-AES and determination of mechanical property (Young's modulus, 
dynamic mechanical analysis) in relation to degradation time. 
4. Biocompatibility study: Evaluation of more biological markers (Collagen I and 
Ca2+ deposition, gene expression using real time quantitative PCR) needs to be 
performed to gain a complete understanding of cell behaviour on the P(3HB)/BG 
surfaces. Use of other immortal osteoblast cell lines (HOS TE85) alongwith 
fibroblasts needs to be considered for evaluating the complete cell response of the 
P(3HB)/BG composites. Implantation of P(3HB)/BG foams directly in bone defects 
and measuring the bone formation and effects on angiogenesis and vascularisation 
of tissue/scaffold constructs is also needed. 
5. Addition of Vitamin E: Examining the release of Vitamin E from the 
substrates. Understanding the effect of Vitamin E on the surface energy of the 
composites and its consequence on ALP activity and osteocalcin expression of MG- 
63 cells. Identifying cell-proteins that may preferentially adsorb on to the substrate 
and also evaluating the antioxidative properties of the composite system. 
6. MWCNT study: Examining the effect of low MWCNT concentration (0-2 wt%) 
on the mechanical and structural properties. Performing ALP and osteocalcin study 
to understand the biocompatible response of MWCNT loaded P(3HB)/BG composite. 
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7. The developed P(3HB)/BG and multifunctional composites should be 
compared for their in vivo behaviour with other similar systems (PDLLA/Bioglass®, 
PLGA/nano-HA) developed in the literature. 
to 
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